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Myc is a crucial regulatory gene capable of altering normal 
cellular proliferation and differentiation. Its mechanism o f action is 
large ly unknown . The c loning and identification of downstream myc 
regulatory targets constitutes a key step towards deeper understanding. 
Beginning with a conditional c-rnyc expression system and a 
physiologic setting where conditional my c expression produced c lear 
phenotypic effects at both cell cycle progression and mRNA expression 
levels, I cloned a set of myc regulated genes. The frequency with which 
myc targets were identified among a panel of cDNAs subject to either up 
or downregulation during Gl of the first cell cycle following serum 
stimulated emergence from growth arrest s uggested that only about one-
third of such genes may be myc targets. Consequently. this work has 
extended the myc target gene c lass to include several extracellular 
matrix proteins, one anaboli c and one catabo li c enzyme, a 
differentiation marker. several important cell proliferation regulators. 
and an assortment of unidentified genes. 
While that c l oning effort was in progress, two groups identified 
max. a gene encoding multiple bHLHzip proteins that can form DNA binding 
oligomers either alone or in a heterotypic complex with myc . After 
incorporating condit i onal max expression into the experimental paradigm 
of conditional myc expression . reexamination of the myc target gene set 
identified individual members that are cooperatively upregulated by myc 
and max and members that are regulated in opposite directions by myc and 
by max. In addition. we made the entirely unexpected observation that 
max is a regulator of a specific subset of the immediate early serum 
response gene class. 
Based on the results of these studies, I propose an integrative 
model accounting for the diverse effects of myc and max on cellular 
function . 
v 
Tabl. ot Content a 
Introduction ...... ... ...... .. .... . . .. .. ...... . ....... .. ..... . . . . 1 
References. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . • . . . • . . . 5 
Chapter 1 Conditional expression of c-myc .. . . ... ..... . ...... 8 
Introduction. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 
Materials and Methods. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 11 
Results. . . . . . . . . . . . . . . . . . . . . . .• . . . . .•. . . . . . . . . • . . . . . . . . . .. 21 
Discussion. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 41 
References . . . . . . . . . . . . . . • . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44 
Chapter 2 Cloning of mid-Gl serum response genes and 
identification of a subset regulated by 
conditional myc expression. . .. .. . ... .. ... . . ........ 49 
Introduction. . . . . . . . . . . . . . . . . . . . . . . . . . • . . . . . . . . . . . . . . . . . . . 50 
Materials and Methods .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53 
Results................ .. . ... . ...... .. .. . . . .. . . . .. . ... . .. . 62 
Discussion. . . . • . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 86 
References. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 92 
Chapter 3 The differential regulatory capacities of 
c-myc and its pairing partner max . ..... .. . . ........ 97 
Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98 
Materials and Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 101 
Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 105 
Discussion. . . . . . . . . . . . . . . . . . . . . . . . . . • . . . . . . . . . . • . . . . . . . . . . 124 
References. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 129 
Con clusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . • . . . .. 134 
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . • . . . . . . . . . . . . . . .. 142 
vi 
Appendix A Towards biochemistry with rnyc and max . .... ......... 144 
Appendix B Dimerization specificity of the leucine repeat motif 
Introduction . .............. .. .... . ......... . . . .. ... .. .. .. . 
Discussion . . .. . ............... . .. ... . . .. . ... . . . .. . .. . .. . . . 
References . .. . . ............. . . . . .. ....................... . 
Appendix C Restriction map comparison programs 








Figur.. and Tabl •• 
Chapter 1 
figure 1.. .. ...... .. ... . ...... .. . . . . ..... ... . . ..... . ... . .. 22 
figure 2 . ........ . .. . . . .... . .. . ... . .... ... ...... ... ...... . 24 
figure 3..... . .... .. . . ......... ... ........ ... ....... . . . ... 27 
figure 4 . . .. .......... .. . . ........... .... ..... . ... . ...... . 29 
figure 5.... .. ... . ....... . .... . . . . .. . . ........... .. .... . .. 31 
figure 6.. . . .. .. . ............ . . . .. . ....... .. .... . .. . ...... 33 
figure 7. . .... .. ..... . .. . ..... .. .. .. . . . . . . . . . . . . . . . . . . . . . . 35 
figure 8.... ... . ... . .... .. . .. . ................... . .. . . .. .. 37 
figure 9...... . ..... . .. .. . .. .......... . .. ... ........ .. . . .. 39 
table 1.... . . .. .. . . .... . .. . . .. . . . .. . . .. . . ................ . 13 
Chapter 2 
figure 1........... . ....... . . . .. ... . . .. .... . . .. . . . ..... . .. 63 
figure 2 ......•....•.• . . . . .. . .... . . . •. ..• . ..... • .. . •.. . . _. 67 
figure 3.. ... . ... ... .. ............ . . ...................... 72 
figure 4 ........ . .. . . . .. . . . ....... ...... .................. 73 
figure 5......... . ........... . .. . .. ..... . . . ... . .... . . .. ... 76 
figure 6. .. . ..... ..... .. ..... . . . . .... . ..... . ... ... .. . . . .. . 82 
figure 7 . . . . . . . . . . ... . . . . . . . . . . . . ... . . . . . . . . . . . . . . . . . . . . . . 84 
table 1...... .. .. . . .... . .. . . .. . ........................... 80 
Chapter 3 
figure 1 ...... . .. . .. . .. ... . . ... . . .......... ................ 113 
figure 2 ...... . . . .. •. . . . .•................... .. ............ 116 
table 1........... ..... . .. .. . .. . .. . .......... . ............. 107 
table 2....... . .. . . .. . .. .... . . .. .. . . . . ... . .. . ... . .... . . .. .. 110 
table 3................ . .. . . .. .... .. . ...... . .. .... . . ... .. . . 122 
viii 
Conclusion 
figure 1 ...... ....•. .... ........ ..... ...• .....•.. ..•• ...... 141 
Appendix A 
figure 1 .. .... . ...... ..... •• • ... . . ..•. . . ........ ....• ...... 146 
figure 2 . ......... ............... ...... ....... .... ....... .. 148 
figure 3 .... ............... •. ... ........ ...... ........ • .... 149 
Appendix B 
figure 1 ............... • . . ... .. .... ........• . . . .• ......... . 159 
figure 2 .. ............... . ....•... . .. ................. ..... 161 
figure 3 ................................................... 163 
figure 4 ..............................................•.... 166 
Appendix C 
programs. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . • . . .. 172 
Appendix 0 




In its most basic form, the eukaryotic cell cycle consists of 
alternating s- and M-phases. That simple osci llation is appropriate for 
cleavage stage embryos where the total mass of the embryo does not 
substant i ally increasei however, such a simple cycle provides no 
opportunity for growth. Addition of Gl and G2 to that basic cycle 
provides pre and post S-phase opportunities for cell growth (Keeton 
1980; Cross et al., 1989). 
At a nontrivial level, progression across the cell cycle phase 
boundaries is controlled by biochemical limitations imposed by the 
presence and relative activity of master regulators of cell cycle 
progression. The G2/M boundary in cellular blastoderm stage Drosophila 
embryos provides a particu l arly c l ean example. Degradation of maternal 
mRNA encoding the Drosophila cdc25 homo log string occurs during cell 
cycle 14. From that point, string mRNA and protein expression occur in 
discrete pulses just before the end of G2 . In the regulatory milieu of 
those cells , conditional expression of transgene string is sufficient to 
drive progression across the G2/M boundary (Edgar and O'Farrell 1990). 
cdc25 family members are protein phosphatases responsible for activation 
of G2 cyclin:cdc2 family MPF (maturation or mitosis promoting factor) 
complexes (Dunphy and Kumagai 1991; Gautier et al ., 1991; Millar et al., 
1991). Frog embryos afford a biochemically homologous system where the 
limitation is at MPF, one step downstream of the cdc25 homolog . Cell 
cycle progression in cleavage stage frog embryos can be arrested in G2 
by inhibiting protein synthesis . Injection of MPF into cycloheximide 
treated frog embryos promotes progression across the G2/M boundary 
(Newport and Kirschner 1984), providing another example of a single 
limiting factor controlling progression across a phase boundary . 
At the biochemical level, progression across the Gl/S boundary is 
less well understood. However, genetic analyses clearly suggest that 
the process is controlled in part by Gl cyclins in analogous complexes 
with cdc2 homologs (Fang and Newport 1991; Koff et al. , 1991; Lewet 
aI.,1991) . 
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In vertebrates, the cells of many adult tissues retain 
proliferative potential, but are arrested in a postrnitotic state termed 
Go (for review, see Pardee 1989) . In the better studied fibroblast 
tissue culture systems, overall RNA and protein synthesis rates in GO 
arrested cel l s are reduced, though a few transcript are upregulated 
following growth arrest , e . g., a-I type 3 collagen (chapter 2). 
Transcription factors that are members of the immediate early serum 
response gene class are generally present at very low levels (Lau and 
Nathans 1987; Alrnendral et al., 1988), and other transcription factors, 
including c-jun homodimer forms of AP-l and the serum response 
transcription factor, are present in relatively inactive forms. 
In GO arrested 3T3 cells, conditional expression of myc family 
(proto)oncogenes is sufficient to drive progression across the GO/Gl 
boundary, through Gl, and into S-phase (Armelin et al . , 1984; Cavalieri 
and Goldfarb 1987; Cavalieri and Goldfarb 1988; Eilers et al . • 1991). 
In the sense of promoting progression across a phase boundary by 
removing the limitation imposed by a single biochemical entity, this 
result is analogous to string and MPF promoted progression across the 
G2/M boundary. However, there is also an important difference. 
Conditional string expression and MPF injection both provide the 
limiting activity in the regulatory milieu in which they normally 
function. On the other hand, conditional myc expression in GO arrested 
cells bypasses the cascade of regulatory events normally following serum 
or growth factor stimulation of cell surface growth factor receptors 
(for review , see Cantley et al., 1991). Thus the conditionally 
expressed protein must function in the absence of other regulators 
normally provided by the immediate early serum response (Lau and Nathans 
1987; Almendral et al.. 1988; Mohn et al.. 1991) (except those that lie 
downstream of it) in the protein phosphatase/kinase balance of the 
quiescent cell . 
c-royc is a member of the immediate early serum response gene class 
(for review, see Bravo 1990). Myc proteins are also members of the 
4 
bHLHzip transcription factor family (for reviews, see Cole 1990i Luscher 
and Eisenman 1990). However, the details of myc family function have 
proven particularly enigmatic. 
protos tomes, so there has been 
Hornologs have not been found among the 
little genetic analysis. Meaningful 
structural analysis followed recognition of their similarity with the 
bHLH and bzip families of transcription factors (for reviews, see Cole 
1991; Prendergast and Zitf 1992). Those same structural homologies led 
to the cloning of max, a gene encoding four bHLHzip proteins that form 
heterodimers with myc family members (Blackwood and Eisenman 1990; 
Prendergast et al., 1991; Makela et al., 1992). 
In this work we identify a spectrum of genes regulated by both myc 
and max, extending the myc target gene class to include several 
extracellular matrix proteins, one anabolic and one catabolic enzyme, a 
differentiation marker, several important cell proliferation regulators, 
and an assortment of unidentified genes. The experimental paradigm used 
in their cloning and identification should greatly facilitate expansion 
of the known members of their target gene class . In addition, this work 
in combination with reverse 
transcription factors will 
regulatory function . 
genetic and in vitro study of the myc:max 
finally allow direct analysis of their 
5 
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Chapter 1 
Conditional expression of c-myc 
Sean V. Tavtigian and Barbara J. Wold 
9 
:Introductio n 
The diverse assays in which effects of the c-rnyc oncoprotein are 
observed s uggest it plays significant roles regulating cell 
proliferation and differentiation. During embryonic development, c-myc 
is strongly expressed in proliferating endodermal and mesodermal tissues 
(Zimmerman et al., 1986; Schmid et al., 1989) . Overexpression and 
deregulation of c-myc are often observed in naturally arising neoplasms, 
and its ectopic expression in transgenic mice vastly increases the 
incidence of a variety of tumors (Leder et 
tissue culture cells, c-myc exerts an 
al . , 1986). Expressed in 
effect on growth factor 
requirements, can drive growth arrested cells into S-phase , antagonizes 
cellular differentiation in some settings, and has been reported to 
modulate gene activity at both transcriptional and post transcriptional 
levels (Prendergast and Cole 1989; for reviews, see Bishop 1986; Cole 
1986) 
The network of biochemical pathways leading from growth factor 
stimulation of a quiescent cell to completion of its cell cycle are 
clearly complex and interactive; present data indicate that several 
distinct signalling pathways proceed via steps involving myc proteins 
(Arrnelin et al ., 1984; Rapp et al . , 1985; Cavalieri and Goldfarb 1988). 
Proliferating fibroblasts synthesize both c-myc RNA and protein 
continuously (Thompson et al., 1985), but their abundance decreases 
dramatically when the cells are arrested in GO . Stimulation of growth 
arrested cells with serum or platelet derived growth factor (PDGF) 
induces c-myc accumulation concomitant with re-entry into the cell cycle 
(Persson et al ., 1985i Thompson et al ., 1985) . A direct role for myc is 
shown when its forced expression in growth arrested cells induces re-
entry into the cell cycle (Armelin et al., 1984; Cavalieri and Goldfarb 
1987) . Furthermore, blockage of myc protein 
stimulation with antisense oligonu cleotides 
progression to S-phase (Heikkila et al., 1987). 
synthesis during serum 
apparently antagonizes 
10 
C-myc has long been postulated to be an important regulator of 
gene activity. Its product is a nuclear phosphoprotein, and the timing 
of its expression following serum stimulation of quiescent cells 
suggests that it acts before initiation of DNA synthesis. The primary 
structure of c-myc shares with the adenovirus Ela proteins and SV40 
large T antigen two copies of a structural motif (Figge et al., 1988), 
required in ras cotransformation assays, which may be either a 
retinoblastoma protein binding site and/or a phosphorylation site (Dyson 
et al. , 1989; Ewen et al. , 1989; Luscher et al. , 1989) . Near its 
C-terminus the protein contains a basic region adjacent to a helix loop 
helix domain, a motif mediating multimerization and DNA binding in a 
number of differentiation effector proteins (Caudy et al . , 1988; Murre 
et al., 1989; Wright et al., 1989). Contiguous with the second loop of 
the helix loop helix domain is a leucine repeat, another structure 
mediating protein multimerization. Among the proteins sharing regions 
of similarity with c-myc are known transcriptional regulators ; current 
data indicate that many are sequence specific DNA binding proteins; 
(Myers et al., 1981; Hauschka and Weintraub, unpublished) 1 Others, 
including the Adenovirus Ela proteins, appear not to require DNA binding 
to exert their regulatory activities (Hoeffler et al., 1988; Reichel et 
al., 1988). 
Here we have established cell lines stably transfected with a 
metal inducible c-myc gene. Conditions were defined under which myc RNA 
and protein levels were effectively regulated. We report the effect of 
transient and prolonged myc induction on the cell cycle and on the 
activity of a series of genes, including several previously reported to 
be targets of c-myc regulation . 
1 Basic helix loop helix domain differentiation effector proteins 
appear to function as heterodimers (Lassar et al. , 1991) I but the 
possibi l ity remains that some structurally related transcription factors 
such as USF/MLTF and AP-4 may function as homodimers (Gregor et al., 
1990 ; Hu et al., 1990). At very high protein concentrations c-myc will 
form DNA binding homodimers, but a recently cloned pairing partner of 
c-myc, max/myn protein (Blackwood a n d Eisenman 1990 ; Prendergast et al., 
1991), preferentially forms DNA b i nding heterodimers with c-myc and 
cooperates strongly with c-myc in ras cotransformation assays. 
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Materiala and mathods 
Re c ombinant p lasmids . Plasmids were constructed essentially 
according to the methods of Maniatis et al . (Maniatis et al., 1982). 
pMyc23c (figure 1) encodes the mouse c-myc proto-oncogene and was used 
to stably transfect NIH 3T3 cells. The plasmid was assembled in several 
steps in pT7T3-18 (Bethesda Research Laboratories, Gaithersburg, MD). 
From 5' to 3', it consists of a 756 bp Tag I - Sac I fragment from the 
MTV LTR bearing a glucocorticoid regulated enhancer (Payvar et al., 
1983), a 218 bp Sac I Bgl II fragment containing the mouse 
rnetallothionein-I promoter (Mueller et al., 1988), a 550 bp Xba I - Sac 
II fragment from the first intron and second exon of the mouse c-myc 
genomic clone lambda myc 5 (Hood and Barth, unpublished), a 922 bp Sac 
II Nsi I fragment containing the remainder of the c-myc coding 
sequence derived from the c-myc eDNA myc 29 (Kim, Mueller, and Wold, 
unpublished), and a 302 bp Hgi AI - Hind III fragment containing the 
poly-A addition signal from the mouse Mt-l gene (Mueller et al., 1988). 
The Taq I site at the 5' end of the enhancer fragment was filled-in and 
ligated to a filled-in Eco RI site within the polylinker , regenerating 
the Eco RI site . The Bg1 II site at the 3 ' end of the Mt-I promoter was 
ligated into the Bam HI site of the polylinker , destroying both sites; 
similarly, the Nsi I - Hgi AI fusion between the 3' end of the rnyc eDNA 
fragment and the 5 ' end of the Mt-I poly-A addition fragment destroyed 
both sites. 
Plasmid pNeo 3, an HSV tk promoted neo construct (Bond and Wold 
1987), was used as a G418 selectable marker in the preparation of stably 
transfected ce l l lines. pRSV lacZ (W. Albert, unpublished) was used as 
an internal control in transient cotransfection assays, as was pMSV CAT-
S (Harland and Weintraub 1985) Plasmid pHHS CAT contained a 1 kb 
fragment of a human hsp 70 promoter (Drabent et al., 1986) which had 
been deleted to +26 and fused to the gene encoding chloramphenicol 
acetyl transferase. 
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The fo l lowing plasmids were assemb l ed in T7 T3 duel promoter 
vectors for synthesizing RNA hybridization probes. pMyc2-XS contains an 
approximately 940 bp Xba I - Sac I fragment spanning the entire second 
exon of c-myc. pMtmyc2-SR contains a 416 bp Sacl - Eco RV fragment from 
pMyc23c including the 5' end of the transcript and extending into c-myc 
sequences. pMycl-HA contains a 122 bp Hind III - Alu I fragment from 
the first exon of c-myc. The Hind III site is located between PI and P2 
(Bernard et al. , 1983) within the c-rnyc promoter. pMHS-SX contains a 
646 bp Sma I - Xba I internal fragment from the mouse HSP 70 eDNA MHS 
2 1 4 (Lowe and Moran 1986). pFos-PP2 contains a 108 bp Pvu II - Pst I 
fragment spanning the 5' end of the c-fos transcript (Van Beveren et 
a1., 1983) . pp53-XA contains a 1005 bp Xho I - Asp 718 fragment from 
the p53 tumor antigen gene (Tan et al. , 1986) . pBS contains an 
approximately 135 bp 3 ' end fragment from a mouse tubulin ~5 eDNA (Lewis 
et al " 1985) from which the po l y-A tract has been trimmed with 
exonuclease Bal 31. peAT-SPII contains a 153 bp Sau IlIA - Pvu II 
fragment from the gene for chloramphenicol acetyl transferase in which 
two lysine codons (3 and 4) were changed from AAA to AAG by a site 
directed mutagenesis. pRSV lacZ-ES contains a 213 bp Eco Rl - Sau 3A 
fragment of pRSV lacZ spanning the 5 ' end of the RSV transcript and 
extending into Lac Z sequences . Unexpectedly, RNase protections of RSV 
lacZ transcripts with the RSV lacZ probe yield two protected fragments. 
One protection product was consistent with a transcript initiating at 
the RSV promoter. The second protected fragment was shorter i its 
structure has not been investigated 
Cell culture . NIH 3T3 cells were maintained in Dulbecco modified 
Eagle medium (DME) supplemented with 10% calf serum (Gibco) or 10% fetal 
calf serum, (Hyclone Laboratories and Hazleton Biologics), as specified 
in individual experiments, 100 U of penicillin G per ml, and 7 . 5 U of 
streptomycin per mI . Cel l s were transfected with a ca l cium phosphate 
co-precipitate of plasmid and carrier DNAs by a standard procedure 
(Wigler et al . , 1979). Using p Neo 3 as a selectable marker, 
13 
Table 1 Probe descriptions. All RNA analyses were solution 
hybridization RNase protection assays. The abundance of the various RNA 
species examined varied widely; the specific activity at which each 
probe species was synthesized was chosen to partially normalize the 
resultant signals, and was held constant from experiment to experiment 
a. Units of sensitivity are: transcripts! x 20 cpm- 1 x cell-1 
b. 
c. 
For transcripts originating 







will protect longer probe 
Because of sequence differences between the MHS 214 probe and 
the MHS 213 and 243 messages, protection of these messages by the 
MHS 214 probe results in a series of bands about 85 nucleotides in 
length. 
d . The BS probe is included in the same hybridization with either 
pS3-XA or RSVlacZ-ES; consequently, either 1 or 4 ug of RNA is 
used per hybridization, respectively . The sensitivity of the 
hybridization is compensated by synthesizing the probe at 4000 
Ci/mMol when 1 ug of RNA is used and synthesizing it at 1000 































































































































































































































































































































































































































































































































































NIH 3T3 cells co-transfected with pMyc23c were initially selected for 
growth in 600 ~g /rnl G418 (Gibeo). After 3 days, the G418 concentration 
was reduced to 400 ~g /rn l, and individual clones were maintained in 200 
J.lg /ml G418. In the first two sets of transfections, relatively fast 
growing clones were chosen for individual analysis, whi Ie remaining 
clones were pooled. Of more than fifteen individual clones checked, 
none synthesized more RNA from the c-myc transgene than from their 
endogenous c-myc gene. In contrast , the pooled cel l lines expressed 
considerably more myc RNA. In a third transfection, slow growing clones 
were deliberately selected. Of 10 clones tested, 4 expressed high 
level s of myc23c RNA. Initial analysis of RNA from these cells using 
probes sensitive to the 5' and 3' ends of the Mtmyc23c transgene showed 
that the predicted myc23c transcript was made. Subsequently, several 
individual myc23c expressing lines were reisolated from the myc23c 
expressing pools. Although the cell lines were initially selected and 
propagated in DME plus 10% fetal bovine serum (Hyclone Laboratories), 
they were transferred to DME plus 10% calf serum (Gibco) for routine 
cell culture through the subsequent experiments. 
Culture in defined medium was essentially as in Zhan and Goldfarb 
(Zhan and Goldfarb 1986), with the modifications noted below . Tissue 
culture dishes (6 cm , 10 cm, and 24 well, Nunc) were first coated with 1 
mg/ml polylysine for 2-3 hours at 37°, rinsed with phosphate buffered 
saline (PBSA) and coated overnight at room temperature with 15 ~g /ml 
bovine fibronectin in phosphate buffered saline . Defined medium (DMI) 
cons i sted of a 3:1 mixture of DME and Ham's F12 (Flow Laboratories, 
McLean, VA) supplemented with 15 roM HEPES pH 7.4, 4 11M manganese 
chloride , 10 11M ethanolamine , 100 nM sodium selenite, 5 I1g /ml 
transferrin, and 500 I1g /ml bovine serum albumin-linoleic acid complex . 
We did not add histidine or hydrocortisone. Hormonal supplements were 
30 ng/ml insulin and 10 pg/ml transforming growth factor B (RD Systems, 
Inc.). We found that l ow concentrations (10 pg/ml is 1/10th the ED50 
for stimulation of soft agar colony formation by NRK fibroblasts 
16 
(Roberts et al., 1985) of TGF- P , which should facilitate assembly of 
exogenous fibronectin (Allen-Hoffman et al.. 1988), improved cell 
survival through the timecourse of the experiments . 
RNA preparation and measurement. For zinc titrations in serum 
con ta i ning media, 10 em plates were seeded with 4xl0 5 cells in 10 ml of 
medium. Forty eight hours later, DME or DME containing ZnS04 was added 
to the concentrations indicated in the figure legend. Volumes added 
ranged from 0.45 to 1.0 mI. Early in this work we noticed that control 
inductions performed by removing the medium and replacing it with either 
new or conditioned medium resulted in transient induction of genes 
including c-rnyc and metallothionein-I. This problem was largely 
eliminated by adding the inducing agents in 5-10% of the volume of the 
medium in the culture dish . Cells were harvested 4 hours later. For 
zinc titrations in defined media, 10 ern polylysine/fibronectin coated 
plates were seeded with lxl0 6 cells. Twelve hours later, cells were 
washed once with PBSA and fed with 10 ml of OMI. Twelve hours later, 
ce l ls were refed with OMI. Twenty four hours later , 3 : 1 OME:FI2 with or 
without zinc was added in the same manner as above . 
For timecourse 
plates were seeded 
inductions, 
with 3T3 
10 em polylysine/fibronectin coated 
cells at 7 . 5x10 5 , or with the myc 
overproducing lines 10-2 or 3-5B at 1.2xl0 6 per plate. Twelve hours 
later cells were cotransfected with a CaP04 co-precipitated mixture 
containing 1 ~g of pMSV CAT-S, 3 ~g of pHHS CAT, 6 ~g of pRSV lacZ , and 
15 ~g of calf thymus DNA. Cells were 10% DMSO shocked 10 hours later, 
then fed with 10 ml of DMI . Cells were refed with OMI 12 hours later. 
Twenty four hours later, cells were induced with the addition of 0.5 ml 
of feta l calf serum or 1 ml of 3:1 DME :F12 with or without 220 ~ ZnS04' 
Cells were harvested according to the timecourse indicated in the figure 
legends. 
RNA was prepared by a modified guanidinium thiocyanate-organic 
extraction protocol. The guanidinium solution was 4M guanidinium 
t h iocyanate, 50 roM Tris pH 7.6, 12.5 roM EDTA , and 2% N-Iaury l sarcosine. 
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Aliquots of this solution were adjusted to 1% 2-mercaptoethanol just 
before use. To harvest RNA from a 10 em culture dish, the cells were 
lysed on the plate in 1 rol of guanidinium solution. The lysate was 
transferred to a 15 ml polypropylene tube and incubated at 60 0 for 5 
minutes. 3 rnl of prewarmed phenol, 3 rnl of chloroform , and 3 ml of 
prewarmed 100 mM sodium acetate pH 4 . 5 were added sequentially at 5 
minute intervals and shaken thoroughly. After addition of the sodium 
acetate the RNA prep was incubated at 60° for 10 minutes and then at 00 
for 10 minutes. Samples were centrifuged at 12,OOOg for 10 minutes at 
4°. The aqueous phase was reextracted with ether. RNA was precipitated 
by the addition of 1 ml of 10 M anunoniurn acetate and 5 . 5 ml of 
isopropanol. The pellet was redissolved in TE (10 mM Tris pH 7.5, 1 mM 
EDTA), transferred to a 1.5 ml eppendorf tube , adjusted to 300 rnM sodium 
acetate, ethanol precipitated, and redissolved in TE. We observed that 
RNA prepared from transiently transfected cells by this method often 
contain enough residual plasmid DNA to result in a significant 
hybridization background. Digestion of portions of the RNA prep with 1 
unit of DNase I per ~g of nucleic acid eliminated this background. 
RNA probes were synthesized essentially as reconunended by the 
enzyme manufacturer. Full length probes were excised from 5% acrylamide 
gels crosslinked with BAC (N , N'-bis-acrylylcystamine, Bio-Rad) and the 
acrylamide was dissolved with 200 mM 2-mercaptoethanol in TE. RNase 
protections were performed by a modification of the procedure described 
by Zinn et, al, (Zinn et al. , 1983). One to 4 ~g of total cellular RNA 
plus tRNA to make a total of 25 Jl9 were coprecipitated with probe . 
Samples were redissolved in 30 Jl l of RNA hybridization buffer, (40 roM 
Pipes pH 6.7, 400 mM NaCl, 1 mM EDTA, 80% formamide) denatu red at 80 0 
for 10 minutes, and hybridized for >12 hours. Probe concentrations and 
hybridization temperatures were optimized so that hybridizations 
proceeded to at least 90% of completion in 12 hours . Hybridizations 
were digested with the addition of 300 ~ l of 1000 Units/ml RNase Tl (US 
Biochemicals) in RNase digestion buffer (10 mM Tris pH 7 . 5, 300 mM NaCl, 
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5rnM ECTA) for 60 minutes at 30 0 , followed by 200 II I of 250 Ilg/m1 
proteinase K, 1% SDS for 15 minutes at 300. Samples were prepared for 
electrophoresis, fractionated on 5% denaturing acrylamide gels, dried, 
and exposed to X-ray film. Handling of samples containing dissolved SAC 
acrylarnide was facilitated by co-precipitating RNA samples and probe out 
of 100 rnM 2-mercaptoethanol, adjusting gel loading buffer to 1% 2-
mercaptoethano l , and using well silanized tubes . 
Immunocytochemical ataining . Cells were grown in Le ighton tubes 
(Costar) . Adherent cells were rinsed with PBS and fixed for 10 minutes 
in buffered 10\ formalin (American Scientific Products). The cells were 
rinsed with PBS and sequentially immersed in: 
acetone , 7 minutesi and PBSA , 10 minutes. 
PBSA, 10 minutes; -20 0 
Immunoperoxidase s taining employed Vectastain ABC kit reagents 
diluted according to the manufacturer's (Vector Laboratories) 
directions. The cells were covered with diluted blocking serum for 20 
minutes prior to 16-20 hour, 37 0 primary antibody incubations in a 
humidified chamber. Six different antibody solutions l oca lized in 
patches were inc ubated on each Leighton tube insert. Anti-human c-myc 
antibodies were prepared against recombinant protein purified from E. 
coli (R . Koski and W. Bryce, unpublished data) . For competiti on 
experiments, antibodies were pre-incubated with recombinant c-myc 
protein for 30 minutes at 37° . Biotinylated a nti-mo use IgG or anti-
rabbit IgG secondary a ntibody incubations were for 30 minutes at room 
temperature. The avidin-biotinylated horseradish peroxidase ABC complex 
was applied to the ce lls f or 60 minute s . The 0.5 mg / ml 3,3'-
diaminobenzidine tetrahydrochlor ide I 0.01% H202 substrate incubations 
were for 6 minutes . The stained cells were immers ed in: H20, 5 
minutes; 95% ethanol, 3 minutes (twice); 100% ethanol, (twice); dipped 
15 times in xylenej and coverslipped with Permount (Fisher). 
DNA Re p1ication Assay.. Poly1ysine/fibronectin coated 24 well 
plates were seeded at a density of 2x104 ce lls per well in 0 . 5 ml of DME 
plus 10% calf serum. Four hours later each well was washed with 1 ml o f 
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PBS and refed with 0.75 ml of DM! . Twelve to 18 hours later the cells 
were refed with 0.75 rol of OM!. Twenty four hours later, 3 :1 DME : F12, 
ZnS04 diluted in 3 : lOME F12. growth f ac t ors , and/or fetal bovine 
serum was added to the wel l s. Volumes added ranged from 15 to 37.5 ~l. 
For zinc and h ormone titration experiments , entry into S-phase was 
monitored by adding 37.5 ~l of 50 uCi / ml tritiated thymidine to each 
well 14 hours after stimulation. In timecourse induction experiments, 
zinc was added as above; subsequent ly, z inc containing media were 
removed at the times indicated in the lege nd, and the cells were washed 
and refed with OMI . Again , tritiated thymidine was added 14 ho urs after 
stimulation. Experiments were terminated 10 hours after thymidine 
addition by washing the ce lls with TBS (50 rnM Tri s pH 7.5, 0.9% NaCl) 3 
times and the n fixing them in 1:1 methanol acetone for 90 seconds. 
After drying, the wells were coated with warmed Kodak NTB4 nuclear track 
emulsion and exposed for 36 hours at r oom temperature before being 
developed. Cell counts were aided by staining nuclei briefly with 1 
fl g / m1 Hoe c h st 333 42, an interco lating fluorescent dye which soa ks 
through dried emulsion efficiently. 
s outhe rn BIot a. DNA was prepared from ce lls scraped from one 10 
cm plate by digesting them in 800 ~ l of 250 ~g /ml proteinase K, 0.5% 
SDS, 400 rnM NaCl, 2 rnM EDTA, 20 rnM Tris pH 7.5 overnight at 550 . The 
digests were phenol ch l o r o form extracted twice, ether extracted once, 
and precipitated by the addition of 125 ~l o f 60% polyethylene glycol. 
The DNA was washed with 100% ethanol and 70% ethanol, dried, and 
redissolved in TE. 
Cellular DNAs were digested with appropriate restriction enzymes 
and fractionated on an 0.8% agarose gel. Aft er denaturation and 
neutralization, the DNA was transfered to Hybond N (Amersham) in 10 X 
SSPE . Filters were baked for 2 hours at 80° . Prehybridization solution 
was 6X SSPE, 50% f ormamide, 1% SDS , 1 mg / ml polyvinylpyrolidone, 200 
fl g / m1 tRNA, 0.1% tween 20, and 10% dextran sulfate. Hybridzatio n 
solution was the same with the addition o f 2xl0 6 cpm/ml of an anti-
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sense RNA probe synthesized from pMyc2-XS at a CTP specific activity of 
400 Ci/mMole. Prehybridization was at 500 for 1 hour, hybridization was 
at 50° for 12 hours, and the final wash was in O.1X SSPE, 0.1% SDS at 
68 0 . 
Welltern Blota . Polylysine/fibronectin coated 6 em plates were 
seeded at a density of 2 . 5-4.0 x 10 5 cells per plate in DME plus 10% 
calf serum. Twelve hours later, plates cells were washed with PBSA and 
fed with 3 ml of DM1 . Twelve hours later cells were refed with 3 ml of 
DM!. Twenty four hours later cells were induced with 300 ~l of 3 , 1 
DME,F12, 150 ~1 of fetal bovine serum (Hazleton Biologics), or 300 ~ l 
of 220 ~ ZnS04 in 3,1 DME,F12. Cells were harvested over a 16 hour 
timecourse as indicated in the figure legend. Cel ls were lysed in 200 
~ 1 of loading buffer (80 mM Tris pH 6.8, 100 mM dithiothreitol , 2% SDS, 
10% glycerol). Cell lysates were frac tionated on acrylamide SOS gels 
and electroblotted to Nitroplus 2000 (Micron Separations). Filters were 
blocked for 2 hours at room temperature in 1X TBS, 0.5% Tween 20, 2% 
BSA. Antibody incubations were in the same solution with the addition 
of 2 ~g/ml anti-myc monoc lonal antibody H60C37 125 1 labelled to a 
specific activity of approximately 100 Ci/mMole. Antibody incubat i o ns 




Preparation and cha rac terization o f c e ll lin. .. We have prepared 
a series of NIH 3T3 cell lines which express a stably transfected, zinc-
inducible c-myc gene . The inducible c-rnyc gene (Mtrnyc23c) (figure 1) 
consists of the glucocorticoid regulated enhancer from murine mammary 
tumor virus and the mouse metallothionein-I (Mt-I) promoter upstream of 
sequences encoding mouse c-myc. The 3' untranslated region of c-rnyc, 
which includes sequences specifying relatively rapid RNA turnover, 
(Jones and Cole 1987; Schuler and Cole 1988), was replaced with the 3 ' 
untranslated region of Mt-I . This plasmid was cotransfected with pNeo3 
(Bond and Wold 1987) into NIH 3T3 cells. G418 resistant clones were 
screened for zinc induced expression of either transgene mRNA or overall 
c-myc protein levels. Two independent transformants are further 
characterized here. 
In initial characterizations of induction conditions, the effects 
of ZnS04, CdS04, and dexamethasone on accumulation of the myc23c and 
endogenous c-myc transcripts were examined . As a control, the 
endogenous ~5 tubulin transcript, expression of which is not expected to 
be affected by the inducing agents, was also monitored. Zinc and 
cadmium induction gave similar results, but the effective concentration 
of cadmium was always significantly lower than the effective 
concentration of zinc. Induction of the myc23c transcript by 
dexamethasone was tested and proved unexpectedly transient and 
inconsistent; the matter was not pursued further. Figure 2 presents 
data comparing transcripts levels in the myc23c expressing cell line 
10-2 with parental NIH 3T3 cells as a function of zinc concentration. 
Growing exponentially in medium containing 10% calf serum (figure 2a), 
the cells tolerated zinc concentrations up to 100 ~M. In 10-2 cells 
basal expression of the myc23c message was easily detected, and its 
abundance increased from about 10 transcripts per cell to several 
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The structural gene has 
been linked to the glucocorticoid regulated enhancer from murine 
mammary tumor virus (Payvar et al., 1983) and the mouse Mt-I promoter 
(Mueller et al., 1988) . The Bam HI / Bg1 II and Nsi I / Hgi AI 
junctions are no longer recognized by the enzymes used in their 
creation. The wavy line denotes the expected transcript initiating 
within the Mt-I promoter and terminating at the Mt-I polyadenylation 
signal . 
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cells contained 2- to 4-fold less endogenous c-myc RNA than parental 3T3 
cells, but their endogenous c-myc RNA levels increased with added zinc 
until they equaled those of 3T3 cells at high zinc concentrations, about 
20 transcripts per cell. The abundance of tubulin ~5 RNA (Lewis et al., 
1985) was essentially invariant within each cell line. Anticipating 
cell cycle progression studies of growth arrested cells, a context which 
provides a clear phenotype from conditional c-rnyc overexpression 
(Cavalieri and Goldfarb 1987i Cavalieri and Go ldfarb 1988), transcript 
levels were examined in cells which had been growth arrested in defined 
medium before treatment with zinc (Zhan and Goldfarb 1986) (figure 2b). 
The pattern of transcript regulation was qualitatively similar. The 
abundance of the myc23c transcript was 2- to 3-fold lower in either the 
presence or the absence of zinc inducer than in ce ll s growing in serum 
containing medium, but remained highly inducible by zinc. As expected , 
both 3T3 and 10-2 cells expressed less endogenous c-myc transcript when 
they were growth arrested than they did while growing exponentially. 
Expression of tubulin ~5 RNA was both reduced and essentially invarient 
across the titration. 
At zinc concentrations above 10 ~ in defined medium or above 40 
I-lM in medium supplemented with 10% calf serum, the abundance of the 
myc23c transcript in 10-2 cells exceeded the abundance of c-myc RNA in 
the control cells. However, the physiological effects of c-myc 
expression presumably depends on c-myc protein, and we could not predict 
a priori the level of rnyc protein that would accumulate from the rnyc23c 
transcripts. Therefore, myc protein levels were monitored by Western 
blot, probing with an iodinated monoclonal antibody to c-myc. Control 
NIH 3T3 cel l s and two myc23c expressing lines, 10-2 and 3-SB, were 
growth arrested in defined medium; c-myc expression in 3T3 cells was 
stimulated with serum while c-myc expression in 10-2 and 3-SB cells was 
stimulated with zinc. In a pairwise comparison of lysates prepared from 
un induced and induced cells (figure 3a) , we found that growth arrested 
3-SB cells (as assayed by 3H thymidine incorporation) contain as much 
24 
Pigure :l . C-myc expression as a function of zinc concentration. A . 
Zinc titration in medium containing 10% calf serum. NIH 3T3 cells and 
myc23c expressing 10-2 cells were seeded on 10 em plates at a density of 
4xlO S cells per plate. Forty eight hours later, the media were adjusted 
to the concentration of ZnS04 indicated at the tops of the lanes (0 -
100 J.1M). Cells were harvested for RNA preparation after 4 hours of 
induction. B . Zinc titration in defined medium. NIH 3T3 cells and 10-
2 cells were seeded and brought to growth arrest as indicated in 
materials and methods. The media were then adjusted to the 
concentration of ZnS04 indicated at the tops of the lanes (0 - 30 J.1M). 
Cells were harvested for RNA preparation after 4 hours of induction. 
tRNA lane: hybridization containing yeast tRNA but no sample RNA . The 
analysis was by RNase protection; data on the probes used to detect the 









NIH 3T3 Cells 10-2 Cells 
Zinc concentration in medium containing lOS calf serum, uM 






75 100 1.. 
---
Zinc concentration in defined medium, uM 












c-myc protein as serum stimulated 3T3 cells, while 10-2 cells express 
about twice as much. In a tirnecourse analysis (figure 3b), accumulation 
of myc protein in zinc stimulated 3-SB and 10-2 cells peaked after 2 
hours of induction, but even after 16 hours of induction was still 
several-fold higher than steady-state uninduced levels. 
Irrununocytochemical staining of cells with anti c-myc monoclonal and 
polyclonal antibodies confirmed the expected nuclear localization of 
c-myc protein synthesized during zinc inductions (data not shown). 
Hyc-da pendent cell cycle progre ssion. We examined c-rnyc mediated 
progression of qui scent cells through Gl to S-phase. Several points 
were of particular interest . First, we wished to demonstrate biologic 
activity of overproduced c-myc in this systemi cell cycle progression 
experiments provide an appropriate assay . Second , previous studies, in 
different cell hosts, have uncovered synergistic cooperation between myc 
overproduction and the activities of specific growth factors; we sought 
to define a cooperative interaction which would increase the magnitude 
of c-myc's regulatory activity in this system . Finally, this inducible 
system afforded the opportunity to examine the duration of c-myc 
expression required to promote entry into S-phase. 
Initial data demonstrated that quiescent 10-2 or 3-5B cells 
stimulated with serum, PDGF, or zinc dependent myc overexpression 
responded by traversing G1 and entering S-phase as expected (Armelin et 
al., 1984; Rapp et al . , 1985; Cavalieri and Goldfarb 1987) . Within each 
cell line, c-myc overproducing cells enter S-phase in response to c-myc 
induction in a dose dependent manner (figure 4a). Surprisingly, 3-5B 
cells, which make substantially less c-myc protein than 10-2 cells 
(figure 3), enter S-phase two to three times more efficiently in 
response to myc induction than do 10-2 cells . 
is regarded a~ inefficient 
cells but an efficient inducer of ~ ~ccumulation 
Classically, PDGF mitogen for 3T3 
(Muller et al., 
1984; Roberts et al . , 1985) . HC/ our hands, 
~"" 
PDGF by itself 
stimulated up to 35% of growth arre cells to reenter the cell cycle 
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Figure 3. Western analysis of zinc stimulated c-myc prtotein 
expression from cells cultured in defined medium . NIH 3T3 cells , 10-2 
cells, and 3-5B cells were seeded, brought to growth arrest, annd 
induced as indicated in materials and methods. The labelling antibody 
was 1251 conjugated anti c-myc monoclonal H60C37 . A. (-): cells were 
mock induced . ( + ) , 3T3 cells were induced by adjusting the medium to 
5% fetal bovine serum. 3-5B and 10-2 cells were induced by adjusting 
the medium to 20 ~ ZnS04. All cells were harvested after 4 hours of 
induction. B . 3-5B and 10-2 cells were harvested over a 16 hour 
timecourse following induction. Cells in the MOH tirnepoint were 
harvested 4 hours after mock induction. The other samples were 
harvested at the times indicated at the tops of the lanes. 
28 
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(figure4C) . EGF and TGF-B by themselves did not stimulate entry into 
S-phase . Also, neither EGF nor TGF-B cooperated with either PDGF or 
zinc stimulated myc expression in this assay (figure 4b) . Although we 
were able to alter growth conditions such that EGF both stimulated cell 
cyc l e reentry by itself and cooperated with just sub-threshold 
concentrations of PDGF (data not shown), we could not define a condition 
where EGF was inneffective by itself but still able to cooperate wi th 
PDGF. 
When zinc pulses ranging in length from one hour to continuous 
exposure were used to induce transient c-myc inductions (figure 5) , the 
number of quiescent cells recruited into S-phase increases with 
increasing duration of c-myc expression at least through the 14 hour 
timepoint. In particular, simulating only the burst of high level c-myc 
expression characteristic of serum stimulated emergence from GO is 
clearly not sufficient to induce these cells to enter S-phase . From 
prior experiments in which the timing of S-phase was determined, we know 
that extending the labelling window past 24 hours of induction does not 
significantly increase the number of cells seen to enter S-phase. 
Consequently, consistent with the timecourse of its expression following 
serum stimulation (see figure 7), we conclude that c-myc activity plays 
an important role through G1, perhaps extending to S-phase. 
RNA analysia during cell cycle progression In this ce l l 
system, c-myc stimulation is sufficient to recruit up to 30% of growth 
arrested cells into S-phase, in this respect resembling the effect of 
PDGF. This raises two substantial molecular level questions. 
whether other regulators , normally 
following serum stimulation , are 
appearing with or before 




overexpression, or are instead recruited by c-myc. A second is what are 
the gene regulatory targets of c-myc, either direct or indirect , and 
which of those are required to induce progression to S-phase. 
To begin to address these questions, we examined the expression of 
genes of established regulatory importance that are subject to induction 
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Figure 5. Tirnecourse of zinc induced DNA replication in 3-58 cel l s . 
Cells were seeded and brought to growth arrest as indicated in 
materials and methods. At t=O, media were adjusted to 20 ~ z inc. At 
the times indicated along the X-axes, zinc containing media were 
removed , and the cells were washed and refed with defined medium 
lacking zin c . Cells were 3 H thymidine labelled , fixed, 
autoradioghraphed, stained, and counted as indicated in materials and 
methods . To combine data from several repetitions of the experiment , 
each data set was n ormal ized to the average of the induced 19 and 24 
hour tLffiepoints within that experiment; each point shown i s the average 
from three independent experiments. Error bars are the sum of one 
standard deviation for the mock induced data and one standard deviation 
for t he zinc induced data at that timepoint. 
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following emergence from growth arrest (c-fos, c-myc, pS3 tumor 
antigen), and genes previously reported to be targets of regulation by 
c-rnyc (mouse HSP 70, transfected human HSP 70). Since it is not an 
endogenous mouse gene, Human HSP 70 was examined by transient 
transfection using MSV CAT and RSV lacZ cotransfected controls. Tubulin 
~5 again served as an endogenous control . 
The expression of our group of test genes was first examined in 
3T3 ce ll s that had been growth arrested in defined medium and then 
stimulated with 5% FBS. An RNA analysis of this experiment is presented 
in figure 6. In terms of the temporal pattern of their regulation, the 
transcripts fell into several groups. As expected, c-fos was induced 
dramatically by the 30 minute timepoint and disappeared within two hours 
of induction . Also as expected, c-myc was induced by one hour, peaked 
at four hours, and was still above basal un induced levels sixteen hours 
after induction. Endogenous HSP 70 , transfected human HSP 70 (HHS CAT), 
transfected MSV CAT, and transfected RSV lacZ all fell into a third 
group; the transcripts were induced by two hours after stimulation but 
had decayed back to basal levels after twelve hours. Finally, the p53 
tumor antigen and tubulin ~5 transcripts formed yet another group; their 
transcripts were induced by two hours after stimulation and then stayed 
at induced levels through the remainder of the timecourse . 
Of these, expression of the HSP 70 transcripts were of particular 
interest because studies from Kingston and colleagues 
1984; Kaddurah-Daouk et a1. , 1987) suggested 
(Kingston et al ., 
that transiently 
transfected Drosophila and human HSP 70 promoters might be targets of 
myc regulation. We first compared the metal response of HSP 70 in 
parental 3T3 cells and 10-2 cells (figure 7). Basal abundances of the 
mouse HSP 70 transcripts MHS 213, MHS 214 , and MHS 245 (Lowe and Moran 
1986) were all on the order of 1-3 transcripts per cell; they were 
induced sharply by zinc at concentrations above 20~ . The pattern of 
expression in parental NIH 3T3 and myc23c expressing 10-2 cell lines was 
qualitatively similar, the only difference being that the response in 
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Figur .. 6 . 
3T3 cells 
Timecourse nalysis of RNA expression in serum induced NIH 
cultured in defined medium. NIH 3T3 cells were seeded, 
transfected, brought to growth arrest, and induced as indicated in 
materials and methods . Cells were harvested for RNA preparation over a 
16 hour timecourse following induction. Cells in the MOM tirnepoint were 
mock-induced and harvested 4 hours later. The other samples were 
induced by adjusting the media to 5% FBS; cells were harvested at the 
times indicated at the tops of the lanes. The samples for the 16 hour 
HHS CAT and 16 hour MSV CAT points were lost . tRNA lane: hybridization 
containing yeast tRNA but no sample RNA. The analysis was by RNase 
protection; data on the probes used to detect the indic ated messages are 
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Figure 7 . Analysis of HSP 70 and metallothionein-I expression in zinc 
induced cells cultured in defined medium. Mouse HSP 70 MHS 214 is 
shown , but MHS 213 and MHS 245 behave similarly . NIH 3T3 cells and 
myc23c expressing 10-2 cells were seeded and brought to growth arrest 
as indicated in materials and methods. The media were then adjusted to 
the zinc concentrations indicated along the X- axes. Cells were 
harvested for RNA preparation after four hours of induction. 
Transcript prevalence data were calculated from densitometer scans of 
autoradiograms of RNase protections. Transcripts per cell was 
calculated as: 
j;>rolected cj;>m lug lolal RNA-I] 
prolected probe activity, cpm mo -I 
X I j.Lg lolal RNA 
50,000 cells 
X 6.02 x 1023 molecules mole-I 
corrected for probe decay over the course of the experiment. CPM 
represented by each band was backca.lcu.lated from a n interna.l standard 
on the ge.l. More accurate.ly , this is a measure of transcr ipts pe r 2Q 
pg of t gt al RNA; in our experience , a reasonable estimate of the RNA 
content of growth arrested 3T3 cells . 
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10-2 cells was shifted to slightly lower zinc concentrations, resulting 
in larger fold inductions at high zinc concentrations. In light of the 
amount of c-rnyc induced in 10-2 cells as the zinc concentration is 
increased form 0 to 20 ~, the similarity in the pattern of expression 
of HSP 70 in the two cell lines does not suggest regulation by c-myc. 
Work by Morimoto and colleagues (Wu et al., 1986) also suggests that HSP 
70 transcription can be induced by zinc through the function of a metal 
response element (MRE) in the promoter; this superficially implies that 
the two types of transcripts should exhibit similar zinc dose response 
curves. However, induction of HSP 70 RNA did not parallel that of Mt-Ij 
instead, in both cell lines . HSP 70 accumulation was abruptly induced at 
zinc concentrations which were near the maximum of the more gradual dose 
response curve of Mt-I . Although the difference between the zinc dose 
response curves of the Mt-I transcript and the mouse HSP 70s could be 
accounted for by very different transcription factor binding affinities 
and cooperativity at the two types of promoters, a more likely 
hypothesis is that physiologic stress resulting from high zinc 
concentrations induces HSP 70 transcription through activation of the 
heat shock transcription factor. 
We proceeded to examine the t imecourse of c-myc and HSP 70 
expression in 3T3, 10-2, and 3-5B cells (figure 8) at 20 JiM zinc, a 
concentration sufficient to drive about 30% of growth arrested 3-SB 
cells through Gl into S phase while eliciting little induction of HSP 
70. Although the MHS 214 transcript was induced up to 5-fold over the 
timecourse of the experiment, slightly more than expected on the basis 
of the experiment in figure 7, its expression did not correlate with 
that of c-myc; indeed, the largest induction of HSP 70 occurred in the 
parental 3T3 cells. There was also no correlation between expression of 
the transfected human HSP 70 transcript and c-myc. Together, these data 
revealed no regulation of HSP 70 attributable to the effect of c-myc. 
Since HSP 70 can be induced by zinc alone, we cannot rule out the 
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I'igure 8 . Tirnecourse analysis of c-myc and HSP 70 transcript 
expression in zinc induced cells. NIH 3T3, 10 - 2, and 3-58 cells were 
seeded, transfected, brought to growth arrest , and induced as indicated 
in materials and methods. Cells were harvested for RNA preparation 
over a 16 hour timecourse following induction. Cells in the " 0" 
timepoints were mock induced and harvested 4 hours later; the other 
samples were harvested at the times indicated along the X-axes. 
A . Expression of the endogenous c -my c and transgene myc23c 
transcripts . Note that the scale for myc 23c is 10-times the scale for 
c-myc. D_ Expression of the endogenous HSP 70 MRS 214 and transfected 
HSP 70 MHS CAT transcripts. Since " transcripts per cell" is rather 
meaningless for a transiently transfected gene, HHS CAT is plotted on a 
dimensionless scale. Transcript prevalence data were calculated from 
densitometer scans of autoradiograms of RNase protections. 
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effect of zinc; however, we prefer the hypothesis that previous reports 
of HSP 70 regulation by c-rnyc were artifactual consequences of cell 
cyc le and stress responses resulting from transient calcium phosphate 
cotransforrnations. 
Expression of c-fos, p53 tumor antigen, tubulin ~5. and 
transfected MSV CAT transcripts were also measured from the RNA samples 
used in the experiment of figure 8 (figure 9) . In all 3 cell lines, 
c-fos RNA was present at less than 1 transcript per cell and did not 
vary significantly with zinc addition. This datum demonstrates that the 
burst of c-fos RNA synthesis following serum stimulation of growth 
arrested cells is bypassed upon c-myc stimulated cell cycle reentry_ As 
in figure 2, endogenous c-myc RNA levels were repressed in 10-2 and 3-5B 
cells relative to 3T3 cells; they were further repressed over the 
timecourse of the experiment in 3-5B cells. While p53 tumor antigen and 
tubulin ~5 were co-regulated during serum stimUlation, they were not co-
regulated here. P53 tumor antigen transcript levels remained steady in 
control 3T3 cells, but they were induced 2- to 3-fold between 4 and 12 
hours after zinc addition in 10-2 and 3-5B cells; expression of tubulin 
~ 5 RNA was near constant in all three cell lines. Induction of p53 
tumor antigen here was not completely unexpected; its timecourse of 
induction following serum stimulation of growth arrested 3T3 cells is 
consistent with the possibility that c-myc might playa regulatory role, 
and p53 tumor antigen is among those proteins which are often 
overexpressed in cells whose growth characteristics have been altered by 
c-myc overexpression (Reich and Levine 1984; Shiroki et al., 1986). 
Expression from the transfected human HSP 70 and MSV CAT were quite 
similar to each other and did not vary with zinc addition in any 
consistent manner. 
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Figur e 9 . Timecourse analysis of transcript expression from zinc 
induced cells cultured in defined medium . NIH 3T3, 10-2 , and 3-SB cells 
were seeded, transfected, brought to growth arrest, and induced as 
indicated in materials and methods. Cells were harvested for RNA 
preparation over a 16 hour timecourse following i nduction. Cells in the 
" 0· tirnepoint were mock induced and harvested 4 hours later. The other 
samples were induced by adjusting the media to 20 ~ ZnS04 i cells were 
harvested at the times indicated at the tops of the l anes . * . the II 0" 
timepoint of the c-myc NIH 3T3 panel was lost . In other experiments, 
this point was indistinguishable from adjacent points . tRNA lane: 
hybridization containing yeast tRNA but no sample RNA . The analysis was 















































































































































































































































Diacu •• ion 
We have prepared and characterized two cell lines that express a 
rnetallothionein promoted c-myc gene. Following treatment with zinc or 
cadmium, induction of endogenous metallothionein I and stably 
transfected myc23c RNA occurred as expected. C-myc protein accumulated 
in the nuclei, and the cells, if they had been growth arrested, 
reentered the cell cycle, traversed GI, and entered S-phase. 
The complexity of the immediate early serum response, the number 
of known or suspected transcription factors regulated by that response, 
and the documented changes in both transcriptional and post 
transcriptional regulation occurring with that response (Lau and Nathans 
1987; Almendral et al., 1988), reasonably imply that c-myc acts in 
concert with other mid Gl regulatory factors. In this light it is not 
surprising that c-myc overexpression by itself is only modestly 
effective in stimulating growth arrested cells to progress through Gl to 
S-phase. 2 The differences between individual cells that do or do not 
initiate DNA synthesis in response to c-myc, the number of obligatory 
steps lying between the role(s) of c-myc and initiation of DNA 
synthesis, and the relative importance of regulatory pathways perhaps 
parallel or perhaps interconnected with those involving c-myc, are all 
presently unknown. While our approach can identify some regulatory 
effects initiated by c-myc alone, those which are co-dependent upon 
c-myc and other cell cycle regulated proteins are less likely be 
observed. 
First, previous work in constitutively overexpressing cell lines 
has demonstrated negative autoregulation by c-myc (Leder et al., 1983; 
Rapp et al.. 1985; Mango et al.. 1989); that effect is observed here. 
Both 10-2 and 3-SB cells express less endogenous c-myc transcript by 
about 2-fold relative to NIH 3T3 cells . 3-SB cells, which show a 
stronger cell cycle response to c-myc overproduction than 10-2 cells, 
2 It remains to be seen whether coexpressed c-myc and max/myn will 
prove significantly more effective than c-myc by itself at recruiting 
growth arrested cells back into the cell cycle . However, max/myn is 
subject to delayed early serum response (Prendergast et al . , 1991) ; 
unless it turns out to be positively regulated by c-myc, its activity 
should become limiting in growth arrested cells which have been induced 
to overproduce c-myc. 
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further repress their endogenous c-rnyc transcript following zinc 
induction . The kinetics of the response, first visible at the 2 hour 
timepoint when c-myc protein levels also peak, suggest that it might be 
relatively direct. 3 
Previous work with transiently cotransfected cells suggested that 
HSP 70s were targets of regulation by c-rnyc. In our work, no purely myc 
dependent induction of either endogenous or transfected HSP 70 genes 
could be observed. Comparison of mouse HSP 70 and transfected human HSP 
70 responses to zinc induction in parental 3T3, 10-2 and 3-SB ce lls at 
zinc levels sufficient to st imulate progression to S-phase in the myc23c 
expressing cell lines (figure 8) revealed no effect attributable to 
c-myc. However , s ince HSP 70 can clear ly be induced by zinc alone, 
probably through stress related activation of the heat shock 
transcription factor, we cannot rule out the possibility that a small 
effect due to c-myc was masked by the larger effect of zinc. 
Comparison of p53 tumor antigen and tubulin ~5 expression provides 
an example of differential regulatory responses to serum and c-myc. 
Both transcripts respond to serum with similar kinetics. P53 tumor 
antigen does n ot respond to zinc in 3T3 ce lls , but it is induced in the 
4 to 12 hour time range following induction of c-myc . In contrast, 
tubulin ~5 responds to neither zinc nor c-myc. Thus the simi l arity of 
the serum response by p53 and tubulin ~5 can be dissected by their 
different responses to c-myc . Thi s suggests that p53 is, directly or 
indirectly , a target of regulation by c-myc, while the serum regulated 
pathway leading to induction of tubulin ~ 5 cannot be directly myc 
dependent. Although reproducible, induction of the p53 tumor antigen 
transcript is relatively modest and delayed with respect to the peak of 
c-myc levels . On the basis of the kinetics and magnitude of its 
response, it seems most likely that p53 is an indirect target, 
reflecting events in the 20-30% of cells that enter S-phase in response 
to c-myc expression. 
On the basis of previously published work, we had expected that 
EGF would augment the cell cycle effect, and presumably the gene 
3 Negative autoregulation of c-myc occurs at the level of 
transcription ini tiation, but the identity (ies) of the transcription 
fact or(s) involved has not yet been determined (Grignani et al., 1990; 
Penn et al., 1990). 
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regulatory effects, of c-myc overexpression. Although we were able to 
observe an interaction between just sub-threshold concentrations of PDGF 
and EGF on quiescent 3T3 cells, no cooperative interaction between c-myc 
and either EGF or TGF-~ was found. The difference between our work and 
previous studies likely arises from differences in the cell lines, 
culture conditions, or purity of growth factor preparations 
In this work we confirmed expected negative autoregulation of 
c-myc and provided evidence that the p53 tumor antigen transcript is a 
target of regulation by c-myc. Working with the hypothesis that the 
activity of c-myc is respo nsible for regulating an identifiable subset 
of the genes induced or repressed in Gl following emergence from growth 
arrest, our data suggest that screening a large number of cDNA clones 
subject to mid Gl induction or repression in similar fashion would 
identify other likely targets of c-myc . While for any individual clone 
there would be no a priori way of knowing how many regulatory steps 
occur between c-myc overproduction and an observed accumulation or decay 
of transcript abundance, isolation of a substantial number of such 
clones should permit definition of one or more pathways invo lving c-myc. 
Identification of such target genes will be central in understanding the 
biological role played by c-myc in regulating the normal ce ll cycle. 
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Chapter 2 
Cloning of mid-G1 serum response genes and 
identification of a subset regulated by conditional myc expression 
Sean V. Tavtigian and Barbara J. Wold 
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:Introductio n 
When exponentially growing NIH or Balb/e 3T3 cells are deprived of 
serum growth factors, cell cycle progression halts after mitosis and the 
cells enter a proliferation arrested state termed GO. Restoration of 
mitogens activates signalling cascades that stimulate emergence from GO 
growth arrest and support further cell cycle progression (for review, 
see Pardee 1989) . Exit from GO initiates a specialized and temporally 
protracted Gl phase. 
Progression across the GO/Gl boundary is characterized by rapid, 
robust, protein-synthesis-independent up-regulation of transcription 
from a set of genes termed the immediate early serum response genes (Lau 
and Nathans 1987; Almendral et al., 1988; Mohn et al., 1991). Prominent 
among the immediate early response genes are known or suspected 
transcription factors of the AP-l, myc, nuclear receptor, and zinc 
finger families (for review, see Bravo 1990). Their synthesis at the 
GO/Gl transition suggests that they lead a transcriptional regulatory 
cascade important for progression through Gl . From a cell biological 
perspective, an important next step is to identify the targets of these 
regulators and eventually define the individual and collective roles 
played by these targets in executing progression through Gl and into S-
phase. From a more molecular perspective , further understanding of the 
immediate early regulators centers on learning how they stimulate or 
repress expression of their target genes. Knowledge of physiological 
targets of the immediate early regulators is presently very limited , and 
one goal of this work was to expand the repertoire of candidate 
physiological targets . The paucity of targets has been especially acute 
for myc family regulators , and these are of particular interest to us . 
Consequently , a second goal of this work was to identify genes affected 
by conditional myc expression in the context of GO -t S progression. 
c-myc contains a prominent region of sequence similarity with 
other transcription factors, the basic/helix-Ioop-helix/leucine repeat 
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(bHLHzip) motif. In other bHLHzip proteins, this motif governs 
protein: protein 01 igomerizat ion and DNA binding, and its presence 
suggests by analogy that myc functions as a component of an oligomeric 
transcription factor . This prediction was supported when it was shown 
that the bHLHzip bearing C-terminal fragment of c-rnyc can , at very high 
concentrations, form homodimers with DNA binding specificity for the E 
box sequence CACGTG (Blackwell et al., 1990). In addition , fusion of 
the c-myc basic region, its candidate DNA binding domain, with the HLH 
dimerization domain of E12 resulted in a chimeric protein that 
efficiently formed homodimers with myc-type DNA binding specificity 
(Prendergast and Zitf 1991). A major recent breakthrough was the 
cloning of a natural pairing partner of c-myc, max/myn protein 
(Blackwood and Eisenman 1990; Prendergast et al. , 1991). Like c-myc, 
max/myn is a bHLHzip protein. The two proteins form DNA binding 
heterodimers efficiently in vitro and are associated in vivo (Wenzel et 
al., 1991; Blackwood et al., 1992). Functional studies of max/myn are 
at a very early stage, but the presence of max/myn has recently been 
shown to augment the activity of c-myc in the activated ras 
cotransformation of secondary rat embryo fibroblasts to the growth 
transformed phenotype, although max/myn alone cannot (Prendergast et 
al. , 1991). 
In an immortalized but non-tumorgenic cell environment such as 
that of NIH or Ba1b/c 3T3 cells, the patterns of immediate early 
expression of c-myc and delayed early expression of max/myn (Prendergast 
et al . , 1991) suggest that the activity of a putative c-myc:{max/myn) 
heteromeric transcription factor will be stimulated by serum and will 
peak during the extended G1 that follows. This leads to the hypothesis 
that myc, in association with max/myn or some similar partner, is 
responsible for regulating an identifiable subset of the genes that are 
induced or repressed following serum stimulated emergence from growth 
arrest. Moreover, in the absence of serum factors, ectopic conditional 
expression of myc is sufficient to drive GO arrested cells through Gl 
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and into S-phase (Arrnelin et al., 1984; Cavalieri and Goldfarb 1987; 
Eilers et al., 1991), implying that among targets of irrunediate early 
regulators those that can respond to rnyc are functionally sufficient to 
drive progression. Following these lines of reasoning, we have prepared 
eDNA libraries from growth arrested and mid-Gl serum stimulated 3T3 
cells , differentially screened those libraries with corresponding eDNA 
probes, and obtained a panel of eDNA clones subject to either up- or 
down-regulation with rnid-Gl kinetics. Previously, we had constructed 
cell lines that conditionally overproduce c-myc in response to treatment 
with zinc and, following growth arrest, progress through Gl in response 
to c-myc overproduction (see chapter 1). In combination with 
conceptually similar cell lines expressing a c-myc estrogen receptor 
fusion (Eilers et al., 1989; Eilers et al., 1991), these cell lines here 
served as sources of RNA with which to screen the panel of serum 
regulated clones for their response to myc under conditions where myc 
overproduction drives progression from GO through S-phase. 
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Katerial. and Met hoda 
Recombinant p lasmida used i n stabl e t r ansfections . Plasmids were 
constructed essentially according to Maniatis (Maniatis et al., 1982). 
Plasmid myc23c encodes the mouse c-rnyc proto-oncogene and was used to 
stably trans feet NIH 3T3 cells. The plasmid was assembled in several 
steps in pT7T3-18 (Bethesda Research Laboratories, Gaithersburg, MD) . 
From 5' to 3' , it consists of a 756 bp Taq I - Sac I fragment from the 
MTV LTR bearing a glucocorticoid regulated enhancer (Payvar et al .. 
1983), a 218 bp Sac I Bgl II fragment containing the mouse 
metallothionien I promoter (Mueller et al., 1988), a 550 bp Xba I - Sac 
II fragment from the first intran and second exon of the mouse c-myc 
genomic clone lambda myc 5 (Hood and Barth, unpublished) , a 922 bp Sac 
II Nsi I fragment containing the remainder of the c-rnyc coding 
sequence derived from the c-rnyc eDNA myc 29 (Kim, Mueller, and Wold , 
unpublished), and a 302 bp Hgi AI - Hind III fragment containing the 
poly-A addition signal from the mouse Mt-1 gene (Mueller et al., 1988) . 
The Taq I site at the 5' end of the enhancer fragment was filled-in and 
ligated to a filled-in Eco RI site within the polylinker, regenerating 
the Eco RI site. The Bgl II site at the 3' end of the Mt-I promoter was 
ligated into the Bam HI site of the polylinker, destroying both sites; 
similarly, the Nsi I - Hgi AI fusion between the 3' end of the myc cDNA 
fragment and the 5' end of the Mt-I poly-A addition fragment destroyed 
both sites. 
Plasmid pNeo 3, an HSV tk promoted neo construct (Bond and Wold 
1987), was used as a G418 selectable marker in the preparation of stably 
transfected cell lines. 
Cell culture . At the outset of this work, NIH 3T3 cells and c-myc 
transfected derivitives were maintained in Dulbecco's modified Eagle 
medium (DME) supplemented with 10% fetal bovine serum (Hyclone 
Laboratories), 100 U of penicillin G per ml, and 7.5 U of streptomycin 
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per ml. Cells were transfected with a calcium phosphate co-precipitate 
of plasmid and carrier DNAs by a standard procedure (Wigler et al" 
1979). Using pNeo 3 as a selectable marker, NIH 3T3 cells co-
transfected with pmyc23c were initially selected for growth in 600 ~g/ml 
G418 (Gibeo). After 3 days, the G418 concentration was reduced to 400 
~g/rnl, and individual clones were maintained in 200 ~g/ml G418. In the 
first two sets of transfections, relatively fast growing clones were 
chosen for individual analysis, while remaining clones were pooled . Of 
more than fifteen individual clones checked, none synthesized more RNA 
from the myc23c transgene than from their endogenous c-myc gene. In 
contrast, the pooled cell lines expressed considerably more myc RNA. In 
a third transfection, slow growing clones were deliberately selected. 
Of 10 clones tested, 4 expressed high levels of the myc23c mRNA . 
Initial analysis of RNA from these cells using probes sensitive to the 
5' and 3' ends of the myc23c transcript showed that the predicted 
transcript was made. Subsequently, several individual myc23c expressing 
lines were reisolated from the myc23c expressing pools. 
For cell cycle progression work and RNA preparation, NIH 3T3, 
c-myc transfected derivitives thereof, and Balb/c 3T3 cells were 
maintained in DME with 15 roM hepes (Irvine Scientific) supplemented with 
10% calf serum (Gibco) and Ix glutamine penn strep (Irvine Scientific). 
For experiments comparing Balb/c 3T3 cells with Balb/c 3T3 derived c-myc 
estrogen receptor fusion protein expressing MER #6 cells, both were 
maintained in phenol red free DME supplemented with 5% calf serum 
(Gibco), 2 roM Hepes free acid, and 1x glutamine penn strep (Irvine 
scientific) . 
Culture in defined medium was essentially as in Zhan and Goldfarb 
(Zhan and Goldfarb 1986), with the modifications noted below. Tissue 
culture dishes (15 cm and 24 well , Nunc) were first coated with 
polylysine (1 mg/ml in H20 , Sigma) for 2-3 hours at 37°, rinsed with 
phosphate buffered saline (PBSA) and coated overnight at room 
temperature with bovine fibronectin (15 ~g/ml in PBSA, Sigma). For cell 
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cycle progressi o n wo rk and RNA preparation, defined medium (DMI-2) 
consisted of DME F-12 hepes (Flow Laboratories), 4 JlM manganese 
c hloride, 10 ~M ethanolamine, 100 nM sodium se lenite , Ix g lutamine 
(Irvine Sc i e ntific) , 5 ~g/ml a pot ran s ferrin, a nd 500 Jl9/m1 bovine serum 
albumin-linoleic ac id complex (S igma). Hormo nal supplements were 30 
ng /ml insulin and 10 pg/ml TGF-P (RO Systems, Inc) . We found that l ow 
concentrations (10 pg/ml i s l / lOth the EDSO for stimulation o f soft agar 
colony formati on by NRK fibroblasts) of TGF- P, which should fac ilitate 
assembly o f exogenous fibronectin (Allen-Hoffman et al., 1988), improve d 
ce ll surviva l through the timecourse of the exper iments . We did not add 
hi s tidine or hydrocortisone . 
For experiments compar ing Balb/c 3T3 cel l s with MER #6 ce ll s , 
defined medium (DMI-3) con s i sted o f 1:1 phenol red free DME a nd phenol 
red free F1 2 (Gibco) , 10 roM Hepes pH 7 .2, 4 ~ manganese ch l or i de, 10 ~ 
ethanolamine, 100 nM sodium selenite , 1x glutamine / O. lx penn strep 
(Irvine Scientific), 5 ~g/ml a po transferrin (Sigma), 500 ~g/ml bovine 
serum albumin-linoleic ac id complex, 30 ng /ml ins ulin, and and 10 pg / ml 
TGF-P· 
RNA Preparation Polylysine/fibronectin coated 15 em plates we r e 
seeded at a density of 3xl 06 cells per p l ate in 25 ml o f OME plus 1 0% 
calf serum. Twelve ho urs later the cell s were washed with PBS and fed 
with 25 ml of OMI. Twelve ho urs later the ce lls were refed with 25 ml 
o f OMI. Twenty four hours later the ce ll s were serum induced with the 
addition o f FBS to 1 0% final concentration, z inc induced with the 
addition of various concentrations of zinc sulfate in OME phosphate free 
hepes (Irvine), or mock induced with the addit i on of an app r opr iat e 
v o lume of OME phosphate free hepes . 
Whe n RNA was intended for library or probe preparation, cel ls were 
harvested in 5M guanidinium thiocyanate, 50 roM Tri s pH 7.5, 12.5 rnM 
EDTA, 2% N-lauryl sarcosine , and 1% 2-mercaptoethanol. Lysa tes were 
adjusted t o 1.5 ~g/ml ethidium bromide a nd an approximate density o f 1 . 6 
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g/ml with CsTFA. Lysates were spun at 41,500 rpm for 30 hours in an 
SW55 rotor , the RNA band was withdrawn, ethanol precipitated twice, and 
red i ssol ved in TE (Mirkes 1985). 
When RNA was intended for RNase protections, cells were harvested 
in 4M guanidinium thiocyanate, 25 roM sodium citrate pH 7.0, 0.5% N-
lauryl sarcosine, and 100 mM 2-mercaptoethanol . 0.1 volumes of 2M 
sodium acetate pH 4.0 , 1 volume of phenol, and 0.2 volumes of chloroform 
were added sequential l y with vigorous mixing following each addition. 
The preparations were chilled in an ice bath for 15 minutes and then 
centrifuged at 10,000 rpm for 10 minutes at 4° in an SS34 rotor. The 
aqueous phase was reextracted with 1 volume of 1 : 2 phenol:chloroform, 
precipitated twice , and redissolved in TE (Chomczynski and Sacchi 1987). 
cDNA Clo n e Sele ction and Management . Cloning: (1) Poly A plus 
RNAs were prepared from growth arrested and 8 hour serum stimulated 
Balb/c 3T3 cells. (2) First strand cDNAs were eventually used as 
probes. Hemimethy l ated double stranded cDNAs were directionally cloned 
into the vector A EXLX+ (Palazzolo et al., 1990) (3) Biotinylated cRNA 
prepared by transcribing phage library DNAs en masse was hybridized to 
the first strand RNA; biotin cRNA from the growth arrested library was 
hybridized to serum stimulated cDNA and biotin cRNA from the serum 
stimu l ated library was hybridized to growth arrested cDNA . 
Heteroduplexes and unhybridized cRNA were removed with the addition of 
streptavidin followed by phenol extraction. (4) The resultant 
subtracted cDNAs were 32p labelled by priming with random nonamers and 
extending with T7 DNA polymerase. A -backprobe- was generated by 
similarly labelling a limited collection of serum regulated c l ones plus 
clones selected in preceeding rounds of library screening [see step 6]. 
(5) A. libraries were plated at a density of 1000 plaques per 15 cm 
plate . Three lifts were made from each plate. One lift was probed with 
the growth arrested subtracted probe , a second lift was probed with the 
serum stimulated subtracted probe , and a third lift was probed with the 
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backprobe. Plaques differentially hybridized to by the first and second 
probes and not l abel l ed by the backprobe were picked for further 
analysis . (6) eDNA inserts were peR amplified from primary p l aques 
using primers based on flanking vector sequences. The 3 ' end primer was 
32p labelled, resulting in 3 ' end labelled cDNAs . After gel 
purification, fragments were sUbjected to partial restriction digest 
mapping from their 3' ends with Hae III , Hin fI, and Sau 3A. 
Restriction maps were compared by computer ana lysis (appendix C) . Where 
a mRNA species was represented by more than one clone, only the longest 
corresponding eDNA was used for further analysis. cDNAs from this level 
of analysis were combined for use in the backprobe [see step 4]. The 
rnid-Gl l ibrary was screened through 6 rounds of 6 plates each, while the 
growth arrested library was screened for two rounds of 6 plates. 
Characterization ! (1) cDNA bearing plasrnids were excised from 
primary A clones by a cre-lox recombination system (Palazzolo et al ., 
199 0) . Where more than one c DNA was obtained from the primary plaque, 
they were all maintaind for further analysis . (2) cDNAs were dideoxy 
sequenced from their 5' ends. (3) Resultant sequences were used to 
generate restriction maps as well as for seqence homology searches of 
GENBANK and EMBL using the program BLAST (Altschul et al., 1990) . (4) A 
5 ' end fragment from each cDNA was subcloned into a duel polymerase 
promoter plasmid to generate a riboprobe template. (5) The timecourse 
of expression of each RNA in serum stimulated NIH 3T3 cells was checked 
by ribonuclease protection . (6) Expression of those clones subject to 
serum regulation with mid-SR kinetics was further characterized in the 
conditional myc expressing ce ll lines 3-5B (see chapter 1) and MER #6 
(Ei l ers et al., 1989; Eilers et al., 1991). 
peR cloning. Probes for the transcripts Gl cyclin 02, prothymosin 
a , and max /myn were c l oned by amplification from first strand cDNA. peR 
primers were : 
Cy 02 5 ' , 
Cy 02 3', 
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GCG GAA TTC TGG ATG CT(C/Gj GAG GT(A/C/G/Tj TG(C/Tj GA 
CGC GGA TCC IGC (A/C/G/TjA(A/C/G/Tj GAA GGT CTG IGC ITG 
(C/TjTT 
prothymosin a 5', CGC GAA TTC ATG TCA GAC GCG GC(A/C/G/Tj GT(A/C/G/Tj 
GA 
prothymosin a 3 ' , CGC GGA TCC CTG CTT CTT GGT (C/TjTC (A/C/G/TjAC 
(G/AjTC 
max/myn 5', GCA GAT CTG CCA CCA TGA GCG ATA ACG ATG ACA T(C/TjG A(G/AjG 
T 
max/myn 3' , GCG TCG ACT CAG CTG GCC TCC ATC CGG A(G/Aj (C/Tj TT(C/Tj TT 
Prothymosin a and Gl cyclin D2 fragments were cloned as Eco RI -
Bam HI fragments into duel promoter vectors to serve as riboprobe 
templates. A Bg1 II (peR generated site) - Sma I fragment from the 5' 
end of max/myn was subcloned for the same purpose. 
Other ribopro be template • . Several other duel promoter plasrnids 
were prepared for use as riboprobe templates in the work. pmyc1-HA 
contains a 122 bp Hind III - A1u I fragment from the first exon of 
c-myc . The Hind III site is located between PI and P2 (Bernard et al., 
1983) within the c-myc promoter. pmyc2-XR contains a 192 bp Xba I -
Eco RV fragment starting near the 3 ' end of the first intron of c-myc 
and extending into the second exon. pMHS-SX contains a 646 bp Sma I -
Xba I internal fragment from the mouse HSP 70 eDNA MHS 214 (Lowe and 
Moran 1986) . pfos-PP2 contains a 108 bp Pvu II Pst: I fragment 
spanning the 5 ' end of the c-fos transcript (Van Beveren et al., 1983). 
pp53-XA contains a 1005 bp Xho I - Asp 718 fragment from the p53 tumor 
antigen gene (Tan et al., 1986). p~5 contains an approximately 135 bp 
3' end fragment from a mouse tubulin ~5 cDNA (Lewis et a1., 1985) from 
which the po1y-A tract has been trimmed with exonuclease Bal 31. 
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RNA Me aaur8ment . RNA probes were synthesized using T7, T3, or SP6 
RNA polymerase essentially as recommended by the enzyme manufacturer. 
Full length probes were excised from 5% acrylamide gels crosslinked with 
BAC (N,N'-bis-acry l y l cystamine, Bio-Rad) and the acrylamide was 
dissolved with 200 mM 2-mercaptoethanol in TE. RNase protections were 
performed by a modification of the procedure described by Zinn et al . 
(Zinn et al., 1983). One or two ~g of total cellular RNA plus tRNA to 
make a total of 25 I1g were coprecipitated with probe. Samples were 
redissolved in 30 Jl l of RNA hybridization buffer, (40 roM Pipes pH 6.7, 
400 roM NaCl , 1 mM EDTA, 80% formamide) denatured at 80 0 for 10 minutes . 
and hybridized for >12 hours . Probe concentrations and hybridization 
temperatures were optimized so that hybridizations proceeded to at least 
90% of completion in 12 hours . Hybridizations were digested with the 
addition of 300 ~l of 1500 Units/ml RNase T1 (BRL) in RNase digestion 
buffer (10 mM Tris pH 7 . 5, 300 mM NaCl, 5mM EDTA) for 60 minutes at 300 , 
followed by 200 ~l of 250 ~g/ml proteinase K, 1% SDS for 15 minutes at 
30 0 . Hand l ing of samples containing dissolved BAC acrylamide was 
faci l itated by co-precipitating RNA samples and probe out of 100 roM 2-
mercaptoethanol and using well silanized tubes. Samples were prepared 
for electrophoresis, fractionated on 5% denaturing acrylamide gels, 
dried, and exposed to X-ray film . Count per minute data were also 
obtained from dried gels on a phosphor imager (Molecular Dynamics) and 
converted to transcript per cell data using internal CPM standards. 
DNA Replication Assays . For experiments with NIH 3T3 and 3-5B 
cel l s , Po l ylysine/fibronectin coated 24 well plates were seeded at a 
density of 2xl0 4 cells per well i n 0.5 ml of DME p l us 10% serum. Twelve 
hours later the cells were washed with PBS and fed with 0 . 75 ml of OMI. 
Twelve hours later the cells were refed with 0.75 ml of OM! . Twenty 
four hours later the cells were zinc induced with the addition of 
various concentrations of zinc sulfate in DME phosphate free hepes 
(Irvine) , mock induced with the addition of an appropriate volume of OME 
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phosphate free hepes, or serum induced with the addition of FBS to 5% 
final concentration . For experiments with Balb/c 3T3 and MER #6 cells , 
fibronectin coated 24 well plates (Collaborative research) were seeded 
at a density of 3xl04 cells per well in 0.5 rnl of phenol red free DME 
(Gibeo) that had been adjusted to 4rnM hepes with the addition of dry 
hepes free acid, 5% calf serum , Ix glutamine penn strep (Irvine 
Scientific), and Ix GMS-X medium supplement (Gibeo). 24 hours later the 
cells were reted with 0 . 75 ml of the same medium . 72 hours later the 
cells were ~ -estradiol induced with the addition of various 
concentrations of ~ -estradiol in phenol red free DME, mock induced with 
the addition of an appropriate volume of phenol red free DME, or serum 
induced with the addition of FBS to 15% final concentration. In both 
procedures, entry into S-phase was monitored by adding 37 . 5 J.1 1 of a 
l abelling mixture containing 5-bromodeoxyuridine and 5-fluorouracil 
(Amersham) 14 hours after stimulation. Experiments were terminated 10 
hours after labelling mix addition by washing the cells withe PBSA and 
then fixing them in 5% acetic acid in ethanol . Irnmunoperoxidase 
staining employed the Arnersham cell proliferation kit. Wells were 
washed 3 x 3 minutes with PBS, incubated with 8-fold diluted anti 
bromodU mAE I nuclease mix for 4 hours at room temperature, washed 3 x 3 
minutes with PBS, incubated with 4-fold diluted peroxidase labelled anti 
mouse Ab for 2 hours at room temperature, washed 3 x 3 minutes with PBS, 
stained with nickel/cobalt enhanced DAB, and counterstained with fast 
green FCF . 
We.tern BIota . Polylysine/fibronectin coated 6 cm plates were 
seeded at a density of 2.5-4.0 x 10 5 ce l ls per plate in DME plus 10% 
calf serum. Twelve hours later , plates cells were washed with PBSA and 
fed with 3 ml of DM!. Twelve hours later cells were refed with 3 ml of 
OMI. Twenty four hours later cells were induced with 300 II I of 3: 1 
OME:F12, 150 f..1 1 of fetal bovine serum (Hazleton Biologics), or 300 J.1 1 
of 220 ~ ZnS04 in 3:1 DME:F12. Cells were harvested over a 16 hour 
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timecourse as indicated in the figure legend. Cells were lysed in 200 
~1 of loading buffer (80 mM Tris pH 6.8, 100 mM dithiothreitol , 2% SOS, 
10% glycerol). Cell lysates were fractionated on acrylarnide SDS gels 
and electroblotted to Nitroplus 2000 (Micron Separations). Filters were 
blocked for 2 hours at room temperature in IX TBS , 0.5% Tween 20, 2% 
aSA. Antibody incubations were in the same solution with the addition 
of 2 ~g/ml anti-myc monoclonal antibody H60C37 125 r labelled to a 
specific activity of approximately 100 Ci/mMole . Antibody incubations 




Cloning Stra t egy . Our goal in this work was to identify genes 
that are physiological targets of transcriptional regulators induced 
during the immediate early serum response, especially c-myc. eDNA 
libraries were prepared from both serum starved and a-hour serum 
stimulated Balb/e 3T3 cells. These libraries were screened with probes 
enriched for sequences either induced or repressed in response to 
mitogen stimulation. Figure 1 presents an outline of the cloning 
strategy i detai led cons iderations are presented in Materials and 
Methods. The design was influenced by several considerations . First, 
we focussed the selection scheme on the kinetics of progression through 
Gl following emergence from GO . In this experimental regime , the a-hour 
timepoint is reproducibly within GI, close to the restriction point (R-
point) I beyond which entry into S-phase becomes insensitive to 
inhibition by serum removal (Pardee 1989). Thus, execution genes whose 
new transcription and translation are needed for progression from Gl to 
S should be well-represented at the 8-hour point (entry into Sunder 
these conditions is at -14 hours). The 8-hour point was also expected 
to allow for the decay of prominent GO 
that are down-regulated in response 
transcripts derived from genes 
to serum. We will refer to 
transcripts differentially regulated at 8 hours as mid-serum response, 
or mid-SR, to distinguish them from a potentially distinct class 
regulated in mid-Gl of exponentially growing cells. A second strategic 
consideration was that we wanted to obtain clones corresponding to mRNAs 
of all prevalence classes. This was achieved by us ing subtracted 
hybridization probes enriched 
which effectively increased 
abundance cDNAs (Sargent 1987; 
in differentially expressed 
the screening sensitivity 




anticipated that some genes whose expression is initiated early , 
qualifying them as members of the immediate early kinetic class, will 
continue to be expressed through Gl, and that this later phase of 
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Figure 1 
A. c DNA library preparation 
1. prepare ds cDNA from 8 hour serum stimulated cells; clone into i.. Exlx 
-.. 15x106 independent clones 
2. prepare ds cDNA from GO arrested cells; clone into i.. Exlx 
-.. 7x106 independent clones 
B. Probe preparation 
1. 10 probe: ss cDNA derived from serum stimulated cells 
2. preparation of subtracting cRNA 
a. prepare i.. DNA from arrested library 
b. transcribe with T7 RNA pol and biotinylated NTPs 
-.. biotinylated sense cRNA 
3. preparation of subtracted cDNA 
a. hybridize 1° ss cDNA with biotinylated cRNA 
b. remove heteroduplexes and cRNA 
___ serum stimulated subtracted cDNA probe - the unreacted 
ss cDNA is enriched for sequences differentially up-regulated 
in seum stimulated cells 
C. Library screening 
1. plate at low dens~y : -1000 plaques per plate 
2. make 3 lifts per plate: 
a. screen with the serum stimulated subtracted probe 
b. screen with the arrested subtracted probe 
c. screen with the "backprobe" (see below) -----, 
3. select clones that: 
a. score positive with the serum stimulated probe 
b. score negative with the arrested probe 
c. score negative with the backprobe 
- low redundancy serum stimulated eDNA clones 
D. Preparation of backprobe 
1. PCR amplify cDNA inserts from selected clones 
2. gel purify and pool DNAs 
--- backprobe --------------~ 
64 
expression may also identify them as mid-SR class genes. c-Myc itself, 
for example, displays such a pattern of expression (Muller et al . , 1984; 
Lau and Nathans 1987). While there are several different possibilities 
for the regulatory basis of such expression, we wanted to detect such 
genes in the initial screen. For this reason, we did not initially 
eliminate all immediate early class genes, but later identified them as 
a kinetic subset. 
An important practical goal in cloning exercises of this sort is 
to reduce labor by eliminating redundant clones as early in the process 
as possible. At the level of initial plaque screens, we reduced the 
repeated selection of cONAs derived from a few prevalent and 
differentially expressed mRNAs. As indicated in figure 1, this was done 
by proceeding through several successive rounds of library screening, 
making triplicate lifts from each plate. The differential probes were 
hybridized to the first and second lifts, whereas a -backprobe M , 
generated by pooling cDNAs already obtained in earlier rounds of 
screening, was hybridized to the third lift; only plaques yielding 
differential signals on the first and second lifts and scoring negative 
on the third lift were selected . To further reduce the number of 
redundant clones maintained after a given round of screening, 
restriction maps were generated from the 3' ends of the newly selected 
clones; a computerized comparison of the new clone restriction maps with 
the existing clone maps (appendix C) was used to identify and omit 
redundant clones. Plasmids bearing potentially unique cDNAs were 
automatically subcloned (Palazzolo et al., 1990); plasmid miniprep DNAs 
were sequenced from their 5' ends, yielding 250 to 325 bp of sequence 
from each clone. Sequences were searched against the Genbank and EMBL 
sequence libraries using the program BLAST (Altschul et al . , 1990); 
remaining redundant cDNAs identified during the database searches, 
usually either short or internally initiated copies of highly expressed 
mRNAs, were eliminated at this stage. 
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The growth arrested and serum stimulated eDNA libraries contained 
7xl0 6 and 1.5xl07 clones, respectively. These cells contain in the 
range of 3-10 x 10 5 mRNA molecules per cell (Jendrisak et al., 1987), so 
the libraries are large enough to ensure that even the rarest mRNA 
species are represented, except for possible exceptional sequences that 
may have been peculiarly poor substrates for reverse transcription. 
Although the libraries are comprehensive, the screening reported here 
was not extensive enough to be saturating and was more complete for the 
serum induced case than for the repressed case. Thus the serum 
stimulated library was screened through six rounds of six plates each 
(at -1000 plaques per plate) while the growth arrested library was 
screened through two rounds of six plates each . From 100 differentially 
hybridized plaques approximate l y 40 cDNAs were found to be non-redundant 
by the criteria of 3 ' end restriction mapping and limited 5' end 
sequence analysis . 
described below . 
These were subj ected to further analyses as 
Expression in growth arrested and serum stimulated cells. The 40 
candidate a-hour response clones were next tested for the kinetics of 
their response to serum. At this point members of the immediate early 
kinetic class were identified and separated from those clones whose RNAs 
were most strongly differentially regulated at the a-hour point , mid-Gl 
relative to GO. For operational purposes, we defined mid-SR regulated 
clones as those either (1) expressed at higher levels a hours following 
serum stimulation than 1 hour following, or (2) repressed during Gl 
following serum stimulation of quiescent cells. To confirm magnitude 
and timing of regulation, ribonuclease protection assays were used. The 
sources of RNAs used for screening were NIH 3T3 cells that had been 
brought to growth arrest in defined medium, then mock or serum induced 
for I hour or a hours, and harvested for RNA preparation. This 
screening u sed RNA from NIH 3T3 ce ll s with the intention of filtering 
out c l ones whose response was particular to the Balb/c 3T3 line used to 
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construct and screen the original libraries. Antisense RNA probes 
generated from the 5' end of each eDNA were hybridized to total RNA, 
digested with RNase TI, and fractionated on denaturing polyacrylamide 
gels. Quantitative data from each set of ribonuclease protections were 
obtained from dried gels on a phosphor imager (Molecular Dynamics). 
Using internal standards on each gel, transcript prevalence was 
calculated (Figure 2). Of the 40 unique clones obtained from initial 
screens, 18 were classified as mid-SR genes ; 15 of these were induced 
and 3 were repressed by serum treatment. The remaining clones were 
either subject to stimulation by serum with predominantly early Gl 
kinetics or were not reproducibly regulated. The clones expressed most 
highly at one hour have not yet been subs cree ned to differentiate those 
that are regulated independently of protein synthesis (the criterion 
that distinguishes the immediate early class) from those that are 
dependent on immediate early products. Nomenclature: serum stimulated 
clones were initially named I-8-x where 1-8 indicates serum induced at 8 
hours and x is the number assigned to the primary plaque upon its 
selection . Repressed clones were named R-8-x where R-8 indicates serum 
repressed at 8 hours. Where an original phage plug later proved to 
contain more than one eDNA clone, the clone number is followed by a 
letter, i.e., I-8-10A and I-8-10B. 
Expression of clones subject to mid-SR regulation is presented in 
figure 2. For comparison with other work, panel A presents the classic 
immediate early transcripts c-fos and c-jun (Muller et al. , 1984; Lau 
and Nathans 1987 ; Almendral et al., 1988), as well as the additional 
recently cloned genes of potential interest max/myn, Id, and G1 cyclin 
D2 (Benezra et al. , 1990; Blackwood and Eisenman 1990; Lew et al., 1991; 
Matsushime et al. , 1991; Prendergast et al., 1991). The serum induced 
1-8 clones (panel B) and serum repressed R-8 clones (panel C) correspond 
to mRNAs from all prevalence classes, as anticipated from the cloning 
strategy. For example , I-8-l6 [cytoplasmic (A-X) actin), R-8-l [alpha-l 
(3) collagen], and R-8-9 [translation elongation factor 1] were all 
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Pigure ~. Expression o f cloned transcripts regulated in NIH 3T3 cells 
with mid-SR kinetics.NIH 3T3 cells were seeded and brought to growth 
arrest in defined medium as indicated in materials and methods. 
Arrested cells were mock or serum stimulated. RNAs generated fro m mock, 
serum stimulated, and exponentially growing cells were analyzed by 
ribonuclease protect i on. Quantitative data from each set of 
ribonuc lease protections were obtai ned from the dried gels on a 
phosphor imager (Molecular Dynamics). Using internal s tandards o n each 
gel, transcript per cell was calculated as: 
orotected com (Lla total RNA·1) X 1 Lla total RNA 
50,000 cells 
X 6.02 x 1023 molecules mole·1 
protected probe activity , cpm mol·1 
corrected for probe decay over the course of the experiment. 
More accurately, this is a measure of transcripts per 20 Pcr o f total 
1lliA; in our experience, a reasonable estimate o f the RNA content o f 
growth arrested 3T3 cells. 
A. Reference serum response transcripts. B . Serum induced 
transcripts. c. Serum repressed transcripts. Timecourse : 0, mock 
induced ; 1, 4, 8, 12, serum treated for 1, 4, 8, or 12 hours ; Gr, 
exponentially growing ce ll s . Abbreviatio ns: a - l(III) C, a-I type III 
collagen; EF-l, translation elongation factor 1; a-l( VI)C , a -I type VI 
collagen; MGSA, melanoma growth stimulatory activity; TIp, Tl protein; 
LDH, lactate dehydrogenase; LTT, liver thiol transferase; G3PDH, 
glyceraldehyde-3-phosphate dehydrogenase; ODC , ornithine decarboxylase; 
HSA, heat stable antigen . 
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A Serum treatment (hrs) Quantitation 
(transcripts per cell) 
Reference 
serum 0 1 8 Gr 0 1 8 Gr 
response 
transcripts 
c-fos 73600 6 4 
c-jun * 36 260 30 
max I myn 21 22 51 25 
Id * 2 120 73 
G1 cyclin 02 24 39 75 18 
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B Serul1l treatment (hrs) Ouantitation 
(transcri pts per cell) 
SerulII 
IIldliced 0 1 8 Gr 0 1 8 Gr 
transcripts 
1-8-1. tenascin 7 29 880 62 
1-8-6, MGSA 47 63 400 11 
1-8-9 41 48 143 31 
1-8-10A, T1p 10 68 250 39 
1-8-108, LDH 46 65 405 99 
1-8-16, actin * 1400 6700 7100 
1-8-23 5 15 19 4 
1-8-29 11 13 57 22 
1-8-308 19 24 38 22 
1-8-32, LTT 27 45 190 32 
1-8-33, G3PDH * 440 570 1200 
1-8-34 
* 11 17 320 
1-8-36, ODe * 32 40 84 
1-8-41, HSA 22 24 100 2 ~ 0 
I 8 -47 * 11 220 790 
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C Serum treatment (hrs) Quantitat ion 
(transcripts per ce ll) 
Serum 
repressed 0 4 12 Gr 0 4 12 Gr 
transcripts 
R-8-1, a -1(III)C * 2900 460 58 
R-8-9, EF-1 1600 1400 650 1000 
R-8-26, n-1(VI)C * 550 550 200 
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present at more than 1000 transcripts per cell. At the other extreme, 
1-8-23, 1-8-29, and I-8-30B were present at SO or fewer transcripts per 
cell at the 8 hour serum induction timepoint. The degree of regulation 
varied from a reproducible but modest 2-fold induction of I-8-30B to 
more than lOO-fold stimulation of 1-8-1 (tenascin] and 50-fold 
repression of R-8-1 [alpha-l (3) collagen]. 
The regulatory capacity of conditional myc expression. The burst 
of transcription factor expression in the immediate early serum response 
implies a transcriptional cascade acting through the Gl that follows 
emergence from GO. The panel of mid-SR genes identified here are 
possibl e direct or indirect targets of the immediate early regulators. 
We next focused on determining wh i ch, if any, could be regulated by 
c-royc. To screen for myc responsiveness, we used an NIH 3T3 cell line 
(3-5B) that expresses c-myc driven by the metallothionein-I promoter 
(see chapter 1) . This cell line is subject to growth arrest in defined 
medium , as is the parental NIH 3T3 line. As in other conceptually 
similar cell lines with inducible myc activity, c-myc expression under 
arrest conditions is sufficient to stimulate a subpopulation of the 
growth arrested cells (50-60%) to reenter the cell cycle, traverse GI, 
and e n ter S-phase (Figure 3) . During the course of such an experiment, 
the transgene c-myc (myc23c) transcript is induced in the 3-5B cell line 
by about 20-fold (figure 5) and c-myc protein peaks at levels exceeding 
those present in a serum stimulated NIH 3T3 cells by 5- to 10-fold 
(figure 4) 
The degree of 
expression in this 
cell cycle progression due to conditional myc 
system is very similar to that reported in 
conceptually similar systems . Thus following growth arrest in defined 
medium, 40-50% of Balb/c 3T3 cells expressing c-myc under control of a 
glucocorticoid regulated promoter reenter the cell cycle following 
transcriptional induction of myc expression (Caval i eri and Goldfarb 
1987). And following growth arres t by contact inhibition, 50-60% of 
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Figure 3 . Emergence from growth arrest stimulated by conditional myc 
expression. A. NIH 3T3 and conditional myc23c expressing 3-5B cells 
were seeded and brought to growth arrest in defined medium as indicated 
in materials and methods . Arrested cells were mock or zinc stimulated; 
zinc doses are indicated at the bottom of each column . B. Similar 
experiments comparing parental Balb/e 3T3 cells with the c-myc estrogen 
receptor fusion protein (myc ER) expressing cell line MER H6. Cells 
were seeded and brought to growth arrest in medium containing 5% calf 
serum as indicated in materials and methods . Arrested cells were mock 
or ~-estradiol (100 nM) stimulated as indicated at the bottom of each 
column. Cells were labelled with BrdU from 14 to 24 hours following 
stimulation. Fixation and immunoperoxidase staining were as in 
materials and methods. Approximately 400 cells were counted for each 
zinc dose; labelling index is the number of BrdU stained cells divided 
by the total number of cells . 
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Figure 4. Western analysis of c-myc protein expression in NIH 3T3 and 
myc23c expressing 3-5B cells. A. (-): cells were mock induced. ( + ) : 
3T3 cells were induced by adjusting the medium to 5% fetal bovine serum. 
3-5B cells were induced by adjusting the medium to 20 ~M ZnS04. All 
cells were harvested after 4 hours of induction. B . 3-5B cells were 
harvested over a 16 hour timecourse following induction . Cells in the 
MOM tirnepoint were harvested 4 hours after mock induction. The other 
samples were harvested at the times indicated at the tops of the lanes . 
Cells were seeded , brought to growth arrest, induced, harvested, and 
blotted as indicated in materials and methods. The labelling antibody 
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Balb/c 3T3 cells expressing a c-myc estrogen receptor fusion protein 
reenter the cell cycle following hormonal activation of the fusion 
protein (Eilers et al., 1991; see also figure 3). 
As an initial calibration of RNA level responses to conditional 
c-myc in our system, we examined the expression of three already known 
Gl-regulated transcripts (the immediate early genes c-fos and endogenous 
c-myc, a nd the mid-SR gene p53 tumor antigen; tubulin ~ 5 serves as an 
unaffected control) (Figure 5) . In both parental 3T3 cells and rnyc23c 
expressing 3-SB cells, c-fos RNA was present at very low levels and did 
not vary significantly with c-myc expression. In accord with other work 
(Eilers et al., 1991) , this result demonstrated with high sensitivity 
that the immediate early burst of c-fos RNA synthesis following serum 
stimulation is bypassed in a c-myc stimulated emergence from GO . As in 
other myc transgene expressing cell lines, endogenous c-myc RNA levels 
were chronically repressed in 3-5B cells relative to 3T3 cells 
(Cleveland et al., 1988; Grignani et al . , 1990; Penn et al . , 1990) ; this 
was probably a consequence of elevated basal expression of trans gene 
c-myc in 3-5B cells. In addition , the endogenous c-myc transcript was 
further repressed over the timecourse of the myc transgene induction. 
That myc itself shows different regulation in response to full serum 
stimulation (up-regulation at mid-G1 relative to GO) compared to the 
response to ectopic transgene myc (down-regulation relative to GO)' 
raises the possibility that other genes from the mid-SR panel might 
display disparate responses in our mitogen- versus myc-driven GO ... S 
experimental regimes. 
p53 transcript levels remained steady in control 3T3 cells treated 
with zinc, but they were induced 2- to 3-fold between 4 and 12 hours 
after zinc addition to 3-5B cel l s , consistent with its timecourse of up-
regulation in response to serum stimulation (Reich and Levine 1984). 
This identifies p53 as a target, direct or indirect, of myc in this 
experimental regime . This result is consistent with previous 
observations that p53 is among the proteins that are overexpressed in 
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Pigure S. Comparison of selected mRNA expression in NIH 3T3 and myc23c 
expressing 3-5B cells. NIH 3T3 and 3-5B cells were seeded and brought 
to growth arrest in defined medium as indicated in materials and 
methods. 
J.I.M zinc. 
Arrested cells were either mock stimulated or treated with 20 
RNAs generated from mock and zinc treated cells were analyzed 
by ribonuclease protection . Timecourse: 0, mock stimulated cells; 
.5-12 , cells treated with zinc for 0.5 to 12 h ours. Please note that 
the ratio of the sensitivity of the c-myc to myc23c protections was 8:1; 
the sensitiviy of the c-fos protection was equivalent to that of the 
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cells whose growth characteristics have been altered by chronic c-myc 
overexpression (Shiroki et al., 1986), although it has been difficult in 
such systems to discriminate obligate responses to myc from various 
indirect effects. Nevertheless I among known candidates for direct 
regulation by mye, p53 presently stands out as a good candidate for 
direct interaction with myc because its expression in trans feet ion 
assays is dependent on an E-box sequence element reminiscent of the in 
vitro-defined rnyc binding site (Ronen et a l., 1991). The presence of 
s u c h an E-box is only suggest ive of a direct myc interaction, since this 
E-box sequence is also a target for strong in vitro binding by MLTF /USF 
(Carthew et al. , 1985; Gregor et al., 1990), max/myn homodimers 
(Blackwood and Eisenman 1990; Prendergast et al ., 1991) and TFlI-i (Roy 
et al ., 1991). However, the observed response to conditional myc shown 
here provides additional support for a direct regulatory interaction 
between myc and p53. The data also suggest that the magnitude of myc 
response expected from unknown target genes in the mid-SR pane l may be 
quantitatively modest, as is t h e case for pS3. 
Identification of myc regulated transcripts among the panel of 
mid-SR regulated clones. Th e metallothionein promoted c-myc gene 
expressed by 3-5B cells included a glucocorticoid regulated enhancer 
derived from MMTV which was pos it ioned upstream of the promoter and 
metal regulatory elements from the murine metallothionein gene. We had 
or i gina lly planned to use this second, metal-independent myc induction 
system to control for possible phenotypic effects secondary to metal 
treatment. This would have substantially improved confidence by showing 
a myc response via two independent conditional expression systems. 
Unfortunately, regulatio n of the myc23c transgene by glucocorticoids 
proved weak and inconsistent in this cellular environment and was not 
pursued further. Instead, we substituted the cell line MER #6 which 
expresses a c-myc estrogen receptor fusion protein (myc-ER) in the 
Balb/c 3T3 cell background (E ilers et al., 1989; Eilers et al., 1991) (a 
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kind gift from Sabine Schirm and J. Michael Bishop). The format for 
characterizing the effect of myc on the expression of the individual 
members of the mid-SR collection was straightforward. NIH 3T3 and 3-SB 
cells were brought to growth arrest at low density in defined medium and 
either mock or zinc stimulated; similarly, Balb/c 3T3 and MER #6 cells 
were brought to growth arrest at low density in defined medium and 
either mock or estrogen stimulated. The mock stimulation conditions 
included medium changes, inducing agent solvents and manipulations 
parallel to metal or hormone inductions. RNAs were harvested 8 hours 
after mock, zinc, or estrogen treatment. Transcript levels were 
measured by ribonuclease protection and quantitated on a phosphorimager. 
Table 1 and figure 6 present the effect of conditional myc 
expression on the mid-SR regulated cDNAs. Each data point from the 
NIH"'3-SB system results from a single experiment; results from the 
Balb/c"'MER #6 system are averaged from 3 successive experiments _ To 
more simply visualize myc response in the two conditional myc systems, 
figure 6 presents data from Table 1 in a scatter diagram format _ In 
figure 6A, each cDNA is represented as a point where fold-regulation by 
the c-myc estrogen receptor fusion protein in MER #6 cells is the x-
value and fold-regulation by c-myc in 3-SB cells is the Y-value; for 
those transcripts that lie away from the central cluster, the X-error 
bars delimit +/- one standard deviation as derived from three 
independent experiments with the Balb/c and MER #6 cells. While most of 
the transcripts cluster around (1,1), indicative of no significant 
response to elevated myc expression, I-8-10B (lactate dehydrogenase], 
1-8-36 [ornithine decarboxylase], 1-8-29 [unknown], and I-8-30B 
[unknown] all lie in the upper right quadrant, indicative of induction 
by myc_ To better visualize myc-driven repression, the data were 
replotted in figure 6B as the reciprocal of the values in 6A. In this 
analysis , I-8-1 (tenascinj and 1-8-41 [heat stable antigen] lie in the 
upper right quadrant , indicative of repression by myc_ Of the 18 mid-SR 
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Table lA. eDNA clones subject to serum regulation with mid-SR kinetics 
Cell system: NIH 3T3 3-5B MER#6 
Induction: by serum' by conditional myc2 
at 8 hours expression at 8 hours 
clone # clone identity 
1-8-1 tenascin 110 0.69 0.33 +/- .2 
1-8-6 MGSA3 8.6 1.0 0.66 +/- .1 
1-8-9 not identified 3.6 1.0 0.84 +/- .3 
1-8-10A mouse Tl protein 26 0.9 not detected 
1-8-10B lactate dehydrogenase 8.9 2.21 2.0 +/- .1 
/-8-16 A-X actin 4.6 0.6 0.88 +/- .1 
1-8-23 not identified 3.2 not done 0.96 +/-.3 
1-8-29 not identified4 5.1 1.73 5.0 +/- .6 
1-8-30B not identified 2.0 2.5 1.4 +/- .2 
1-8-32 liverthiol transferase 7.0 1.1 0.86 +/- .1 
1-8-33 G-3-P dehydrogenase5 2.9 1.2 1.0 +/- .1 
1-8-34 not identified 28 0.89 1.3 +/- .7 
1-8-36 ornithine decarboxylase 2.6 3.96 1.7 +/- .2 
/-8-41 heat stable antigen 4.6 not detected 0.5 +/- .1 
1-8-47 not identified 70 1.49 1.4 +/- .2 
Repression :6 by serum by conditional myc 
at 12 hours expression at 8 hours 
R-8-1 Alpha-l (3) collagen 50 1.7 1.0 +/- .1 
R-8-9 elongation factor 1 2.4 not done 1.1 +/- .2 
R-8-26 Alpha-l (6) collagen 2.7 not done 1.1 +/- .1 
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Table lB . eDNA c l ones subject to serum regulation with rnid -SR kinetics 
Cell system: NIH 3T3 3-59 MER #6 
Induction: by serum by conditional myc 
at 8 hours expression at 8 hours 
alpha prothymosin 1.7 3.3 1.2 +/- .1 
c-myc 15 0.36 0.76 +/- .4 
Gl cyclin 02 3.1 1.6 1.5 +/- .2 
max/myn 2.4 2. 1 1.2 +/- .3 
p53 tumor antigen 3.8 2.3 1.2 +/- .2 
c-fos 0.83 0.96 not done 
c-jun 0.80 0.79 not done 
fra-l 8.5 1.0 not done 
HSP 70 MHS 214 3.0 1.2 not done 
Id 31 0.89 not done 
1. Induction by serum: transcript prevalence in serum stimulated 
cells divided by transcript prevalence in growth arrested cells . 
2. Induct i on by conditional rnyc expression : 
fold change upon induction in conditional cel l line 
fold c hange upon induction in control 3T3 cell line 
3. MGSA : melanoma growth st imulatory activity 
4. Shares some sequence homology wi th methylenetetrahydrofolate 
synthetase. 
5. G-3-P dehydrogenase , g1ycera1dehyde-3-phosphate dehydrogenase. 
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Figure 6 . Scatter diagram analysis of rnid-SR regulated transcript 
expression in conditional rnyc expressing 3-SB and MER #6 cells. Data 
are from table 1. A . Data for each transcript are plotted on a 
scatter d i agram . The X-value for each point is: 
fold change upon induction in MER #6 cells 
fold change upon induction in Balb/c 3T3 cells 
The Y-value for each point is: 
fold change upon induction in 3 -SB cells 
fold change upon induction in control NIH 3T3 cells 
The Balb/cAMER #6 experiment was iterated 3 times; the plotted data are 
average values and the X-error bars delimit +/- one standard deviation 
for these data. Clone numbers are provided for those transcripts that 
were clearly upregulated by conditional myc expression. B. Data for 
each transcript are replotted on a scatter diagram where the X- and Y-
values are the reciprocals of the values i n part A . Clone numbers are 
provided for those transcripts that were clearly downregulated by 
conditional myc expression. 
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regulated mRNAs, 5 (lactate dehydrogenase , orni thine decarboxylase, 
tenascin, 1-8-29, and I-8-30B) are induced or repressed more than 2-fold 
following stimulation of myc expression in one of the two systems; in 
each case, that same mRNA is regulated in the same manner, though not 
necessarily to the same degree, in the alternate myc expressing cell 
system. I-8-47 was about l.S-fold induced following expression of rnyc 
in both cell systems . Expression from the inunediate ear ly serum 
response genes c-fos, c-jun, and c-myc and the previously identified 
rnyc-responsive gene prothymosin a were also measured in this experiment. 
Myc behaved essentially as before in 3-5B cells (Figure 5), while in MER 
#6 cells myc was repressed to very low levels, presumably due to basal 
activity from the myc-ER fusion protein (Eilers et al . , 1989) . Neither 
c-fos nor c-jun responded to myc expression in either system. 
Prothymosin a was induced in 3-5B cells, confirming in this NIH 3T3 
cellular background the original observation myc of inducibility 
reported in MycER expressing Rat 1 cells (Eilers et al ., 1991). 
Prothymos in 0. waG not, however, induced above background in MER #6 
cells, in agreement with prior studies (Hevezi and Bishop, personal 
communication) . For the key myc responses reported here, primary RNA 
level data are presented in Figure 7 . 
Viewed as a whole, the myc and serum screening results suggest 
that roughly one third of mid-SR induced or repressed cDNAs can also be 
regulated, at least in part, by c-myc, although the data do not reveal 
whether myc-regulation is direct or indirect. The screening results 
also revealed that among the mid-SR genes that were most profoundly 
regulated in response to serum, there are several that were unaffected 
or even affected inversely by myc. As discussed below, this suggests 
that a myc-driven GO ~ S progression differs qualitatively from a 
parallel, serum-driven progression in potentially interesting and 
previously undetected ways . 
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Pigure 7. Expression of selected myc regulated transcripts. NIH 3T3, 
myc23c expressing 3-58, Balb/e 3T3, and mycER expressing MER #6 cells 
were seeded and brought to growth arrest in defined medium as indicated 
in materials and methods. NIH 3T3 and 3-5B cells were mock or zinc 
treated; Balb/e and MER #6 cells were ~-estradiol treated. Cells were 
harvested after 8 hours of st imulation . RNAs were analyzed by 
ribonuclease protection. The induced zinc condition was 20 ~ for a ll 
transcripts except for r-8-29, for which it was 15~ . The induced ~­
estradiol condition was 100 nM in all cases. Abbreviations: LDH, 
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Diacu •• ion 
The emergence of cells from a quiescent GO arrested state into the 
cell cycle is a multistep process that begins with the immediate early 
response to mitogens and extends into the specialized Gl phase that 
follows (for review , see Pardee 1989). The immediate early response 
occurs in the first hour of this mitogen initiated G1 and is dominated 
by new transcription of genes encoding transcriptional regulators 
including c- fos, jun and c-myc. The distinction between this Gl and 
that of exponentially growing cells is already evident at this early 
time point , since rnyc and fos are not detectably up-regulated at the 
Mitosis/Gl boundary in cycling cells but are instead expressed at a much 
lower and constant level throughout the cycle (Thompson et al ., 1985; 
Blackwood et al., 1992). Identification of many of the immediate early 
genes as transcriptional regulators has raised the question of what 
their regulatory targets are and how those targets contribute to 
progression toward S-phase . In this work we have cloned cDNA copies of 
messenger RNAs that are either up- or down-regulated at a later time in 
the serum initiated Gl cascade with the expectation that these will 
include direct and indirect targets of immediate early regulators. In 
particular, for the case of myc regulated RNAs, the pattern of 
expression for myc and max/myn suggested that the potential 
c-myc:{max/myn} transcription factor should be prominent during the mid-
Gl period following serum stimulation of arrested cells. From 18 
different mid-SR class cDNAs isolated, a subset that respond in a rnyc-
driven progression through GO were selected . 
Serum- drive n and myc-drive n e me rgenc e fr om GO a r e qualitative ly 
and quantitative ly diffe r e nt. Following stimulation of myc expression 
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ultimately enter S-phase. In contrast . >95% of these same cells will 
enter S-phase following serum stimulation, which suggests that there is 
at least a significant quantitative difference in the responsiveness of 
cells to rnyc versus serum; a substantial qualitative difference might 
also exist. These are not mutually exclusive possibilities, but our 
results emphasize to an unanticipated extent the existence of 
substantial qualitative differences. 
Comparison of the serum response with myc response first shows 
that many genes strongly regulated by serum do not respond detectably to 
myc. This result is consistent with expectations based on earlier 
studies (Eilers et al., 1991; Yang et al ., 1991). Thus, some prominent 
members of the immediate early serum response are not induced by ectopic 
mYCi rather, in a myc driven emergence from GO regulators such as fos 
are apparent ly bypassed. It is therefore reasonable to expect that 
there will be some genes whose induction in response to serum depends 
heavily or entirely on the bypassed regulators. Even the limited panel 
of mid-SR genes presented here includes a dozen that are good candidates 
for regulation by non-my c immediate early regulators. At the cellular 
level, we can conclude that these myc-insensitive mid-SR products are 
not essential for progression to S-phase, although they may account for 
differences in the character and quantitative success of the full 
mitogen response compared with the myc response. Viewed from a 
different perspective, it is even possible that some mid-SR genes that 
are absent from the myc response class contribute to myc induced 
progression through their absence by virtue of normally limiting 
progression toward S-phase in a full serum response. Finally, the 
complex differences between the myc-responsive set and the larger serum 
responsive set highlight a practical point . It is possible that there 
exist genes that are regulated by myc in the absence of serum that are 
Il2.t. regulated at all by serum a l one ; in our two step screen for myc 
response these would have been absent from the starting pool . If these 
exist, a direct ± myc subtractive screen will be needed to find them. 
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A second and extreme sort of divergence between serum and rnyc 
driven Gl phases is revealed in the cases of myc itself and tenascin 
[1-8-1], an extracellular matrix protein. Both were substantially up-
regulated in rnid-Gl by serum, while ectopic rnyc expression resulted in 
modest but reproducible down-regulation. This divergence in regulatory 
pattern clearly shows that the myc stimulated pathway is not a simple 
subset of the full serum stimulated response. It will now be crucial to 
determine the mechanistic basis for each type of response . 
Although there were major qualitative and quantitative differences 
in rnyc response versus serum response for many of the rnid-SR cDNAs, 
there were also some that responded similarly . Among these were lactate 
dehydrogenase [I-8-10BI. 1-8-29. ornithine decarboxylase [1-8-36 1. and 
p53 tumor antigen . These similarly affected products are good 
candidates for proteins obligatorily involved in the regulation or 
execution of any successful progression from GO to S-phase. 
Some genea are member s of b o th ~ediate early and mid - SR groups. 
A good example of the anticipated and probably complex overlap between 
immediate early and rnid-SR genes is ornithine decarboxylase (1-8-36), 
which is up-regulated in a c-rnyc driven cycle and in serum driven re-
entry, but is also an immediate early gene (induced rapidly by serum in 
a protein synthesis independent fashion) by virtue of the presence of a 
functional eRE related element within its promoter (Palvimo et al., 
1991). That such overlap might be observed was foreshadowed by the fact 
that c-myc is an immediate early regulator, but also continues to be 
expressed in mid-G1' Indeed, we have found that ectopic myc expression 
in 3-SB cells and similar lines must be expressed throughout G1 in order 
to support entry into S-phase (chapter 1), showing that it is also 
functional beyond the immediate early period. 
other myc targeta. Several prior studies have been directed at 
identification of myc regulatory targets, and some of these targets were 
89 
scree n ed in the course of this work for responsiveness in the 
Gl - S-ph ase inducible system. Chronic overexpression of rnyc leads to 
transcr i ptional repression of c-myc and to repression of MHC class I 
transcripts (Bernards et al. , 1986 ; Cleveland et a l ., 1988; Versteeg et 
a 1.. 1988; Gr i gnani et a1. . 1990; Penn et a 1 .. 1 990) We found here 
t hat myc autorepression is also observed upon short-term myc 
overexpression . In constitutive rnyc overexpressing lines , Prendergast 
and Cole were able to identify two myc regulated clones , MRl 
(plasminogen activator inhibitor I) , and MR2 . At the mechanistic level, 
their data s u ggested that regu l ation was post-transcriptional in both 
cases (Prendergast et al., 1990). Yang et al. identified three 
col l agen transcripts transcriptionally 





transcriptional l y induced by a c-myc estrogen receptor fusion protein in 
a Rat-1 cell background , though not in a Balb/c 3T3 cell background 
(Eilers et al . , 1991; Yang et al. , 1991 , Hevezi and Bishop , personal 
communication ) . Here we also observed its failure to respond in the 
Balb/c based MERH6 cells, but found it to be myc-responsive in the NIH 
3T3 based 3-5B cells. Except for a collagen family member, our mid-SR 
screens did not identify any of the previously ident i fied targets. This 
is expected because the screening was not extensive enough to be 
satu rating, even though the libraries themselves are comprehensive. 
Additional rounds of screening would be expected t o yield substantial 
numbers of new mid-SR and myc responsive clones. 
Differences and similarities in myc response in MER#6 and 3-SB myc 
induction systems . For the mid-G1 regulated genes obtained in our 
cloni ng effort, myc regulated expression in the NIH A)-S B and 
Ba 1 b/c'MER #6 systems corroborated nicely; there was a 1 , 1 
correspondence between down-regulated, unregulated, and up-regulated 
transcripts . This result lends confidence that the observed responses 
are indeed attributable to myc. The correspondence may also reflect the 
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fact that we intentionally tried to filter out cell line specific 
differences by screening the Balb/e 3T3 based libraries with NIH 3T3 
serum response probes. In contrast , we did find differences in the 
responses of rnyc target genes that were selected for screening in the 
conditional myc expression systems independent of their appearance in 
the rnid-SR panel. These included prothyrnosin a, Gl cyclin D2, p53 tumo r 
antigen, and max transcripts , all of which were all up-regulated in 3-SB 
but not MER #6 cells. Fo r most of these we are not yet certain whether 
they are legitimate myc targets, and if they are , whether the observed 
differences in myc response stem from a functional distinction between 
c-myc and the c-rnyc estrogen receptor fusion protein or reflect 
differences between NIH 3T3 and Balb/c 3T3 cells . In the specific case 
of prothymos in n. its identity as a gene induced by myc in some, but not 
all, cell types is strengthened by the fact that it was myc responsive 
in Rat-1 cells carrying the rnycER fusio n protein (Eile rs et al., 1991) 
and in the NIH 3T3 based 3-5B ce lls. 
Eventually, studies of rnyc and its regulatory targets should be 
able to explain both the normal function and immortalizing potential of 
c-myc in terms of the regulatory pathways in which it participates and 
the functions of the gene produc ts that 
early point, the identities of some 
it regulates. 
of the cDNAs 
At this very 
isolated are 
interesting. In the direction of promoting cell cycle progression , 
ornithine decarboxylase catalyzes the first step in polyamine synthesis; 
its activity is a necessary correlate of DNA synthesis . Beyond the 
abi lity of mammalian G1 cycl ins to form complexes with p34 cdc2 and cdk 
protein kinases a nd complement yeast G1 cyclin deficiencies (Koff et 
al., 1991; Lew et al., 1991; Matsushime et al . , 1991), their functions 
have not yet been worked out. However G1 cyclin D2, which lies 
downstream of the CSF-1 receptor (Matsushime et a l ., 1991) is up-
regulated by c-myc; furthermore , a requirement for proper c-myc 
expression can be dissected away from stimulation o f c-jun and c-fos 
expression via CSF-l receptor mutants (Roussel et al . , 1991). 
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Mechanism a of myc r esponsiv e n e ss. At the level of 
characterization presented here, we cannot know how many regulatory 
steps occur between accumulation of c-myc protein and up- or down-
regulation of a particular myc responsive mRNA. Also , we do not know 
the mechanism(s) responsible; they may be either transcriptional, post-
transcriptional or a combination of both. However, it is interesting to 
note that the promoters of lactate dehydrogenase, ornithine 
decarboxylase , and p53 tumor antigen all contain potential myc binding 
sites as previous ly de fined by in vi tro target si te selection 
experiments (Blackwell et al., 1990; Halazonitas and Kandil 1991; 
Kerkhoff et al., 1991). We have recently shown that the candidate site 
within LDH is a good in vitro binding site for myc :max/myn heteromers or 
max/myn homo-oligomers (Appendix A). Also, a potential myc binding site 
within the mouse p53 promoter, located just downstream of the cap site, 
is a positive regulator of p53 expression (Ronen et al., 1991). While 
other transcription factor:::, notably USF/MLTF and TFlI-i (Carthew et 
a1., 1985; Gregor et al., 1990; Roy et al., 1991), can recognize the 
same core E-box sequence, these genes may in fact be directly regulated 
by c-myc/max in its role as a transcription factor or by max/myn homo-
oligomers. It will now be crucial to understand in detail the balance 
between levels of myc and max/myn hetero- and homo-oligomers and how 
these levels correlate with the responses to myc and serum reported 
here. A relevant observation from this work was that induction of 
ectopic myc in 3-5B cells results in up-regulation of max/myn RNA, so 
that active rnyc:max/myn heteromers are probably able to form. However, 
if rnax/myn levels exceed available myc protein, max/myn homodimers may 
compete successfully for DNA binding sites with myc : max heteromers 
(Blackwood and Eisenman 1990; Prendergast et al., 1991; Makela et al., 
1992) to antagonize the effect of a myc containing transcription factor. 
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Chapter 3 
The differential regulatory capacities 
of c-myc and its pairing partner max 
Sean v. Tavligian and Barbara J . Wold 
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Introduction 
More than a decade of work with rnyc gene family members has 
uncovered important roles in normal cellular proliferation, 
differentiation, and oncogenesis (for reviews, see Bishop 1986; Cole 
1986) . But ce ll biological measures of myc regulatory function have not 
yet been connected with explanatory molecular level functions . Several 
lines of evidence support the long standing hypothesis that myc proteins 
are transcription factors: (1) Conditional expression of c-myc or N- myc 
(Armelin et al., 1984; Cavalieri and Goldfarb 1988; Eilers et a1., 1991) 
in growth arrested cells stimulate progression to S-phase. (2) c-Myc is 
expressed throughout the 14 hour Gl that follows mitogen stimulation of 
quiescent cells, which suggests that myc proteins playa role in Gl 
before the transition to S-phase (Muller et al., 1984; Pardee 1989). 
This argues for a role that precedes direct involvement in DNA 
replication , the other postulated mechanism of myc functi on. (3) At the 
molec ular level, myc proteins are members of a t.ranscription factor 
family defined by adjacent basic, helix- loop-hel ix (Murre et al., 1989), 
and leucine repeat (Landschulz et al. , 1988) motifs, responsible for DNA 
binding, oligomerization, and oligomerization with an emphasis on 
specificity (Hu et al., 1990; O ' Shea et al., 1992), respectively. In 
vitro experiments have defined an E box DNA sequence (CACGTG) for which 
myc proteins have specific binding affinity (Blackwell et al., 1990; 
Kerkhoff et al., 199 1; Prendergast and Ziff 1991). (4) Finally, the 
expression of several genes whose promoters contain copies of the myc 
target E box were found to be regulated by conditional myc expression 
(chapter 2) . 
Among the bHLH, bzip, and bHLHzip protein families are individual 
members that efficiently form DNA binding homodimers, e.g., GCN4 
(Kouzarides and Ziff 1989; Sellers and Struhl 1989), and members that 
bind DNA either preferentially or exclusively as heterodimers, e. g., 
MyoD (Lassar et a1., 1991). Myc family proteins are members of the 
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latter class. To date, one gene, called max or myn, specif i es at least 
four distinct bHLHzip products (Blackwood and Eisenman 1990; Prendergast 
et al. , 1991; Makela et al., 199 2) all of which can form DNA binding 
heteromers with myc family members in in vitro assays . Also, myc and 
max proteins are associated in vivo to the extent that myc is 
quantitatively coprecipitated by anti max sera, but the converse is not 
true (Wenzel et al., 1991; Blackwood et al . , 1992) . 
Max differs from myc in several significant features. In addition 
to forming heteromers with mye, 
hornodirners. As a homodimer I 
max 
max 
can efficiently form DNA binding 
DNA binding may be regulated by 
phosphorylation, but DNA binding by rnyc:rnax heterorners appears not to be 
(Berberich and Cole 1992). Unlike 
relatively stable (Blackwood et al., 
rnyc proteins, 
1992) . This 
max proteins are 
stability implies 
that low mRNA levels can support the accumu l ation of significanct levels 
of max protein; in contrast, c-myc protein accumulates and decays in 
rapid response to changes in the abundance of its mRNA. Max transcript 
levels are modestly induced during mid-Gl of the first cell cycle 
following serum stirnulated ernergence from growth arrest , i.e., the gene 
encodes a rnid serum response (mid-SR) class transcript (Prendergast et 
al., 1991; chapter 2) , but both the transcript and protein are present 
at appreciable levels throughout the cell cycle (Blackwood et al ., 
1992) . Finally, the max proteins are very srnall, and no data published 
to date suggest that they posess a transcription activation domain. 
Previously, we identified a nurnber of myc regulated transcripts 
among a panel of mid-SR class genes (chapter 2). Their identification 
as myc regulated transcripts was made by showing that they are either up 
or down-regulated in response to induction of conditional myc expression 
in GO arrested 3T3 cells. In that experimental setting, the only sourc e 
of max activity was supplied by the endogenous max gene. The degree to 
which regulation by myc depended on the presence of rnax, or was 
rnodulated by shifts in the ratio of max to myc, was unknown. Here we 
investigate this possibility using cell lines that provide altered max 
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expression either constitutively or conditionally. In addition, we 
present cell lines that supplement max levels in previously described 
conditional rnyc expressing backgrounds (chapters 1 and 2 ; Eilers at al., 
1991) . These are used to test: (1) the cell cycle progression effects 
of varied levels of the two regulators, (2) their effects on the 
expression of previously identified myc regulated mid-SR class genes, 
and (3) their effects on the expression of several immediate early 
serum response class genes. 
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Materials and methods. 
Max expression vector . The coding sequences for max and max-9 
were cloned by amplification from f i rst strand eDNA derived from serum 
stimulated Ealb/e 3T3 cells. Synthetic oligonucleotide primers were: 
max 5', GCG GCT AGC GAT AAC GAT GAC ATC GAG 
max 3', GCG TCG ACT CAG CTG GCC TCC ATC CGG A[G/A] [CIT] TT[C/T ] TT 
A synthetic Bam HI - Xba I fragment (here called LE for linker 
ep i tope) containing a concensus translation initiator (Kozak 1988) and 
e ncoding the influenza HAl epitope recognized by the monoclona l antibody 
l2CA5 (Wilson et al . , 1984) was l igated to the Nhe I - Sal I max and 
max-9 fragments. Subsequently , the Bam HI - Sal I fragments encoding 
LEmax and LEmax-9 were used to replace the Bg1 II - Xho I c-myc encoding 
fragment of pmyc23c (see chapter 1) , generating the metallothionein- I 
promoter driven conditional max expression vectors pLEmax and pLEmax-9. 
Cell culture. Cell lines were maintained in phenol red free DME 
(Gibeo) that had been adjusted to 4mM hepes with the addition of dry 
hepes free acid. Medium supplements were 5% calf serum (Gibco), Ix 
glutamine penn-strep (Irvine Scientific), and Ix GMS-X supplement 
(Gibco). G418 resistant cell lines were maintained i n medium containing 
100 ~g/ml G418 (Gibco). Hygromycin resistant cell lines were maintained 
in medium supplemented with 100 ~g/ml Hygromyein B (Boehringer Manheim) . 
Ce l ls were cultured exclusively on fibronectin coated plates ; t hese were 
either purchased from Collaborat i ve Research or prepared by coating 
dishes (6 cm, 10 cm, 15 cm and 24 well, Nunc) for eight hours to 
overnight at room temperature with bovine fibronectin (15 ~g/ml in PBS , 
Sigma) . 
Selection of max expressing cell line8 . NIH 3T3 , mye23e 
express i ng 3-SB (see chapter 1) , Ba l b/c 3T3 , and c-myc estrogen receptor 
fusion protein express i ng MER #6 ce lls (Eilers et al ., 1991) were seeded 
102 
on fibronectin coated 6 well plates at a density of 5xl0 4 cells per 
well. 24 hours later, the cells were rinsed twice with trans feet ion 
medium (1:1 phenol red free DME :phenol red free F12, Ix glutamine, O.Ix 
penn-strep, Ix GMS-X) and then transfected with the addition of 1 ml of 
trans feet ion medium containing 100 ng of drug resistance marker, 900 ng 
of max encoding plasmid, and 17 ~g of TransfectAce cationic liposomes 
(BRL). NIH 3T3 and Balb/e 3T3 were transfected with the G418 resistance 
marker pNeo 3 (Bond and Wold 1987) plus either pLEmax or pLEmax-9. 3-5B 
and MER #6 cells, which are already G418 resistant, were transfected 
with the hygromycin resistance marker pY3 (Blocklinger and Diggelmann 
1984) plus either pLEmax or pLEmax-9. After 5 hours, the medium was 
adjusted to 5% calf serum with the addition of culture medium containing 
10% calf serum. Drug resistant cell lines were selected in either 270 
~g/ml G418 or 200 ~g/ml hygromycin plus 100 ~g/ml G418. After resistant 
colonies were established as lines, they were maintained as indicated in 
cell culture . 
Max expressing cell lines were selected by immunostaining with the 
anti-HA epitope mAb 12CAS. Candidate cell lines were seeded in adjacent 
wells of fibronectin coated 24 well plates, mock or zinc stimulated for 
4 hours, PBS rinsed, and fixed in 4% formaldehyde, Ix PBS for 10 
minutes. Cells were blocked for 20 minutes in 4% goat serum, 0.4% 
Triton-X100, 1% BSA, Ix PBS; incubated with 10 Ab overnight at 40 in 1% 
goat serum, 0.4% Triton-XI00, 1% BSA, Ix PBS; incubated with 20 
(biotinylated goat anti-mouse, Vector Laboratories) Ab for 1 to 2 hours 
in 0 . 02% Triton-XI00, 0.25% BSA in lx PBS; incubated for one hour with 
streptavidin biotin peroxidase complex (Amersham) in lx PBS; and stained 
with nickel/cobalt enhanced DAB. 
Cell cyc l e p r ogr e ssio n experiments. Cells were seeded at a 
density of approximately 3xl0 4 cells/well in fibronectin coated 24 well 
plates. 24 hours later the cell were refed with 0.75 ml medium. 72 
hours later the cells were zinc induced with the addition of various 
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concentrations of ~-estradiol. zinc sulfate, or both in phosphate free 
MEM (Gibeo), mock induced with the addition of an appropriate volume of 
phosphate free MEM, or serum induced with the addition of FBS to 15% 
final concentration. The cells typically formed confluent monolayers 
about 48 hours after seeding . In both procedures, entry into S-phase 
was mon i tored by adding 37.5 ~l of a labell ing mixture containing 5-
bromodeoxyuridine and 5-fluorouracil (Amersharn) 14 hours after 
stimulation. Experiments were terminated 10 hours after labelling mix 
addition by washing the cells with PBS and then fixing them in 5% acetic 
acid in ethanol. Immunoperoxidase staining employed the Amersham cell 
proliferation kit. Wells were washed 3 x 3 minutes with PBS, incubated 
with 8-fold diluted anti BrdU mAB / nuclease mix for 4 hours at room 
temperature, washed 3 x 3 minutes with PBS, incubated with 4-fold 
diluted peroxidase labelled anti mouse Ab for 2 hours at room 
temperature , washed 3 x 3 minutes with PBS, stained with nickel/cobalt 
enhanced DAB, and counterstained with fast green FCF. 
RNA preparation . Ce l ls were seeded at a density of approximately 
2x10 6 cells/plate on fibronectin coated 10 cm plates. 24 hours later, 
they were refed with 10 ml of medium; the cells were subsequently 
brought to growth arrest and zinc, estrogen, or mock stimulated as in 
the cell cycle progression experiments . cells were harvested in 4M 
guanidinium thiocyanate, 25 roM sodium citrate pH 7.0 , 0 . 5% N-lauryl 
sarcosine, and 100 roM 2-mercaptoethanol. 0.1 volumes of 2M sodium 
acetate pH 4.0, 1 volume of phenol, and 0 . 2 volumes of chloroform were 
added sequentially with vigorous mixing following each addition. The 
preparations were chilled in an ice bath for 15 minutes and then 
centrifuged at 10,000 rpm for 10 minutes at 40 in a SS34 rotor. The 
aqueous phase was reextracted with 1 volume of 1:2 phenol:chloroform , 
precipitated twice, and redissolved in TE (Chomczynski and Sacchi 1987) . 
Transcript measureme nt. RNA probes were synthesized using T7 , T3, 
or SP6 RNA polymerase essentia l ly as recommended by the enzyme 
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manufacturer . Full length probes were excised from 5% acrylamide gels 
crosslinked with BAC (N,N' -bis-acrylylcystamine, Bio - Rad) and the 
acry l amide was dissolved with 200 roM 2-mercaptoethanol in TE. RNase 
protections were performed by a modification of the procedure described 
by Zinn et al . (Zion et al.. 1983). Two or five ).1g of total cellular 
RNA plus tRNA to make a total of 25 ).1g were coprecipitated with probe. 
Sampl es were redissolved in 30 ~l of RNA hybridization buffer , (40 roM 
Pipes p H 6.7, 400 roM NaCl, 1 roM EDTA, 80% formamide) denatured at 80 0 
for 10 minutes , and hybridized for >12 hours. Probe concentrations and 
hybridization temperatures were optimized so that hybridizations 
proceeded to at least 90% o f completion in 12 hours. Hybridizations 
were digested with the addition of 300 ~ l of 1500 units/ml RNase T1 
(BRL) in RNase digestion buffer (10 roM Tris pH 7 . 5, 300 roM NaCl, 5roM 
EDTA) for 60 minutes at 30 0 , followed by 200 ~l of 250 ~g/ml proteinase 
K, 1% SDS for 15 minutes at 30 0 . Handling of samples containing 
dissolved BAC acrylamide was facilitated by co-precipitating RNA samples 
and probe out of 100 roM 2-rnercaptoethanol and using well silanized 
tubes. Samples were prepared for electrophoresis, fractionated on 5% 
denaturing acrylamide gels, dried, and exposed to X-ray film. Count per 
minute data were also obtained from dried gels on a phosphorirnager 
(Molecular Dynamics) and converted to transcript per cell data using 
internal CPM standards. 
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Rellult. 
One goal of this work was to compare and contrast the regulatory 
consequences of conditional rnyc expression with the regulatory 
consequences of 
con sequen ces of 
seemed possible 
conditional max expression and the regulatory 
simultaneous expression of both proteins . I t also 
that the response of particular myc regulated genes 
identified previously might have been limited by max availability. By 
testing these genes in dif f erent rnyc and max environments , we hoped to 
identify target : regulatory condition combinations where the magnitude of 
response is especially robust and therefore suitable for subsequent 
biochemical level analyses. 
In previous work we identified a number of transcripts regulated 
by myc (see chapter 2) . The conditional myc expressing systems used to 
detect myc respons i veness were 3-SB cells, a NIH 3T3 based cell line 
that expresses a metallothionein-I promoter driven c-myc gene (myc23c, 
see chapter 1) and MER-H6 cells, a Balb/c 3T3 based ce ll line that 
expresses a c-myc estrogen receptor fusion protein (mycER, see Eilers 
et a1., 1989; Eilers et al ., 1991). In this study, we have expanded the 
test cell repertoire to i nclude two of the four known forms of max 
(B l ackwood and Eisenman 1990; Prendergast et al ., 1991; Makela et al. , 
1992). These alternative max forms are thought to result from : (1) an 
alternative splicing event that inserts 9 amino acids near its N-
terminus , yielding max-9 (Blac kwood and Eisenman 1990; Prendergast et 
al. , 1991), and (2) an independent alternative sp l ice near the C-
terminus of the leucine repeat, resulting 
truncated prote i ns called ~max and Amax-9 
in synthesis of c-terminal 
(Makela et a1 . , 1992). The 
latter two max species were discovered while the work reported here was 
in progress and were therefore not tested. 
Preparation of max expressing cell lines . To facilitate selection 
of max expressing cell l ines and subsequent biochemical studies , we 
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prepared meta l lothionein-I promoter driven conditional expression 
vectors for HAl epitope tagged (Wilson et al., 1984) max and max-9, 
termed LEmax and LEmax-9, respective l y. These were stably cotransfected 
with either G418 or hygromycin B resistance into NIH 3T3, 3-5B, Balb/c 
3T3 , and MER H6 cells. Transfections and cell culture were carried out 
exclu sively on fibronectin coated p l ates. The resulting cel l lines were 
ma i ntained at re l atively l ow density and were always refed within 24 
hours of splitting until they were well established in culture. These 
h a ndling precautions were suggested by preliminary studies of cell lines 
expressing ectopic myc and max polypeptides. 
Cell lines expressing the tagged max proteins were identified by 
irnmunostaining mock and zinc induced cells for the presence of t he HAl 
epitope. The max expressing cell lines subsequently identified shared 
with previously isolated myc and max expressing cel l lines (data not 
s hown ) the characterist i cs of growth arrest at relat i vely low density 
and a propensity for fibronectin coated plates. Names and genotypes of 
both conditional max and myc plus max co-expressing cell lines are 
presented in table 1 . 
Cell line characterization 
Regulatory effect. on cell cycle progression . Conditional 
express i on of myc in growth arrested cel l s can lead to emergence from 
growth arrest and progression through S-phase (Armelin et al., 1984; 
Cavalieri and Goldfarb 1987; Eilers et al . , 1991); this is true both in 
ce l ls that have been growth arrested at low density in serum free 
defined medium and in ce l ls that have been growth arrested by contact 
inhibi tion in medium containing 5% cal f serum (see chapter 2, also 
Hevezi and Bishop , unpublis hed) . We fou nd t hat survi val of the myc plus 
max co-expressing ce l l l i nes was very poor in the defined med i um growth 
arrest system (Zhan and Go l dfarb 1986 , see a l so chapters 1 and 2) used 
in previous work . On the other hand , over the timecourse required for 
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Derived Proximal myc max Conditional progression: 
cell line parental line transgene transgene basal induced 
NIH3T3 NIH 3T3 0 0 
30-1 NIH 3T3 LEmax 0 0 
31 -4 NIH 3T3 LEmax-9 5 5 
3-58 NIH 3T3 myc23c 30 75 
37-3 3-58 myc23c LEmax 20 (both) 50 
38-8 3-58 myc23c LEmax-9 20 (both) 65 
8alb/c 3T3 8alb/c 3T3 0 0 
32-7 8alb/c 3T3 LEmax 0 0 
34-3 8alb/c 3T3 LEmax-9 5 5 
MER #6 8alb/c 3T3 myc ER 5 55 
-{{max) 10 
36-7 MER#6 myc ER LEmax-9 5 {myel 80 
(both) 80 
Table 1. Summary o f ce ll lines presented in this wo rk. The first four 
columns give the name and genotype of each ce l l line used in this work . 
For the progression experiments presented in the last two columns, 
cells were seeded and brought to growth arrest in medium containing 5% 
calf serum as indicated in materials and methods. Arrested ce ll s were 
mock, zinc (20 I'M), ~-estradio1 (100 nM), or zinc plus ~-estradiol 
stimulated as appropriate to the conditional my c and/or max genes 
expressed by each line. Cells were BrdU labelled from 14 to 24 hours 
following stimulation . Fixation and inununoperoxidase staining were as 
in materials and methods. Approximately 200 ce lls were counted for 
each condition ; data are rounded to the nearest 5%. The conditional 
progression (index) is the number of BrdU stained cells divided by the 
total number of cel l s . 
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our experiments, the co-expressing cell lines tolerated well contact 
inhibition in medium containing 5% calf serum. Therefore, we chose this 
culture arrest condition to compare both the cell cycle progression 
effects and mRNA regulatory capacities of conditiona l max expression, 
conditional myc expression, and max-supplemented conditional myc 
expression. 
The results of cell cycle progression experiments are presented in 
columns 5 and 6 of table 1. Several results stand out: (1) As measured 
by the fraction of cells incorporating BrdU, MER *6 and derived cell 
lines were subject to efficient growth arrest by contact inhibition in 
medium containing 5% calf serum. However, while 3-SB cells were growth 
arrested efficiently at low density in serum free defined medium 
(chapterl, chapter2), 3-5B and its max expressing derivatives were much 
less efficiently arrested by contact inhibition in medium containing 5% 
calf serum (compare an arrested labelling index of -2% in defined medium 
to 20-30% in serum containing medium). (2) Transgene max expression 
alone did not stimulate progression to S-phase in any of the cell lines 
tested. (3) The Balb/c 3 T3 based mycER plus LEmax-9 expressing cell 
line 36-7 is subject to efficient growth arrest by contact inhibition 
and reenters the cell cycle with unprecedented efficiency among myc 
lines (labelling index of 80%) following activation of conditional myc. 
In comparison with the parental MER 1#6 cells , this represents a 
significantly increased progression efficiency (80% versus 55%) and 
approaches the typical response (95%) to full serum stimulation . Since 
the difference between 36-7 and MER 1#6 cell s is detectable with or 
without up-regulation of transgene max expression , the difference could 
be either clonal variation or a consequence of basal max overexpression 
from the transgene . (4 ) Basal expression of max alone from the Mt-I 
promoted transgene appears to promote and stabilize growth arrest . The 
observation is that monolayers o f myc and myc plus max co-expressing 
cell lines pass through a stage in which they are relatively tightly 
packed, continually shed floating cells, and eventually become sub-
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confluent. In contrast, max expressing cell lines form mono layers at 
lower density than parental NIH and Balb/c 3T3 cells . Over long periods 
of arrest, these monolayers appear to be more stable than rnonolayers of 
parental cells. 
Auto and cross regulation invo1ving myc and max . The longstanding 
observation of myc autoregulation (Adams et al . , 1983; Nishikura et al., 
1983) suggested that we should also look for max autoregulation and 
cross-regulation between myc and max. Our stably transfected cell lines 
should allow us to use the endogenous myc and max genes as reporters of 
these potential phenomena. Table 2 presents a survey of endogenous 
c-myc and total max transcript levels across the set of cell lines; the 
hsp 70 transcript MHS 214 (Lowe and Moran 1986) serves as a sensitive 
control for any stress response to the induction conditions. In this 
experiment, the myc transgene and endogenous RNAs were readily 
discriminated. However, the max riboprobe that we used did not 
efficiently distinguish between natural and trans gene max; consequently, 
max level s are the sum of the transgene and endogenous RNA species. 
As expected from prior immunocytochemical screening of the max 
cell lines, all expressed the transgene max RNA. Significant 
conditional induction above basal levels was achieved in the LEmax-9 
cell lines 31-4 (S-fo1d), and 34-3 (12-fold). In contrast, the LEmax 
lines (30-1, and 32-7) expresses no more than 2-fold more total max RNA 
than does their parental line . 
A striking and unexpected observation was that max up-regulation 
powerfully induces c-myc express ion. In three of the max transgene 
expressing lines (30-1. 31-4 . a nd 32-7) the natural c-myc transcript was 
overexpressed 2- to 3-fold under both basal and induced conditions . In 
the fourth conditiona l max cel l line, c-myc RNA initiated from the 
dominant P2 promoter was induced 20-fold in response to conditional max 
expression. This phenomenon is clearly important for the interpretation 
llO 
Table 2 . Expression of mye, max, and hsp 70 in conditional myc and/or 
max expressing cell lines. Cells were seeded and brought to growth 
arrest in medium containing 5% calf serum as indicated in materials and 
methods. Cel l s were harvested for RNA preparation 8 hours fo l lowing 
induction. For Balb/e 3T3 cel l s and derivitives, induction conditions 
were 100 nM ~ -estradiol or 20 11M zinc. For NIH 3T3 cells and 
derivi tives, the induction condition was 25 ~ zinc. RNAs were analyzed 
by ribonuclease protection . Quantitative data from each set of 
protections were obtained from the dried gels on a phosphorimager 
(Molecular Dynamics). Transcript prevalences were calcu l ated from 
internal CPM standards on each gel. 
Terminology: 
1 . Transcript abundance data are given in transcripts per cell, 
ca l culated as: 
protected com (ug total RNA·1) X 
protected probe activity , cpm mol·1 
1 Ltg total RNA X 6.02 x 1023 molecules mole-1 
50,000 cells 
corrected for probe decay over the course of the experiment. 
More accurately, this is a measure of transcripts per 20 P9 of 
total RNA; in our experience, a reasonable estimate of the RNA 
content of growth arrested 3T3 cells. 
2 . Normalized fold change is : 
fold cbange upon indyction in conditional cell line 
fold change upon induction in control 3T3 cell line 
3. Ratio to parental is : 
transcript prevalence in induced conditional cell Hne 














































































































































































































































































































































































































































































































































































































































































of subsequent effects, as high max levels are now appreciated to carry 
with them elevated c-myc. 
Endogenous c-myc transcript levels have previously been shown to 
be subject to transcriptional autorepression (Cleveland at al. , 1988; 
Grignani et al., 1990; Penn et al., 1990) . Here , that phenomenon was 
ref l ected by 1.5- to 3-fold repression of the natural c-rnyc transcript 
in response to conditional myc activation in each of the relevant lines. 
Finally, the hsp 70 control was neither basally overexpressed nor 
significantly induced under any of the regulatory conditions presented 
(table 2) . 
Regulation by max expre s s i on . 
The observation that up-regulation of the c-myc transcript occured 
in all of the max overexpressing cell lines motivated further 
investigation of max as a possible regulator of other immediate early 
and mid-SR class genes. Using the LErnax-9 expressing Ealb/c 3T3 line 
34-3, we first asked how regulation by conditional max expression 
depended on the growth state of the cells. In figure 1A we compare the 
effects of conditional max expression in arrested and growing cells, 
using one immediate early serum response transcript, c-myc , and two 
mid-SR transcripts, I-8-29 and ornithine decarboxylase, as reporters. 
The hsp 70 transcript MRS 214 served as control . The result was clear; 
all three serum regulated transcripts responded strongly to conditional 
max expression in growth arrested cells but showed little to no response 
in exponentially growing cells. Furthermore, the difference between 
responses in arrested and growing cells was not due to performance of 
the conditional expression system; LErnax-9 was sharply induced in both 
cases. 
Figure IS presents normalized un induced transcript levels for the 
induced reporters c-myc, ornithine decarboxylase, and I-8-29; tenascin, 
which was overexpressed but not induced; and hsp 70. Here there were 
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Figure 1 
transcript growth arrested cells growing cells 
[zinc], 11M 
• o 10 20 o 10 20 
LEmax-9 .......•......... ! ............. 15 ,,;:;;*~~T. :, ·: , < . 
c-myc • 29 (IJj ii f !EFi . 1 .2 
1-8-29 fJ!:'::J)WCIIlcr 1 .3 










~ 8 ~ -" ~ 6 " " c 'c 








c-myc ODe 1-8-29 
IS:! Balb/c, arrested 
II 34-3, arrested 
~ 34-3, growing 
tenascin hsp 70 
Figure 1 . Comparison of conditional max expression in GO arrested a nd 
growing cells. A. Transcript reponses to conditional max expression. 
Zinc induction: a = mock , 10 - 10 J.lM zinc , 20 = 20 J..LM zinc , .6 
normalized fold induction at 20 )lM zinc (see definition in table 2 
legend) . B . 
growing cells. 
Comparison of basal transcript levels in GO arrested and 
Data are normalized to transcript levels in GO arrested 
Balb/c 3T3 cells . 
Culture conditions . .Go arrested cells : Balb/c 3T3 cells were 
seeded in medium containing 5% calf serum at a density of I.OxI0 6 cells 
per plate. 34-3 cells were seeded in medium containing 5% calf serum 
at a density of 7.5xlOS cells per plate. The cells were refed 24 hours 
later and zinc stimulated 72 hours after that . Growing cel l s: 34-3 
cells were seeded in the same medium at a density of 1 . OxlO S cells per 
plate. They were refed 48 hours later and zinc stimulated 48 hours 
after that. 
RNA preparation . In all cases cells were harvested 8 hours after 
induction. mRNAs were analyzed by ribonuclease protection. 
Quantitative data from each set of protections were o btained from the 
dried gels on a phosphorimager (Molecular Dynamics) . 
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two correlations that provide some explanation of the differential 
response to conditional max expression between arrested and growing 
cells. First, those transcripts that were expressed at higher levels in 
growing than arrested 34-3 cells were also inducible by conditional max 
expression. Second, 
growth arrested 34-3 
for the inducible reporters, 





arrested Balb/e cells . However, tenascin in arrested 34-3 cells, and 
all of the reporter transcript levels in growing 34-3 cells, were higher 
than in arrested Balble cells . Thus basal overexpression, whether due 
to growth state or a difference between the cell lines, correlated with 
reduced or abrogated responsiveness to c onditional max expression 
Because the immediate early serum response gene c-myc responded 
more strongly to conditional max expression than did any of the mid-SR 
transcripts examined, we examined the timecourse of response of other 
immediate early serum response transcripts to the regulatory pattern 
initiated by conditional max expression in growth arrested 34-3 cells 
(figure 2). Panel A presents total transcript levels for max and c-myc 
over the timecourse of the experimenti of three RNA level experiments 
performed with this cell line, this one showed the smallest regulatory 
responses to max expression that we observed. Even so, c-myc transcript 
levels were induced 11-fold by 4 hours after stimulation of max 
expression. Furthermore, no response was detected from either the 
hsp 70 transcript MHS 214 or the c-fos transcript, both of which are 
extremely sensitive to the toxic effects of heavy metal poisoning (c-fos 
is shown in panel B, hsp 70 data are not shown). This is strong 
evidence that the observed responses were to the myc and max regulators, 
not a zinc stress response. In addition, the expected p23 LEmax-9 
protein synthesized during the 2 to 4 hour induction window is detected 
by immunoprecipitation (appendix A) . 
Panel B presents transcript accumulation rates for the 
transcriptional regulators c-fos, fra-I, c-jun, c-myc, and p53 tumor 
antigen. Like c-myc, the immediate early serum response class AP-l 
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Pigure l . Response of a subset of immediate early and mid-SR class 
transcription factor transcripts to conditional max expression in growth 
arrested cel l s. 34-3 cells were seeded and brought to growth arrest in 
medium containing 5% calf serum as indicated in materials and methods. 
Arrested cells were mock or zinc (20 J.1 M) induced over an 8 hour 
timecourse and then harvested for RNA preparation. RNAs were analyzed 
by ribonuclease protection. Quantitative data from each set of 
protections were obtained from the dried gels on a phosphor imager 
(Molecular Dynamics). Transcript prevalences were calculated from 
internal CPM standards on each ge l . A. Total transcript prevalence for 
max and c-myc. B . Transcript accumulation rates (calculated as 
[.6. transcripts cell- 1 / .6. time] over each interval) for the 
transcription factor transcripts c-myc, c-fos, c-jun, fra-l, and p53 
tumor antigen. c. Transcript accumulation rates for the mid-SR 
transcripts Gl cyclin 02, Gl cyclin 03, I-8-29, and p53 tumor antigen. 
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fami l y members fra-l and c-jun also responded, but c-fos did not. The 
kinetics of c-jun expression were quite fast; its accumulation rate 
peaked within 90 minutes of the point at which max expression was 
stimulated. Fra-l and c-myc responded with slightly slower kinetics, 
and the response of the p53 tumor antigen transcript was reminiscent of 
mid-SR kinetics. Panel C presents transcript accumulation rates for the 
rnid-SR genes p53 tumor antigen , 1-8-29, Gl cyclin 02, and Gl cyclin 03. 
While the tirnecourses of the p53 tumor antigen and 1-8-29 transcript 
responses resembled those expected for mid-SR genes, the Gl eyel in 
timecourses do not. In particular, the Gl cyclin transcripts responded 
early and then decayed away as the cells approached (in a temporal , not 
a biochemical sense) what would be the restriction point if they had 
been driven into a productive cell cycle. 
Regulation of other transc ripts by c on d ition a l myc e xpression with or 
without augmented max . 
The temporal pattern of c-myc and max expression during the first 
cell cycle following serum stimulated emergence from growth arrest 
suggests that the activity of a potential myc:max heteromeric 
transcription factor will peak during the extended G1 of that cycle (see 
chapter 2, also Pardee 1989; Prendergast et al., 1991; Blackwood et a1., 
1992). To identify transcripts that are regulatory targets of c-rnyc, we 
previously cloned a panel of 18 mid-SR clones . From that group of 
clones we identified a subset that are subject to regulation by c-myc 
(chapter 2) . In this work we pursued the regulation of a subset of 
those clones consisting of the anonymous cDNA 1-8-29, lactate 
dehydrogenase, heat stable antigen, ornithine decarboxylase, and 
tenascin . In a conceptually similar cloning exercise , the G1 cyclins 
D1, D2, and D3 were identified as members of the rnid-SR class 
(Matsushime et al., 1991); we subsequently found that G1 cyclin D2 is 
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regulated by c-myc . Finally we followed the expression of another rnyc 
regulated gene, prothymosin a (Eilers et al., 1991; chapter 2). 
In table 3 we compare the regulation of this panel of mRNAs in 
cell lines that conditionally express myc (MER #6 and 3-SB) with 
derivative cell lines that, in addition to conditionally expressing a 
myc protein , basally overexpress LEmax-9 (36-7 and 38-8). The main 
issues in surveying the effects of conditional royc expression on the 
members of this set of target genes are: (1) The magnitude of response 
of individual targets to induced rnyc expression under this arrest 
condition. (2) Possible differences between that response in this 
arrest condition and the low density defined medium arrest condition of 
chapter 2. (3) The consequences of added max expression upon either 
absolute reporter transcript levels or response to conditional myc 
expression. 
Up-re gulation in re s p onse to myc e xpre s s ion . The magnitude of the 
response of myc up-regulated genes in the Balb/c ..... MER #6 system was 
consistently equal to or greater than it was when those responses were 
measured in the culture condition of growth arrest at low density in 
defined medium (see chapter 2) . On the other hand, the magnitude of 
target gene responses to conditional myc expression in the NIH ..... 3-SB 
system was quite similar in both culture conditions. Supplementation of 
max expression in the conditional myc expressing cell lines had 
substantial effects on target expression, but those effects varied from 
target to target. 
The regulatory pattern of 1-8-29 provides an especially 
interesting example. In the Balb/c ..... MER #6 ..... 36-7 series, the transcript 
was S.S- to 7 . S-fold induced by conditional myc expression; in addition, 
the transcript was both more strongly induced and expressed at higher 
basal levels in LEmax-9 expressing 36-7 cells than in MER #6 cells. 
This is a striking case sensitivity to both myc and max; estrogen 
treated 36-7 overexpressed the I-8-29 transcript 62-fold relative to 
120 
estrogen treated Balb/e 3T3 cells. In the NIH'3-SB'38-8 series, the 
I-8-29 transcript was 5- to 6-fold basally overexpressed in both myc 
expressing cell lines, but its additional response to conditional rnyc 
expression was less than 2-fold . 
Gl cyclin D2 and lactate dehydrogenase followed a different 
regulatory pattern. Gl eye lin D2 was induced 2- to 3- fold from basal 
levels in both MER #6 and 36-7 cells, i.e., there was no apparent effect 
due to added max expression. In the NIH system, this same transcript 
was induced just less than 2-fold in both 3-5B and 38-8 cells, but the 
basal level of its expression increased with increasing basal max 
expression. A similar pattern of regulation held for lactate 
dehydrogenase, except that it was slightly more strongly dependent on 
conditional myc expression in the Balb/c~MER #6 ~36 -7 series and slightly 
less dependent on conditional myc expression in the NIH*3-SB*38-8 
series. 
Down-regulation in r e spons e t o myc express i on . Heat stable 
antigen is expressed at modest levels in Balb/c 3T3 cells, but is not 
expressed in the NIH 3T3 isolate in which 3-SB and 38-8 cells were built 
(other NIH 3T3 cells do express this transcript). Basal transcript 
levels for this gene were similar across the Balb/c~MER #6 ~36 -7 series. 
The transcript was 2- to 3-fold repressed by conditional myc expression, 
and the magni tude of repress ion increased wi th added max. The 
regulatory response of the transcript for tenascin may be the most 
unexpected of all. The transcript is repressed by myc. In the 
Ba1b/c'MER #6 '36 -7 series 
MER #6 cells relative to 
this was reflected by basal repression in 
Balb/c 3T3 cells and by repression wi th 
conditional myc expression in 36-7 cells. In the NIH '3-S B'38-8 series, 
repression of the tenascin transcript by myc was observed only upon 
induction of myc expression. However , basal expression of the tenascin 
transcript was dramatically increased with the presence of the LErnax-9 
transcript; basal expression was 7-fold higher in 36-7 cells than in 
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MER *6 cells, and basal levels increased with max expression across the 
NIH A 3-5B A 38-8 series so that they were 25-fold higher in 38-8 cells than 
in NIH 3T3 cells. 
122 
Transcript Balb/c 3T3 based lines NIH 3T3 based lines 
cell line: ~ MEB ;J§:I NIH ~ 38-8 
max transgene: LEmax-9 LEmax-9 
myc transgene: mycER mycER myc23c myc23c 
Q 1 ~ll~lill [l2 
basal 69 84 65 9.7 13 33 
zinc treated 10 25 60 
estrogen treated 71 190 180 
normalized A (1 .0) 2.2 2.7 (1 .0) 1.8 1.7 
ratio to parental 2.7 2.6 2.5 5.9 
(> 1 ~ll~lill [lJ 
basal 48 38 47 27 35 46 
zinc treated 29 39 61 
estrogen treated 48 51 68 
normalized A (1 .0) 1.3 1.5 (1 .0) 1.0 1.2 
ratio to parental 1.1 1.4 1.3 2.1 
l:a:2a 
basal 1.5 6.9 12 1.3 8.1 7.3 
zinc treated 1.7 1.7A 14 16 
estrogen treated 1.4 37 87 
normalized A (1 .0) 5.7 7.5 (1 .0) 1.3 1.7 
ratio to parental 26 62 8.3 9.2 
la!<lalll dllblld[Q\lllllaSll 
basal 44 66 32 76 160 220 
zinc treated 60 97A 390 370 
estrogen treated 50 340 150 
normalized A (1 .0) 4.5 4.0 (1 .0) 1.9 1.3 
ratio to parental 6.7 3.0 4.0 3.8 
QmitbiD~ d~arbox!llii1se 
basal 14 24 22 7.8 16 30 
zinc treated 9.3 46 63 
estrogen treated 14 81 62 
normalized A (1 .0) 3.3 2.8 (1 .0) 2.5 1.8 
ratio to parental 5.9 4.5 5.0 6.7 
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Transcript Balb/c 3T3 based lines NIH 3T3 based lines 
cell line: Balb/c ME.B 36-7 tilli ~ ~ 
max transgene: LEmax-9 LEmax-9 
myc transgene: mycER mycER myc23c myc23c 
~[Qlbll[]lQ~iD a 
basal 860 980 620 270 880 660 
zinc treated 340 1,300 1,200 
estrogen treated 1,100 2,100 1,300 
normalized I; (1 .0) 1.7 1.6 (1.0) 1.2 1.5 
ratio to parental 1.9 1.2 3.8 3.6 
tenascin 
basal 8.6 2.6 19 4.3 27 110 
zinc treated 5.9 20 78 
estrogen treated 8.4 2.2 12 
normalized I; (1.0) 0.85 0.66 (1 .0) 0.52 0.53 
ratio parental 0.26 1.5 3.3 13.1 
b!i!a! stable l!O!ig!i!O 
basal 34 38 37 this transcript is not 
zinc treated expressed by NIH 3T3 cells 
estrogen treated 37 23 13 
normalized I; (1.0) 0.54 0.32 
ratio to parental 0.61 0.35 
Table 3 . Expression of myc target genes in conditional myc express ing 
ce ll lines. Cells were seeded a nd brought to growth arrest in medium 
containing 5% calf serum as indicated in materials and methods. Ce lls 
were harvested for RNA preparation 8 ho urs following induction. For 
Balb/c 3T3 ce ll s a nd derivitives, indu c tion conditions were 100 nM ~-
estradio l or 20 IJM zin c . For NIH 3T3 cel l s a n d derivitives , the 
induction condition was 15 flM zinc for t h e transcripts 1-8-29 and 
lactate dehydrogenase (marked A) a nd 25 flM zinc for all of the others . 
Quantitation a nd a nalysis are as in table 2. 
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Oi.cuaeioo . 
The regulatory effects of myc and max expression can be measured 
indirectly via a number of assays. They vary from inhibition of 
differentiation by myc to in vitro DNA binding by both max homodimers 
and myc:max heteromers at the E box sequence CACGTG . However, without 
knowing the direct effects of myc and max expression on their 
physiologic targets together with some understanding of those targets ' 
function, it is not possible to connect myc and max biochemical 
functions with the biological effects of their expression. 
Cell cycle progression and transformation. Provocative parallels 
can be drawn between: (1) Cotrans formation by myc and act ivat ed ras 
proteins. (2) The consequences of adding max genes to the myc/activated 
ras cotransformation assay. (3) Cell cyc le progress ion in response to 
conditional myc expression . (4) The effects of adding max to cell cycle 
progression experiments, and (5) The growth characterist i cs of max 
overproducing ce ll lines . Thus myc, originally recognized as an 
immortalizing oncogene, cooperates with act ivated transforming 
oncogenes, e.g. , Ha-ras, in transformation assays such as rat embryo 
fibroblast focus formation assays (for reviews, see Bishop 1986; Cole 
1986 ). At low concentrations , added max aids the activity of myc in the 
cotransformation assays (Prendergast et al., 1991) at higher 
concentrations max can become inhibitory, but L\max maintains its 
cooperativity (Makela et al. , 1992). (3) , (4), and (5): Conditional 
expression of myc in growth arrested immortalized cell lines stimulates 
emergence from growth arrest and progression through S-phase (Armelin et 
al., 1984; Cavalieri and Goldfarb 1987; Eilers et al., 1991). Addition 
of transgene max to the condit i ona l myc expressing cell line MER #6 can 
increase the efficiency of conditional cell cycle progression to near 
quantitative levels, but overexpression of max by its e lf is 
qualitatively anti progressive. Thus the effects of myc and max may be 
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parallel in the two assay systems, suggesting that they are both 
measures of the same underlying regulatory phenomenon. 
Regulatio n of mRNA 8xprasaion by myc and max . The expression 
timecourse of c-myc following serum stimulation of growth arrested 
cells, its nuclear localization, its DNA binding capacity (as a myc:max 
heteromer), and the presence of transcription factor specific structura l 
motifs within its primary sequence (for review, see Prendergast and Zitf 
1992) all point to a transcription factor function that should be most 
evident during mid Gl of the extended first cell cycle following 
emergence from growth arrest . I n support of this hypothesis, we found 
that about 1/3 of an assortment of mid serum response transcripts are in 
fact regulatory targets, direct or indirect, of c-myc (see chapter 2). 
The promoters of two of these genes, lactate dehydrogenase and ornithine 
decarboxylase, as well as the promoter of the myc regulated gene p53 
tumor antigen, contain the E box to which myc:max heteromers and max 
homodimers can bind in vitro. Indeed, both myc : max heteromers and max 
homodimers will bind to an E box containing oligonucleotide derived from 
the lactate dehydrogenase promoter (appendix A). However. the presence 
with in the cell of a number of transcription factors , including USF/MLTF 
and TFlI-i (Carthew et a1., 1985; Gregor et a1., 1990; Roy et a1., 1991) 
that can bind this same sequence complicates the implied conclusion that 
they are directly regulated targets. 
Two related patterns become evident in summing across: (I) 
Messenger RNA up-regulation by conditional myc expression in cells that 
have been growth arrested at low density in defined medium (chapter 2). 
(2) Messenger RNA up-regulation by conditional myc expression or 
conditional myc with supplemented max expression in cells that have been 
growth arrested by contact inhibition in medium containing 5% calf 
serum . and (3) Messenger RNA up-regulation by conditional max expression 
in cells that are either proliferating in or have been growth arrested 
by contact inhibition in medium containing 5% calf serum . The first 
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emergent pattern is that when culture conditions are such that cell 
cycle reentry of growth arrested cells remains tightly dependent on 
conditional rnyc expression, the magnitude of mRNA responses to 
conditional myc expression are maintained across culture conditions 
(this follows from comparison of the Balb/cAMER 6 system in chapter 2 , 
table lA and the Balb/c AMER 6 A36-7 system in table 3; a specific 
transcripts to examine is I-8-29) . However, when the interaction 
between culture conditions and basal expression of the conditional rnyc 
transgene is such that the cells do not growth arrest efficiently, then 
the magnitude of rnyc dependent conditional mRNA regulation decreases 
(this follows from comparison of the NIH A 3-SB system in chapter 2, table 
lA and the NIH " 3-SB"38-8 system in table 3 i specific transcripts to 
examine ar prothymosin (). and ornithine decarboxylase). The second 
pattern is that when the transcript levels of direct and indirect 
targets of max are similarly low in growth arrested Balb/c 3T3 and 
LEmax-9 expressing 34-3 cells, those transcripts subject to up-
regulation in response to induced expression of max (c-myc, 1-8-29, 
ornithine decarboxylase) respond with reasonable magnitude. In 
contrast, when the un induced transcript level is higher in arrested 34-3 
cells than in arrested Balb/c 3T3 cells (tenascin), or when transcript 
levels are elevated because the cells are proliferating, then the 
response to conditional max expression is decreased or eliminated. Thus 
in both pr imar i ly myc condi t ional and primar i ly max condi t ional 
settings, good growth arrest correlates with good target transcript up-
regulation in response t o condi tio nal expression of the regulator. 
However , the degree to which this difference results from differential 
postranslational modification of the conditional regulator, versus 
functional redundancy in already growing cells, remains unknown. 
The ability of high levels of max activity to interfere with myc 
ras cotransformation might superficially suggest that max would repress 
expression of myc activated genes. However, this was a pervasive 
pattern in neither the Balb/cAMER #6 A36-7 nor the NIH A3-SBA38-8 cell 
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series . Rather, max up-regulated expression of a specific subset of the 
immediate early serum response transcript class. The most dramatic 
effect was on c-rnyc, but fra-l and c-jun were also up-regulated while 
c-fos, the most strong ly serum growth factor regulated member of that 
class (Muller et al., 1984 i Lau and Nathans 1987; Almendral et al ., 
1988), was not. In addition two myc repressed genes, c -rny c itself and 
tenascin, are induced by max overexpression. Unlike c-myc, the max 
protein is quite stable, not profoundly growth regulated, and present at 
appreciable levels even in growth arrested cells (Blackwood et al ., 
1992). If its functionality either alone, in a heteromeric complex with 
other non rnyc proteins, or in cooperation with other regulators of the 
immediate early serum response, is rapidly stimulated via the protein 
synthesis independent regulatory pathways activated by polypeptide 
growth factors, then it would in fact fit as a regulator of immediate 
early express i on . 
Future prospects. By definition, each of the myc and/or max 
regulated genes we have examined possesses it own unique promoter, 
splicing patterns, characteristics of mRNA stabi lity, etc. 
Consequently, each of them responds to conditional myc and/or max 
expression with its own directional, magnitudinal, and temporal pattern. 
One goal of this work has been to identify those targets whose 
regulation by myc and/or max suggest a particularly promising entree to 
biochemical level analyses. Cl early . the most strongly myc up-regulated 
gene we have identified is r-8-29; a full cDNA sequence and analysis of 
the genomic clone are high priorities. Tenascin and c-myc both provide 
examples of transcripts that are repressed by conditional myc expression 
but up-regulated by max. c-myc is particularly amenable to ana lysis 
because we have both cDNA and genomic clones. Fra-l provides a good 
example of a gene up-regulated by max but largely unregulated by myc 
alone . Both cDNA and genomic clones are in hand and can now be used to 
extend our analysis of its max response. 
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Studying transcript regulation by c-myc in a conditional 
environment where myc expression stimulates emergence from growth arrest 
and cell cyc le progression poses a familiar problem in dissecting 
regulatory cascades: Are the targets we can identify directly regulated 
by myc, or are they indirectly regulated via the rnyc induced ce ll cycle? 
That molecular level question will be answered by direct molecular and 
biochemical studies of the individual regulators . However, the question 
itself implies that the pattern of up and down regu lation controlled by 
rnyc is sufficient to emergence from GO and progression across Gl to 
S-phase. Thus understanding the physiologic role of the myc proteins at 
a ce ll biological level will require continued cloning and functional 
analysis of these targets. Our indirect cloning approach (chapter 2) 
was successful but tedious. However, the difference in the levels of 
expression of 1-8-29 in growth arrested Balb/c 3T3 cells and estrogen 
stimulated {mycER plus LEmax-9) 36-7 cells suggests that a direct 
subtractive cloning approach is now within reach . 
Transcript up-regulation by conditional max express i on poses the 
opposite problem: Why does max up-regulate expression of a variety of 
immediate early regulators but not stimulate cell cycle progression? 
Since max activates a distinct subset of immediate early class 
transcripts, for instancec-myc , fra-l, and c-jun, but not c-fos, the 
answer must lie in the pattern and downstream functions of those genes 
that are regulated. Happily, extensive libraries of immediate early 
probes are available (Lau and Nathans 1987 i Mohn et al., 1991), 
rendering the first step of that problem immediately accessible to 
experimental analysis . 
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At the cell biological level, the functions of the myc family 
proteins will eventually be understood in terms of the identities and 
roles of the genes that they regulate and the various physiological 
contexts in which that regulation takes place. At the molecular level, 
the functions of the rnyc family proteins will ultimately be understood 
in terms of the protein:protein and protein:DNA interactions in which 
they participate and the biochemical modifications that regulate their 
activity. Taken together: (1) the cloning of rnyc target genes presented 
here and elsewhere (Prendergast and Cole 1989; Eilers et al ., 1991; Yang 
et al ., 1991), (2) identification of max, a bHLHzip pairing partner of 
the myc family proteins (Blackwood and Eisenman 1990; Prendergast et 
al., 1991), (3) the in vi tro def ini tion of an E box DNA sequence to 
which they can bind (Blackwell et al., 1990; Kerkhoff et al., 1991; 
Prendergast and Ziff 1991), and (4) development of cell systems in which 
effects of conditional myc (chapter 1, Cavalieri and Goldfarb 1987; 
Eilers et al., 1991i Miner and Wold 1991) and/or conditional max 
(chapter 3) expression can be studied, comprise a powerful set of tools 
with which to probe myc function. 
This thesis includes a substantial contribution to that progress. 
In chapter 1 we described a conditional c-myc expression system and 
defined a physiologic setting where that conditional expression produced 
clear phenotypic effects on both cell cycle progression and mRNA 
expression. However, the primary impact of that work was that it forced 
the conclusion that the methodical cloning of myc target genes was 
required. During that study, possible myc target genes reported in the 
literature, such as hsp 70 (Kingston et al ., 1984; Kaddurah-Daouk et 
al., 1987), were tested and proved not to be detectably regulated by 
myc. The experimental system established in that work also suggested an 
eventually suc cessful approach to the problem. Finally, this cell 
system provided the experimental basis for a study of the effects of 
conditional c-myc on MyoD initiated muscle differentiation (Miner and 
Wold 1991) . 
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Chapter 2 presents the cloning of rnyc regulated genes . The 
frequency with which myc targets were identified among a panel of cDNAs 
subject to either upregulation or downregulation during Gl of the first 
cell cycle following serum stimulated emergence from growth arrest 
(mid-SR class genes) suggests that up to one-third of all such genes may 
be myc targets. Although the screening effort was extensive, it was not 
saturating; statistical considerations suggest that we identified only a 
fraction of the myc target gene class. We were also able to identify a 
number of other target genes by screening mid-SR class genes cloned 
elsewhere whose identities suggested their possible involvement in 
proliferation . In sum, the myc target gene class has been extended to 
include several extracellular matrix proteins, one anabolic and one 
catabolic enzyme, a differentiation marker, several important cell 
proliferation regulators, and an assortment of unidentified genes (see 
summary table). 
While that cloning effort was in progress, two research groups 
identified max , a gene encoding several bHLHzip proteins that can form 
DNA binding oligomers either alone or in a complex with myc family 
proteins. Chapter 3 incorporated conditional max expression into the 
experimental paradigm begun in chapter 1. Reexaminat ion of the myc 
target gene set identified individual members that are cooperatively 
upregulated by myc and max and members that are regulated in opposite 
directions by myc and by max. In addition we made the suprising 
observation that max is a regulator of a specific subset of the 
immediate early serum response gene class. 
A aummary model of myc and max function . 
Although new discoveries concerning the regulatory mechanisms 
underlying myc's profound biological act ivities are being made rapidly, 
enough has been learned through this and other recent work to develop a 
working model that relates myc and max biochemistry to their cellular 
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effects. Figure 1 summarizes what has been learned about various myc 
and max phenotypes, correlates those phenotypes with relative myc and 
max concentrations, and so provides the framework for the model. The 
model presented is the simplest one that can accornodate all current data 
and makes several readily testable predictions. In this model, the 
primary determinants of the rnyc overexpressing phenotype are the 
absolute l evel of rnyc :max heteromers and the ~ of myc :max heteromers 
to max:max homodimers. In addition to these two considerations, it is 
easy to imagine modulating influences not incorporated in the model . 
These include competitive interactions with other CACGTG-binding 
proteins such as USF/MLTF and TFII-i, the possible consequences of 
biochemical modifications to myc and max, the possibilities for higher-
order myc and max containing complexes, and the potential combinatorial 
interactions between max:rnax or myc:max containing complexes and other 
DNA bound regulators. While they must be recognized, these potential 
influences are not included because the data do not require them and 
because their consideration at this stage renders the model space 
unmanageable . Tests of the most simple model will indicate which of 
these are of greater or lesser importance . 
Nyc doe. not function in homotypic comple x e s . Several lines of 
evidence suggest that myc proteins cannot form functional hornodimers . 
In vitro, homodimers can only be formed from c-terminal protein 
fragments , and even then only at very high monomer concentrat ions 
(appendix A . See also Blackwell et al., 1990; Kerkhoff et al., 1991 ; 
Prendergast and Ziff 1991) . Models of the protein:protein dimerization 
specificity inherent in the leucine repeat motif suggest that the rnyc 
leucine repeat may specifically prevent homodimer formation (appendix B, 
see also O'Shea et a1., 1991; O'Shea et al . , 1992). In addition, there 
is evidence from immunoprecipitation analysis that c-myc is 
quantitatively associated with max in proliferating cells in which max 
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is apparently present 1'n sto1'ch1'ometr1'c e (B l k d xcess over c-myc ac woo et 
a!., 1992). 
The role of max . In addition to enabling formation of myc:max 
heteromers , max proteins may have a function(s) independent of myc 
proteins. The predicted structure of the max leucine repeat is 
consistent with favorable homodimer formation (appendix B) . I n vitro . 
max homodi mers form readily (appendix Ai Blackwood and Eisenman 1990; 
Prendergast and Zitf 1991; Makela et al., 1992) , and in our experiments, 
conditional max expression activa t ed a distinct subset of t h e immediate 
early serum response in a setting where there was relatively little 
c-myc protein present (chapter 3) In addition, max proteins are 
relatively stable (Blackwood et al., 1992). This stability implies 
t hat even low max mRNA levels can s upport the accumu lation of 
s i gnificanct levels of max protein 
The ~portanc. of the myc:max ratio . Together with the profile of 
genes regulated by myc and/or max, the data summarized above support a 
model in which the relative balance o f myc and max dictates functionally 
different outcomes . That difference is apparent at the molecu lar leve l, 
wh ere: (I) distinct but overlapping sets of target genes respond 
(chapter 3), and (2) where the same gene is a target o f both regulatory 
complexes , regulation can be in opposite directions, e.g., tenascin and 
c-myc itself (chapters 2 and 3). At the cell biological level, the 
d i fference in outcomes is expressed through the distinct phenotypes of 
max and myc:max overexpressing cells in normal tissue culture growth 
(chapter 3) , ras cotrans format ion experiments (Prendergast and Zi f f 
1991; Makela et al . , 1992), and cell cycle progression experiments 
(chapter 3) . 
c-Myc, either in a complex with max or in complexes with analogous 
but as yet unidentified proteins , regu l ates the expression of a subset 
of the mid-SR gene class. The work presented here (chapter 3) also 
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showed that highly elevated max regulates a distinct set of genes that 
partially overlaps the myc target gene class. In considering the 
consequences of either myc or max overexpression , it is important that 
max proteins can form homodirners whereas myc proteins cannot . They 
therefore have an asymmetric relationship with respect to homotypic and 
heterotypic complex formation. In particular, rnyc overexpression leads 
to overexpression of myc :max heterorners because, in all cases examined 
thus far, there is always some max present to function as a myc partner. 
Equally important, we postulate , is the expectation that rnyc 
overexpression will lead to downward titration of max:max hOIDodimers. 
In contrast, max overexpression leads to overexpression of max:max 
homodimers and alters the ratio of max:max homodimers to myc:max 
heteromers; however, it cannot titrate nonexistent myc:myc homodimers. 
As additional myc :max and max:max regulatory targets become known, a 
primary cause of their pattern of expression will turn out to be 
understood as the consequence of myc :max overactivity coupled with 
max :max underactivity. 
Activated ras cotransformation assays with c-myc, with forms of 
max, or with the two genes together suggest that, up to a certain 
concentration, max and max-9 cooperate with myc in the assay, but at 
higher concentrations become inhibitory (Prendergast et al., 1991; 
Makela et al., 1992) . The inference is that myc:max heteromers are the 
positive agent in the ras cotransformations. Max can become limiting 
for formation of myc:max heteromeric complexes when myc is 
overexpressed; however, vast excesses of max are expected to lead to 
max:max homodimers that can compete with , and block the function of, 
myc:max heteromers. To these observations we add the possibility that 
excess max competes with myc:max heteromers , not just directly for 
binding at their target E boxes, b u t also indirectly by regulating a 
functionally distinct target gene class (chapte 3). The effect on 
cotransformation and proliferation suggests that the sum total 
consequences of max:max overactivity are distinctly anti-proliferative. 
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Key features of this model are: (1) It posits an active role for 
max beyond formation of, and competition with myc:max heteromers. (2) 
It suggests that the ratio of myc :max to max :rnax is functionally 
important . (3) It discounts the possibility of myc homodimers, and (4) 
It suggests that a combination of the absolute myc :max and max:max 
levels, coupled with their ratio, determines the phenotypic read-out. 
We can make several experimentally accessible predictions based on the 
model, (1) In the absence of max, myc overexpression should lead to no 
observable phenotype. (2) Extreme max overexpression, probably 
obtainable only in an extremely tight conditional system suc h as the 
recently reported VP-16 lac repressor fusion system (Bairn et al . , 1991), 
should severely inhibit cell proliferation. (3) Extreme overproduction 
of either max or myc should be rescued by overproduction of the 
corresponding bHLHzip partner. (4) Finally, as the identities and 
functions of the myc:max target gene class members and max:max target 
gene class members are determined, the sum total c hange in their 
expression pattern following alterations in myc or max protein levels 
will explain the cell proliferation and anti differentiation properties 
of the myc and max family proteins . 
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Appendix A 
Towards biochemistry with myc and max 
Sean V. Tavtigian, Dawn D. Cornelison, and Barbara J . Wold 
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Two experimental approaches to myc function are near convergence. 
Reverse genetic pursuit of myc function through structural homology led 
both to the cloning of max and demonstration of in vitro DNA binding by 
max hornodimers and myc max heterodimers. At the same time. goal 
directed eDNA library screening has isolated a suite of max homodimer 
and rnyc:max heterodirner target genes. We should soon be able to begin 
analysis of their function at the molecular biology / biochemistry 
level . 
As a first step in this direction, we have uncovered pH sensitive 
DNA binding by max hornodimers and rnyc max heterodimers (figure 1), and 
demonstrated specific binding to a CACGTG E-box in the LDH promoter 
(figure 2). Using antibodies provided by Elizabeth Blackwood and Bob 
Eisenman, we have also been able to irnrnunoprecipitate LEmax-9 from 
nuclear extracts of zinc stimulated (Balb/c 3T3 LEmax-9) 31-4 cells 
(figure 3). 
Several technical points follow from the gelshifts . The 
translation extracts contained variable amounts of USF/MLTF, identified 
by its specific binding to the probe and relatively low mobility. We 
detected two myc:max heteromeric species . The higher mobility species 
increased its mobility relative to max homodimers with decreasing pH, so 
that at pH 7.0 the two complexes comigrate. Finally, the USF/MLTF, max 
homodimer, and myc:max heteromer species were all effeciently competed 
by unlabelled MM oligo in gelshifts of either the MM or LDH oligos . 
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Figure 1 . pH sensitivity o f DNA binding by max homodimers and myc 
max heterodimers. Synthetic capped RNAs encoding max! and LEAmyc2 were 
synthesized and translated essentially according to the manufacturer's 
recommendations. 2 ~l o f mock or LEAmyc translate or 1 ~l of max or 
{LEArnyc + max} cotranslate were incubated in a 15 ~l binding reaction 
with 50 fmol of the Emyc ol igo MM3. Reactions were incubated at room 
temp for 30 minutes, fractionated o n 5% (39: 1 acrylamide: bis) gels I 
dried, and subjected to autoradiography. 
pH 8 : Binding reactions were 50 roM Tris Taps pH 8.0. Gel running 
buffer was 100 mM Tris Taps pH 8.0 . 
pH 7.5: Binding reactions were 50 roM Tris Mops pH 7.5. Gel 
running buffer was 100 roM Tris Mops pH 7 . 5. 
pH 7: Binding reactions were 50 mM Tris Mops pH 7.0. Gel running 
buffer was 100 mM Tris Mops pH 7.0 
In addition to the pH buffer, binding reactions were 50 mM potassium 
acetate, 5 roM magnesium acetate, 1 roM dithiothreitol, and 5% glycerol. 
Also, individual 15 ~ l reactions contained 1 ~g of dIdC copolymer and 
100 fmol a no n specif i c sing le s tranded oligo. 
1. The max peptide used in this exercise con tained a 1 amino acid 
substitution, Leu 146 Phe , well C-terminal to the bHLHzip motif . 
2. LE.6.myc is a N-terminal deletion o f c -myc that encodes the 
influenza virus HAl epitope just upstream of the bHLHzip mo tif. 
deletion is used because full l e ngth c-myc is relatively insoluble. 
3. TeA GAC CAC GTQ GTe GGG TGT Tce 
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Fi.gure 2 . DNA binding by max homodirners and rnyc max heterodimers 
at Emyc of the lactate dehydrogenase promoter. Synthetic capped RNAs 
encoding maxI and LE.1rnyc2 were synthesized and translated essentially 
according to the manufacturer's recommendations. 1 ~l of mock, LEdmyc, 
max o r {LE&nyc + max} cotranslate were incubated in a 15 J.tl binding 
reaction with 50 fMol of the LDH promoter derived oligo LDH 4/5 1 . 
Competitions included 500 fmcl (lOx) or 5 prnal (lOOx) of the unlabelled 
Emyc ol igo MM (see figure 1). Reactions were incubated at room temp 
for 30 minutes , fractionated on a 5% (39:1 acrylamide:bis) gel, dried , 
and subjected to autoradiography . Binding buffer was 50 mM Tris Mops 
pH 7. A, 50 roM potassium acetate , 5 roM magnesium acetate, 1 mM 
dithiothreitol, and 5% glycerol . In addition , individual 15 ml 
reactions contained 1 mg o f dIdC copo l ymer and 100 fmol a nonspecific 
single stranded oligo. Gel running buffer was 100 mM Tris Mops pH 7 . 0. 
1. LDH 4/5: CCA GCC TAC ACG TGG GTT CCC GCA CGT CCG CTG GGC 
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Figure 3. Imrnunoprecipitation of conditionally expressed max from 
35 S labelled (Balb/c LEmax-9) 34-3 cells. 34-3 cells were seeded on 
fibronectin coated 15 em plates and brought to growth arrest by contact 
inhibition in medium containing 5% calf serum as in materials and 
methods of chapter 3. At t=O, cells were mock or 20 ~ zinc induced. 
At t=2h, the medium was removed, the cells were washed once with met-
medium , and then reted with 10 rnl of met- medium supplemented with 3SS 
met at 400 ~Ci/ml , +1- 15 ~ zinc. At t=4h, the cells were PBS washed, 
scraped, and placed on ice. All subsequent work was in the cold room. 
The cells were washed with TBS, then swelled on i ce for 15 min. in 
1 ml of A7.S. The suspension was adjusted to 0.6% NP40, vortexed for 10 
sec" and spun at 5,000 RPM for 5 min. to pellet the nuclei. The 
supernate was set aside as cytoplasmic extract. 150 ~ l of buffer C was 
pipetted onto the pellet followed by 15 min. of agitation. This mix was 
spun at 5,000 RPM for 5 min, and the supernate was set aside as high 
salt nuclear extract. 150 ~1 of buffer D was pipetted o nto the pellet 
followed by 15 min. of agitation . Thi s mix was spun at 5 , 000 RPM for 5 
min, and the supernate was set aside as detergent nuclear extract . 
The extracts were spun for 1 min. to pellet any remaining debris. 
Nuclear extracts were adjusted to 1 ml with LS-W2. Extracts were 
precleared with 10 ~l of a 50% slurry of BSA blocked protein A sepharose 
(Pharmacia), and then incubated with 4 ~l of a nti max serum (a kind gift 
of Elizabeth Blackwood and Bob Eisenman), 4 ~l of a mixture of 4 anti 
myc mAbs (including H60C37, the mAb used for the Western blots o f 
chapter 1, provided by Ray Koski at Amgen) , and 24 ~l of BSA blocked 
protein A sepharose with agitation for 1 hour . Irnmunoprecipitates were 
washed 4 times with LS-Wl, boiled in reducing loading dye, fractionated 




A7.S, 20 mM Tris Mops pH7.5, 10 mM KC1, 1 mM OTT, 0.1 mM EDTA, O.lmM 
EGTA, 1.0 mM PMSF, 2.6 ~g/m1 aprotinin, 1.2 ~g/m1 antipain, 
0.4 ~g/m1 chymostatin, and 1 ~g/m1 1eupeptin. 
C, 25 mM Tris Taps pH 8.0, 400 mM NaC1, 25% glycerol, 1 mM OTT, 1 mM 
EDTA, 1 mM EGTA, 1 mM PMSF, 2.6 ~g/m1 aprotinin, 1.2 ~g/m1 
antipain, 0.4 ~g/ml chymostatin, and 1 ~g/ml leupeptin. 
D, 25 mM Tris Taps pH 8 . 0 , 400 mM NaC1, 25% glycerol, 0.5% DOC, 0,5% 
SDS, 1 mM DTT, 1 mM EDTA, 1 mM EGTA, 1 mM PMSF, 2.6 ~g/m1 
aprotinin , 1.2 ~g/m1 antipain, 0 .4 ~g/m1 chymostatin, and 1 ~g/m1 
leupeptin. 
LS-W1, Ix PBS, 1% NP-40, 10% glycerol, 0.2 mM PMSF, 1.3 ~g/ml 
aprotinin, 0.6 ~g/ml antipain, 0.2 ~g/ml chymostatin, and 
0.5 ~g/ml leupeptin. 
LS-W2, 0.4x PBS, 1% NP-40, 10% glycerol, 0.2 mM PMSF, 2.6 ~g/ml 
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Appendix B 
Dimerization specificity of the leucine repeat motif 
Sean V. Tavtigian 
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rntroduction 
Three related groups of DNA binding transcription factors are 
currently subjects of intense analysis at both functional and structural 
levels . These are : (1) The basic region leucine repeat [bzip] 
proteins, including GCN4, c-fos, c-jun, C/EBP , etc. (2) The basic 
region - helix-loap-helix [b-hlh] proteins, including myo D1, myogenin, 
E12, mashl, the ase proteins, etc. (3) The basic region - helix-loop-
helix leucine repeat [bhz] proteins , including c-myc, rnax/myn, 
USF/MLTF , TFE-3, AP-4, etc . These groups of proteins share the 
characteristics that DNA binding is mediated by a basic region which is 
immediately adjacent to the n-terminus of whichever motif drives protein 
oligomerization, protein oligomerization is required for DNA binding, 
and the oligomerization domains are amphipathic (X-helices. Also of 
interest, each group contains members which appear to function as 
homodimers (or oligomers) [GCN4, E12, USF/MLTF] in vivo as well as 
members which preferentially (perhaps obligatorily) function as 
heterodimers (or oligomers) [c-fos, myogenin, c-myc]. 
In the case of the bzip proteins , the leucine zipper is both 
sufficient to mediate homo and hetero dimerization and determines 
pairing specificity . Likewise, the helix-Ioop-helix motif of the bHLH 
proteins appears to mediate oligomerization and provide pairing 
specificity. However, the situation for the bHLHzip proteins may be 
more complicated. For instance, some work suggests that myc proteins 
can dimerize via their HLH motif alone 6 , whereas AP-4 requires both its 
HLH and one of its leucine repeat motifs to dimerize, but becomes 
promiscuous with respect to pairing with bHLH proteins following 
deletion of its leucine repeats . S 
While the structure of a dimerized or oligomerized HLH motif is as 
yet unknown, O ' Shea et al. have recently solved a crystal struc ture of a 
dirnerized GCN4 leucine repeat . 1 As expected, the structure is a 
parallel two stranded coiled coil. On the basis of their sequence 
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similarity, the leucine repeats of the other bzip proteins, as well as 
the leucine repeats of the bHLHzip proteins, should share the sarne basic 
structure. Consequently, the GCN4 leucine repeat structure can serve as 
a starting point to assess/rationalize the observed pairing 
specificities of other bzip proteins and perhaps help clarify the same 
issue with respect to the bHLHzip proteins. 
The GCN4 structure 
Prior to solution of its crystal struc ture it was already known 
that the GCN4 leucine repeat dirnerizes as a parallel two stranded coiled 
coil . Such structures share a series of characteristics 4 : 
1. The amino acid sequenc e is arranged as a heptad repeat [a bed e f 
g] wherein the a and d positions are predominantly aliphatic and the 
9 and e positions tend to be charged. 
2. The helical repeat length is approximately 3.64 amino a c ids. 
3. The hydrogen bonds parallel to the helix axis tend to be slightly 
shorter on the hydrophobic (a,d) face o f the helix. 
4. The hydrophobic face forms the interface between the two strands of 
the coiled coil. Characteristics 2 and 3 constrain the structure 
into a shallow left handed supercoil. 
5. The cro ssing angle o f the two helices varies between 0 and 30 
degrees. 
6. The residues at positions a and d of 
holes· into the corresponding pocket 
residues of the other helix . 
one helix pack Mknobs into 
formed by the a, d , e, and g 
7. Consequently, Van der Waals interactions along the hydrophobic 
interface and salt bridges forming between charged residues at the g 
and e positions provide most of the specificity and stability of the 
structure. 
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GCN4 leucine repeat crystals were obtained from a synthetic 33 
amino acid peptide corresponding to amino acids 249 to 281 of the native 
protein. A single heavy metal derivitive was used to obtain initial 
phase angles. 
single table. 1 
A description of the x-ray diffraction data is given in a 
Statistical data are presented as oVerall ~ ~ ~ A. 
not by resolution shell. The data set is reasonably complete, with 92% 
of the native and 87% of the derivitive data used. Reflections were 
measured twice resulting in respectable Rsym values of 0 . 043 and 0 . 038. 
(I'm quoting data for the native structure first and derivitive 
structure second.) The derivitive seems quite good in that the unit 
cells dimensions are almost identical and Riso is a respectable 0.20. 
On the not so good side, the initial phase angles were ambiguous 
because only one heavy metal derivitive was used. In addition, the 
initial electron density map was continuous for 29 amino acids of one 
chain but discontinuous for the other chain . Consequently, a 
considerable amount of computer modeling and mathematical manipulation 
were used to generate the structure. The initial electron density map 
was solvent flattened and then 29 residues of one chain of the coil were 
traced. The second 
polyalanine model of 
chain of the coil was generated by rotating a 
the first chain around the noncrystalographic 
twofold symmetry axis. From this point, the model was used to calculate 
new phase data and then the electron density map was subjected to eight 
rounds of twofold averaging, solvent flattening, and phase resolution. 
At this point the authors had two different models which differed in the 
register of the sequence along the electron density map. The models 
were refined against the x-ray data; the one which gave a lower 
crystallographic R value was then further refined . 
After addition of water molecules, the final structure contained 
31 of the 33 residues in the peptide. The final crystallographic R 
value was 0.179 from 6 to 1 . 8 A resolution; the rms bond angle deviation 
was 2.5 degrees from ideal and the rms bond length deviation was 0.018 A 
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from ideal. On the one hand, these statistics suggest that the 
structure is essentially correct , potentially containing only small 
errors in sidechain p l acement. On the other hand, the second chain of 
the coi l was initially generated by a modelling step which assumed the 
twofold symmetry of the structure , yet the final structure contains a 
significant assymetry (see later). 
Superficial analyat. ot the GCN4 atructure and modeling ot c-foa and c-
jun homodimera , foa / jun heterodimera, c - myc and max homodimara, and 
myc/max heterodimera 
I found several types of analysis to be informative: 
1. Helical net diagrams 
(potential) structure. In 
methodology is employed: 
of the knobs-in to-holes packing of each 
each such diagram given, the following 
a. Polarity is n-term at the bottom and c-term at the top 
b. structures are distorted to make them fit into a spreadsheet grid. 
This alters neither prediction of the knobs-in to-holes packing 
around the A and D residues nor prediction of salt bridge 
interactions at the G and E positions 
c . The sequence of one polypeptide chain is given in BLACK. The 
sense of this chain is such that residue sidechain extend out from 
the page. (Actually, the (predominantly] leucines at position D 
extend out nearly perpendicular to the page. The other residues 
are at various angles to the page. 
d. From the GCN4 structure it is further apparent that, in the 
helical net representation, BLACK CHAIN sidechains at position G 
point slightly down with respect to the helix axis. BLACK CHAIN 
sidechains at position E point slightly up with respect to the 
helix axis . 
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e. The sequence of the other polypeptide chain is given in RED and 
residue positions are referred to as x'. In the sense of its 
orientation, this chain is a mirror image of the black chain; 
residue sidechains extend into the page. RED CHAIN sidechains at 
position E' point slightly down with respect to the helix axis , 
and RED CHAIN sidechains at position G' point slightly up with 
respect to the helix axis . 
f . With respect to this analysis, the main consequence of the G, E, 
G' , and E' sidechain polarity observed in the GCN4 structure is 
that positions of potential salt bridges can be predicted from the 
diagram and then checked in the (model) structures. Residues 
potential participating in salt bridges are circled in green and 
the distance between the sidechains in the (model) structures are 
marked. Residues pairs at II salt bridge positions II which should 
actually repel each other because of their like charges are 
circled in red. 
2. On the computer, the main chain of the polypeptide plus residue 
sidechains at positions A, D, A'. and D' ,with their Van der Waals 
surfaces, were created and photographed. Polarity is such that the N-
term is always at the bottom and the c-term is always at the top (the 
same as in the helical net diagrams.) 
a. This view allowed me to look for inconsistencies in packing along 
the hydrophobic interface. Ideally, the analysis would have 
included looking at VDW surfaces of the E, G, E', and G' residues, 
but time and overall complication prevented this. 
b. In each case the resul tant snapshot is named II x. snapl .• For 
instance, the GCN4 example is named GCN4.snapl and the fos example 
is named fos.snap! . 
3. On the computer, the main chain of the polypeptide plus charged 
residue sidechains at positions E, G, E', and G' were created and 
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photographed. Polarity is such that the N-term is a l ways at the bottom 
and the c-term is always at the top (the same as in the helical net 
diagrams. ) 
a . In each case, Asp and Glu residues are colored dark blue. Lys and 
Arg residues are colored red. 
b. Distances between the ends of potentially salt bridged residue 
pairs were measured . 
net diagrams. 
These distance are indicated on the helical 
c. In each case the resultant snapshots is named ·x.snap2- and , when 
done, ·x . snap3.- The third snapshot was only taken when there was 
something significantly different about the other side of the 
(model) structure . For instance, the GCN4 examples are named 
GCN4.snap2 and GCN4.snap3. 
SubatitutioD Me thodology 
An alignment of the leucine repeat sequences of GCN4, c-fos, 
c-jun, max, and c-myc is given (figure 1). The polarity is n-term at 
the top and c-term at the bottom. Helical repeat position assignments 
(A to G) are given along with residue positions in the dsn2 file. 
Substitutions and refinement were as follows: 
1. In the sequence alignment, all of the residues marked in red were 
substituted into the GCN4 dsn2 file using the replace command in SAM . 
2. Only residues at positions A, 0, E, and G were substituted. 
Positions B, C, and F were always left as their identity in GCN4. 
This was done to balance the fact that A, 0, E, and G residues 
participate in dimer formation with the worry that the substituted 
and refined structures are nonsense (in their fine details) and get 






















































































































































































































































3. Positions 1 and 2 (GO and AI) were not substituted because they did 
not appear to be helical in the GCN4 structure. 
4 . After substitution, the A chain was put through 20 cycles of 
refinement using the commands mode, modI, and reti. Then the B chain 
was put through 20 cycles of refinement. And then the A chain was put 
through 20 more cycles of refinement. Finally, the B chain was put 
through 20 more cycles of refinement. The A and B chains could not 
be refined simultaneously because the synthetic peptides contained an 
acetyl group at their n-term. 
The GCN4 atructur. : 
Packing along the GCN4 hydrophobic interface conforms almost 
exactly into the knobs-inta-holes model. Leucine residues at the 0/0 ' 
positions make side to side contacts along their vow surfaces, and the 
alternating repeat with Leu at the DID' positions and Val at the AlA' 
positions leads to excellent packing with little if any unfilled space 
(GCN4. snapl) . The only irregularity is an A/A ' Asn residue (Asn 16) 
that forms a hydrogen bond within the hydrophobic repeat. 
There are four pairs of potential salt bridges between G/E' and 
G ' /E positions (figure 2): Lys 15 to Glu 20 and Glu 22 to Lys 27. The 
ends of three of these pairs are separated by about 3.5 A in the 
structure and appear to form salt bridges (GCN4.snap2). The fourth, Lys 
15 to Glu 20 on one side of the structure, is forced out of position by 
the Asn 16 residues (GCN4.snap3). On the other hand, indications from 




G E' D A' A D' E G' 
4 ,5 LBJ VAL VAL LBJ 
4 C) LBJ LBJ eJ 3 ,4 GW VAL VAL GW 
3 C) LBJ LBJ ~ 2 ,3 LYS ASN ASN LYS 
2 LBJ LBJ LBJ LBJ 
1,2 LYS VAL VAL LYS 
GW LBJ LBJ GW 
0 ,1 AR3 ~ ~ AR3 
162 
Comparison: c-toa, c-jun, and fos-jun hQterod~er model structures 
The c-fos structure : 
There are no potential salt bridges between the G and E' or E and 
G ' positions. However , there are four pairs of Glu residues which cou ld 
be involved in like c harge repulsion interactions that would destabilize 
the structure (fos.snap2. figure 3). 
The central hydrophobic interface is quite regular and nicely 
filled (fos . snapl). However , there are two pairs of Lys residues 
(positions 16 and 30) buried within the hydrophobic interface. On the 
one hand, the long aliphatic stretch of the Lys sidecha in can pack 
nicely within the interface . On the other hand, the terminal amino 
group would seem to be very unfavorable. Interest ing ly, in the 
potential structure (fos.snap3) the Lys sidechains extend a ll the way 
through the hydrophobic interface to a position where they can form salt 
bridges with Glu 15 and Glu 29 (fos.snap3) (i . e . , from a G'n-l position 
to an An position in the heptad repeat) . 
The c-j un structure: 
From the helical net point of view, there are two potential salt 
bridges in the structure of the c-jun dimer: Arg 1 to Glu 6 on both 
sides of the coil. However, this part of the GCN4 structure is not 
helical, so the physical structure doesn't suggest that particular 
interaction. However , there are two pairs of Ly s residues which cou ld 
be involved in like charge repulsion interactions that would destabilize 
the structure (jun.snap2, figure 3) . 
Like GCN4, c- jun has an Asn residue at an A/A' position (Asn 16) 
that can form a hydrogen bond within the hydrophobic interface. Beyond 
that, there is an Ala residue at an A/A' position (Ala 23) which does 
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Fi.gure 3 c-jun 
G E' o A' A D' E G' 
5,6 LYS VAL VAL LYS 
5 LYS LBJ LBJ LYS 
4,5 GlJIj VAL VAL GlJIj 
4 AR3 LBJ LBJ AR3 
3,4 1l-Fl ALA ALA 1l-Fl 
3 ALA LBJ LBJ ALA 
2 ,3 GlJIj ASN ASN GlJIj 
2 G) LBJ LBJ e;J 1 ,2 LYS VAL VAL LYS 
1 G) LBJ LBJ (j 0 ,1 ILE ILE 
c-fos + c-jun c-fos 
G E' o A' A D' E G' G E' o A' A D' E G' 
5,6 LYS LBJ VAL ILE ILE LBJ LBJ ILE 
5 GW LBJ LBJ G) ~ 
LBJ LBJ C) 4,5 GlJIj LYS VAL GW LYS LYS 
4 LBJ LBJ LBJ G LBJ LBJ LBJ LBJ 3,4 1l-Fl ILE ALA GW ILE ILE GW 
3 GlJIj LBJ LBJ ALA GlJIj LBJ LBJ GlJIj 
2,3 GlJIj LYS ASN GW GW LYS LYS GW 
2 CJ LBJ LBJ G) ~ LBJ LBJ C) 1 ,2 1l-Fl VAL GW 1l-Fl 1l-Fl 
GlJIj LBJ LBJ GW GlJIj LBJ LBJ GlJIj 
0,1 AR3 1l-Fl ILE LBJ LBJ 1l-Fl 1l-Fl LBJ 
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not efficiently fill the space around it in the hydrophobic repeat 
(jun.snap1) . 
The fos-jun heterodimer structure 
From the helical net analysis, there are three potential salt 
bridges in the heterodimer structure (figure 3) : (f05 Glu 22 to jun Arg 
27 , fos Glu 8 to jun Lys 13, and fos Glu 13 to jun Lys 8). In the model 
structure, the first of these is separated by only 3.3A , while the other 
two are 7.5 to 8 A apart . There are no potential charge repulsion 
interactions that would destabilize the structure 
The central hydrophobic repeat is better than that of c-jun in the 
sense that jun Ala 23 is now next to fos lIe 23, filling the space 
between them much better. A/A ' position 16 now has a Lys and an Asn 
residue. The Lys residue cannot form a salt bridge with a nearby Glu 
residue, as in c-fos, so this interaction would seem particularly 
unfavorable . 
Compariaon : e-mye , max, and myc - max heterod~er model structures 
The c-myc structure: 
From the helical net point of view , there is one pair of potential 
salt bridges in the c-myc structure (figure 4) : Glu 8 to Arg 13. 
However, both pairs of residues are separated by 7 . 9 A in the model 
structure (myc.snap2) . On the other hand, there are two pairs of like 
charge repUlsion interactions that wou l d destabil i ze the structure : Arg 
15 to Lys 20 and Lys 22 to Arg 27. 
The central hydrophobic repeat is very irregular. There are three 
charged residues buried at A/A ' pos i t i ons: Gl u2, Lys 9, and Arg 16. 
Furthermore, the Lys residues do not seem to fill their region of the 
hydrophobic interface very well (myc.snapl) 
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The max structure: 
From the helical net point of view, there is again one pair of 
potential salt bridges in this structure : Asp 8 to Lys 13. However, 
both pairs of residues are separated by 8.9 A in the model structure 
(max.snap2, figure 4). There are no potential like charge repulsive 
interactions. 
The central hydrophobic repeat is considerably more regular than 
that of c-myc. Although there are two pairs of buried Asn residues (Asn 
2 and Asn 16) which may form hydrogen bonds as in GCN4, there are no 
buried charged residues. The hydrophobic repeat also appears well 
packed (max.snap1). 
The myc-max heterod imer structure: 
The helical net ana lysis predicts four possible salt bridges in 
the myc-max heterodimer structure (figure 4): myc Glu 8 to max Ly s 13, 
max Asp 8 to myc Arg 13, myc Arg 15 to max Glu 20 , and myc Lys 25 to max 
Glu 27. In the model strucure these charge pairs are separated by 7.9, 
9.0, 5.2, and 6.2 A, respect i vely (rnycrnax. snap2 and rnycrnax. snap3) 
There are no potential like charge r epuls ive interactions. 
The central hydrophobic repeat contains three buried charges 
residues contributed by c-rnyc : Glu 2, Lys 9 , and Arg 16. Max also 
contributes two Asn residues: Asn 2 and Asn 16. On the other hand, the 
VOW surface packing seems better than that of c-myc (rnycmax.snap1) 
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Fi.gure 4 C-MYC: 
G E' o A' A D' E G' 
4,5 s:R GLY GLY s:R 
4 LBJ LBJ 
3 ,4 LBJ LBJ 
3 LBJ LBJ 
2,3 AR3 AR3 
2 G;) LBJ LBJ ~ 1 ,2 LYS LYS 
l"Ifl LBJ LBJ l"Ifl 
0, 1 ASP GW GW ASP 
° GLN ILE ILE GLN 
0 ,-1 l'IR ILE ILE l'IR 
MYC + MAX MAX 
G E' o A' A D' E G' G E' o A' A D' E G' 
4 ,5 s:R AR3 GLY ALA ALA AR3 AR3 ALA 
4 C) LBJ LBJ AR3 GW LBJ LBJ GW 3 ,4 LYS VAL LBJ GLN GLN VAL VAL GLN 
3 G) LBJ LEU LYS GW LBJ LBJ GW 2, 3 ASN AR3 GLN GLN ASN ASN GLN 
2 G0 LBJ LEU Q G) LBJ LBJ ~ 1,2 GW ILE LYS ILE ILE ASP 
GLN LBJ HIS l"Ifl GLN HIS HIS GLN 
0 ,1 ASP ASN GW LYS LYS ASN ASN LYS 
° AR3 ILE t.£T GLN AR3 t.£T t.£T AR3 
0 ,-1 l'IR ILE ILE l'IR l'IR ILE ILE l'IR 
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Dt.cu •• ioD. 
The main questions are whether or not the structural analysis 
presented can help rationalize pairing specificities observed in vitro 
and in vivo, and whether or not the modeling has any predictive value. 
The answer to the first question is c l early yes. In the Fos/Jun 
world the order of observed binding affinity is fos+jun > jun+jun > 
fos+fos. Helica l net analysis suggests that fos/jun has three potential 
charge bridges, one 
hydrophobic repeat 
of which looks good in the model. 
looks better than either that 
And the central 
of jun or fos 
homodimers. C-jun homodimers have no potential charge bridges and two 
potential like charge repulsive interactions. But this is more 
favorable than c-fos which had 4 potential like charge repulsive 
interactions at the E/G ' and G/E' positions as well as four Lys residues 
buried in its hydrophobic repeat. 
The situation with c-myc and max is qualitatively similar. The 
observed pairing affinities are myc+max > max+max > myc+myc . Helical 
net analysis suggests that myc+max has four potential salt bridges, none 
of which look particularly good in the model. VOW surfaces fill most of 
the space within the central hydrophobic repeat, but there are several 
buried c harges . This seems better than rnax+max which has two potential 
salt bridges, neither of which looks particularly good, plus two pairs 
of Asn residues within the central hydrophobic repeat which presumably 
form hydrogen bonds as in GCN4. Final ly, myc+myc has two potential salt 
bridges between E/G ' or E' / G positions, but it also has four potential 
like charge repulsive interactions at similar positions. There appears 
to be one gap in the packing of the central hydrophobic repeat; 
furthermore, that repeat is not particularly hydrophobic - it inc ludes 6 
charged residues! 
Predictive issues are entirely experimental. For instance , could 
one design and synthesize peptides which would pair more efficiently 
with a given bzip protein than its natural pairing partner? Or could 
168 
one use synthetic peptides to clone as yet unknown bzip or bHLHzip 
proteins? Time will tell. 
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Appendix C 
Restriction map comparison programs 
Sean V. Tavtigian 
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Compute rize d r e strict i o n map compar i s o n 
An important practical goal in medium to large scale cloning 
exercises is often to reduce labor by eliminating redundant clones as 
early in the process as possible. In our work, this goal was 
accomplished in three steps . The first step was accomplished at the 
level of plaque screens, and the third step required sequence analysis 
(chapter 2) . The second step involved computerized comparison of 
restriction maps generated from the 3' ends of the selected clones. 
The programs used in this step were written in APL . The first 
program, REGRESSION, generates standard curves from gel profiles of 
molecular weight markers. The second program, MAP, uses those standard 
curves to interpolate the molecular weights of restriction fragments 
generated by partial restriction digests, and formats the restriction 
map data for the map comparison programs . 
The map comparison programs are MAPCOMPARE and MULTICOMPARE. 
Given an ordered array of restriction fragment lengths generated by 
digests of any number of clones by a single enzyme, MAPCOMPARE compares 
the maps and determines which are likely to represent clones of the same 
gene. In essence, the program calculates the variance between the 
l ogically comparable fragments for each pair of clone. MULTICOMPARE 
runs MAPCOMPARE as a subroutine. It allows comparison of the data from 
any number of restriction digests of the same set of clones, increasing 
the probability of correctly identifying redundant clones. 
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rE~REGRESSION ;rA;rB;rC;rD 
(11 'Enter vector of molecular weights' 
(21 rA~lO~ 
(31 'Enter vector of gel positions' 
(41 rB+{] 
(51 ~(Out,Reg)(l+(prA)=prBl 
(61 out.' The # nolecular weights # # gel positions' 
(7J ~o 


























D~' Coefficients are ',IrD (1; 1 
rE~rD(l;l 
, , 
D~'Calcd nws' ,6 Ol10*+/rD'rBo.* (O,~rC) 
D~'real nws ',6 Ol10*rA 
HAP ;1lA;mE;mC;mD;N 
'What are the coefficients of the standard curve?' 
1lA+{] 





'What is the name of cDNA # ',IN 
cName(N;1~6TmC~ 
'Enter the gel band positions of ',cName(N;l,' in ascending order' 
cHap(N;J~10T~mD+{] 
N~N+l 
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Appendix D 
Partial cDNA sequnces of mid-SR clones 
Sean V. Tavtigian and Julianne M. Rogers 
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LOCUS 18-01 243 BP DS-DNA UPDATED 11/30 /90 
DEFINITION - Tenascin 
ACCESS I ON - D90343 
LENGTH - 1320 
SOURCE - Balb/c 3T3 
BASE COUNT 61 A 60 C 69 G 53 T 0 
OR I GIN ? 
18-01.5 Length: 243 Dec 4, 1990 - 04:47 PM Check: 1 657 .. 
1 GCCC=TGT AGAGTACCGC GTCAGTGTGA TTGCCATGAA 
61 CAGTCTCGGG GACTCTAATC ACAGCTCTGG ATGGTCCATC 
121 TCACAGACTC AGAAGCCTTG GCCATGTGGC AGCCAGCCAT 
181 TCATCTCCTA CACA=GAG AGAGTGCCAG AAGTTACACG 
241 TGG 
// 
LOCUS 18-06 259 BP DS-DNA 
DEFINITION - melanoma growth stimulatory activity 
ACCESSION - X12510 
LENGTH - 1175 
SOURCE - Ba1b/c 3T3 









18-06 . 5 Length: 305 September 19 , 1990 15:38 Check : 999 1 
1 ggtaccggat cgaattcgaa ccct t cggTA ACTCCAAAAA TTAATCCCAA 
51 ATTGATCGCT AATTTGGAGG TGATCCCTGC AGGTCCACAG TGCCCTACGG 
101 TGGAAGTCAT AGCTAAACTG AAAAACCAGA AGGAGGTCTG TCTGGATCCA 
151 GAAGCTCCTG CGATAAAGAA AATCATTCAG AAAATATTGG GCAGTGACAA 
20 1 AAAGAAAGCT AAGCGGAATG CACTCGCAGT GGAAAGAACG GCCAGTGTTC 




288 BP DS-DNA UPDATED 12/04/90 






- Balb/c 3T3 
63 A 
ORIGIN ? 
18-09.5 Length, 288 
90 C 65 G 70 T o OTHER 
Dec 4, 1990 - 04,48 PM Check , 3160 .. 
1 CCTTCGCCCA AACCCAAACC ATATCTGGGG CGGTGGGATT CTCTACTGCC AAGCACCCAT 
61 CCTTGGAAGA AAGTTGTTGG CTGATATGCT GATGCTTCCT TGACGTCACC AGAGAGTCCT 
121 CCTCTAGCCA CCAAATATGG CCCCGTCCAT CCTCAATTAC ATACACTCGG GGCCTCCCCA 
181 GCTGCCATAC CACTGGCGCC ACTCTTGAGG GTGGCTGCTG GGTCACACAC TGAGGTCTTC 
241 CACATCCATA TCATCAAGTT CTGATGGTGG TTCAGGTCTT AGCAAGAG 
II 
LOCUS 18-10A 298 BP DS-DNA UPDATED 08/25/90 
DEFINITION - mouse T1 protein 
ACCESSION - M24843 
LENGTH - 2300 
SOURCE - Balb/c 3T3 
BASE COUNT 91 A 67 C 59 G 66 T o OTHER 
ORIGIN ? 
18-10A 5 ' Length, 298 Sep 4, 1990 - 10,00 AM Check, 9682 .. 
1 ACATAAAAAG CCCGCCAAGC TGCAATATCC CTGATTATTT GATGTACTCG ACAGTACGTG 
61 GATCAGATAA AAATTTCAAG ATAACGTGTC CAACAATTGA CCTGTATAAT TGGACAGCAC 
121 CTGTTCAGTG GTTTAAGAAC TGCAAAGCTC TCCAAGAGCC AAGGTTCAGG GCACACAGGT 
181 CCTACTTGTT CATTGACAAC GTGACTCATG ATGATGAAGG TGACTACACT TGTCAATTCA 




273 BP OS-DNA UPDATED OS/16/90 
DEFINITION - lactate dehydrogenase 
ACCESSION - M27554 
LENGTH - 780 
SOURCE - Balb/c 3T3 
BASE COUNT 62 A 67 C 
ORIGIN 7 
77G 67 T o OTHER 
IS - 10b.5 Length, 343 September 19, 1990 15,40 Che c k, 2593 
1 ggtaccggat c gaattcgaa ccc ttcggAA TCCTTAGGCG GGTGCATCCC 
51 TAAACCACCA TGATTAAGGG TCTCTATGGA ATCAATGAGG ATGTCTTCCT 
101 CAGTGTCCCA TGTATCCTGG GACAAAATGG AATCTCGGAT GTTGTGAAGG 
151 TGACACTGAC TCCTGAGGAA GAGGCCCGCC TGAAGAAGAG CGCAGACACC 
20 1 CTCTGGGGAA TCCAGAAGGA GCTGCAGTTC TAAAGTCTTC CCCGTGTCCT 
251 AGCACTTCAC TGTCCAGGCT GCAGCAGGGC TTCTAGGCAG ACCACACCCT 
301 TCTCGTCTGA GCTGTGGTTA GTACAGTGGT GTTGAGATGG TGT 
II 
LOCUS IS-16 295 BP OS-DNA UPDATED 11 /02/90 







- Balb/c 3T3 
62 A 
ORIGIN ? 
18 - 1 6 . 5 Le ngth , 295 
1 TTCGCATCTA CGAGGGCTAT 
61 GGGACCTGAC AGACTACCTC 
121 CAGCTGAGAG GGAAATCGTG 
181 TCGAGCAGGA GATGGCCACT 
241 CTGACGGCCA GGTCATCACT 
II 
88 C 80 G 65 T o OTHER 
Nov 1, 19 90 - 04, 39 PM Check: 5972 .. 
GCTCTCCCTC ACGCCATCCT GCGTCTGGAC CTGGCTGGCC 
ATGAAGATCC TGACCGAGCG TGGCTACAGC TTCACCACCA 
CGTGACATCA AAGAGAAGCT GTGCTATGTT GCTCTAGACT 
GCCGCATCCT CTTCCTCCCT GGAGAAGAGC TATGAGCTGC 
ATTGGAACGA GCGGTTCCGA TGCCTGAGGC TCTTT 
LOCUS 18-23 
179 
227 BP DS-DNA 
DEFINITION - not identified 
ACCESSION 
- 660 LENGTH 
SOURCE 
BASE COUNT 
- Balb/c 3T3 
58 A 
ORIGIN ? 
34 C 58 G 
UPDATED 02/07/91 
77 T o OTHER 
18-23.5 Length: 227 Feb 6 , 1991 - 11:15 AM Check: 6022 . . 
1 CCCCTTCGAT ACAATI'TAAT TCCAGATTTC TrTTTGG= GCTTAAGTGG CATCAAATI'T 
61 TGGTATATI'T CTGTCTTATG TTAAAGAAAT ATATTGCTAA AATGTCA= AGCGCTAATG 
121 TCAGCTGTCA AGGACTAGAT TTACTTTCGC AGGATATGGA GCTCAGTGAG CTGAGGTGGT 
181 GAGGTGTATG TGATCTGTGG GAATTCTGCC ATI'TAACACA GGAGGTT 
II 
LOCUS 18-29 321 BP DS-DNA UPDATED 11/30/90 






- Balb/c 3T3 
78 A 
ORIGIN ? 
18-29 . 5 Length: 321 
1 TTCGAAAGGA TCTATGACAA 
61 TCGAGAGGCA GACATTGTGG 
121 GATTCCATCA GGAACCACCA 
181 CGGAGGTTCT CCTGGGGTCC 
241 TGCTGCGGCT CTGCGCATTC 
301 GCAACATCGA AGATGGCGAC 
/I 
83 C 9lG 69 T o OTHER 
Dec 4, 1990 - 04:50 PM Check: 4063 .. 
TGAGCTGCCC CTGGGCAACA CCTCAGCTTC CAGACAAGCT 
TCTTAGGCTC ACCTAAGCCA GAAGAGATTC CTGCTGCGTG 
TTCTCAATTG CTTCCATGAC TTCTTGTCAG GGAAGCTGAG 
CCGTGGACAA ACTCATTGCA GAAGAGAGCG TGAGTCTCCT 
AGAACATGGT GAGCAGCGGC AGGAGGTGGC TCAGAGAGCA 
T 
LOCUS 18-30B 
DEFINITION - not identified 
ACCESSION 
- 800 LENGTH 
SOURCE 
BASE COUNT 




229 BP OS-DNA UPDATED 12/02/90 
58 C 63 G 44 T o OTHER 
18-30B.5 Le ngth, 229 Dec 4, 1990 - 04,51 PM Ch eck , 7396 .. 
1 TGCTTCCACC TTGGATCCCT GGGCTTTCTG ACCCCCTTCA ACTTTGAGAA CTTCCAATCC 
61 CAAGTGAATC AGGTGATAGA GGGGAATGCC GCTGTCATCC TGAGGAGCCG GCTGAAGGTC 
121 AGGGTGGTGA AAGAGCCCAG AGACAAGAAG ACAGCCATCC ACAACGGCCT CAGTGAAAAT 
181 GGTCTGGACA CAGAGGGCGG AAAACAGGCT ATGCAATACC AGGTCTTAA 
II 
LOCUS 18-32 282 BP OS-DNA UPDATED 12/02/90 
DEFINITION - liver thiol transferase 
ACCESSION - M31453 
LENGTH - 1280 
SOURCE - Ba1b/c 3T3 
BASE COUNT 76 A 78 C 62 G 66 T o OTHER 
ORIGIN ? 
18-32.5 Length, 282 Dec 4, 1990 - 04,52 PM Check: 5237 . . 
1 ACCATTACTT TCAACTGCAC GTTCCTCCCT GGAGAAGCTG CAGCCTGTCA GCATGGCTCA 
61 GGAGTTTGTG AACTGCAAGA TCCAGTCTGG GAAGGTGGTC GTGTTCATCA AGCCCACCTG 
121 CCCCTACTGC AGAAAGACCC AAGAAATCCT CAGTCAACTG CCTTTCAAAC AAGGTCTTCT 
181 GGAGTTTGTG GACATCACAG CCACTAACAA CACCAGTGCG ATTCAAGATT ATTTACAACA 




296 BP DS-DNA 
DEFINITION - glyceraldehyde-3-phosphate dehydrogenase 
ACCESSION - M32599 
LENGTH - 600 
SOURCE - Ba1b/c 3T3 
UPDATED 10/25/90 
BASE COUNT 62 A 89 C 83 G 62 T o OTHER 
OR I GIN ? 
18-33 . 5 Length: 296 Oct 24, 1990 - 12:16 PM Check: 
1 TTCGGGGCCC AGAACATCAT CCCTGCATCC ACTGGTGCTG 
61 ATCCCAGAGC TGAACGGGAA GCTCACTGGC ATGGCCTTCC 
121 TCCGTCGTGG ATCTGACGTG CCGCCTGGAG AAACCTGCCA 
181 GTGGTGAAGC AGGCATCTGA GGGCCCACTG AAGGGCATCT 
241 GTTGTCTCCT GCGACTTCAA CAGCAACTCC CACTCTTCCA 
II 
LOCUS 18-34 282 BP DS-DNA 
DEFINITION - not identified 
ACCESSION 
- 2900 
















BASE COUNT 74 A 63 C 62 G 83 T o OTHER 
ORIGIN ? 
18-34.5 Length: 282 Oct 24 , 1990 - 12:16 PM Check: 4092 .. 
1 CTTCGTTTGT AATCCCTTCA CAGTCCCAGG TTTAGTGAAA AACTGCTGTA AACACGGGGG 
61 ACACAGTTTA ACAATGCAAC TTTTAATGAC TGTTTTCTTT TTCCTTAACT TACTAATAGT 
121 TTGTGGATCT GATAAGCAAG GGTGTGTGGT TGAAGAAAAC CTCTGTGGTG GGCTTAATCA 
181 GTCACTACTA CTATGCAAAC CCTAAACCGG CACCCTGGTG ACCGGGGGCA TTCGTATAAG 




343 BP DS-DNA 
DEFINITION - ornithine decarboxylase 
ACCESSION - Ml0624 
LENGTH - 1070 
SOURCE - Balb/c 3T3 
UPDATED 10/25/90 
BASE COUNT 100 A 82 C 79 G 82 T o OTHER 
ORIG IN ? 
18-36.5 Length, 343 Oct 24, 1990 - 12,17 PM Check: 
1 CTTCGGCTTC TCCCAGTGTA ATCAACCCAG 
61 GAGTGAGAAT CATAGCTGAG CCAGGCAGAT 
121 TCAACATCAT TGCCAAAAAA ACCGTGTGGA 
181 AGTCAAATGA ACAAACCTTC ATGTATTATG 
241 GCATTCTTTA TGATCATGCC CATGTGAAGG 
301 AGAAGTATTA CTCATCCAGC ATCTGGGGAC 
// 
LOCUS 18-41 302 BP DS-DNA 
DEFINITION - heat stable antigen 
ACCESSION - M58661 
LENGTH - 1850 















BASE COUNT 61 A 95 C 76 G 70 T o OTHER 
ORIGIN ? 
18-41.5 Length, 302 Nov 1, 1990 - 04,40 PM Check, 803 .. 
1 TTCGCGAACA TCTAGAGAGT CGCGCCGCGC GCCGACGGAG CGGACATGGG CAGAGCGATG 
61 GTGGCCAGGC TAGGGCTGGG GTTGCTGCTT CTGGCACTGC TCCTACCCAC GCAGATTTAC 
121 TGCAACCAAA CATCTGTTGC ACCGTTTCCC GGTAACCAGA ATATTTCTGC TTCCCCAAAT 
181 CCAAGTAACG CTACCACCAG AGGGGGTGGC AGCTCCCTGC AGTCCACAGC TGGTCTCCTG 





251 BP DS-DNA 
DEFINITION - not identified 
ACCESSION 
LENGTH - 620 
SOURCE - Balb/c 3T3 
BASE COUNT 56 A 50 C 55 G 
ORIGIN ? 
UPDATED 10/19/90 
90 T o OTHER 
18-47 5 ' Length: 251 Oct 20, 1990 - 09:15 PM Check : 5395 .. 
1 ACATTGCTTT TGAAATTTCA AAAGTCATTT TAATACACAC TCACTGAGCT GCCCATGTGT 
61 TTTTAATTGT GCTACCATAG AAGTTCTGTG GAAGATTTTA TTATTGTTGG TTTGATTTTG 
121 GI IIITTAGA GGTGGGGTCT TGCTATGTAG CCCAGGCTGG TCTTGAACTT GCTATGTAGC 
181 CTGACTGGTC TTGAACCCCT GACCTCCTGT GTCCCAAGTG CTAGGATCAC AAAAGACATC 
241 TCCATGCCTG G 
// 
LOCUS R8-01 304 BP DS-DNA 
DEFINITION - Alpha-1 (3) collagen 
ACCESSION - X06700 
LENGTH - 1460 
SOURCE - Balb/c 3T3 
BASE COUNT 74 A 76 C 
OR I GIN ? 
R8-1.5 Length: 304 Nov 
97 G 57 T 
1, 1990 - 04:41 PM 
UPDATED 11/02/90 
o OTHER 
Check : 4582 .. 
1 TTCGTGGAGC TCGAGGTGCT CCGGGTCCCC AAGGTCCACG AGGTGACAAA GGTGAAACTG 
61 GTGAACGTGG CTCTAATGGC ATCAAAGGAC ATCGAGGATT CCCTGGCAAT CCAGGTCCTC 
121 CAGGTTCTCC TGGTGCTGCT GGTCACCAGG GTGCAATTGG TAGTCCAGGA CCTGCAGGTC 
181 CCAGAGGACC AGTTGGACCA CATGGACCTC CTGGAAAAGA TGGAACAAGT GGGCATCCAG 
2 41 GTCCTATTGG ACCACCAGGT CCTAGAGGAA ACAGAGGTGA AAGAGGATCT GAGGGCTCGC 




283 BP OS-DNA 
DEFINITION - Elongation factor 1 
ACCESSION 
- 1800 
- Balb/c 3T3 
LENGTH 
SOURCE 
BASE COUNT 89 A 63 C 77G 54 T 
ORIGIN ? 
R8-9.5 Length, 283 Feb 13, 1991 - 11,21 PM 
1 GGGAGCGGGT TTGCCGTCAG AACGCAGGTG TTGTGAAAAC 
61 AATGGGAAAG GAAAAGACTC ACATCAACAT CGTCGTAATC 
121 GTCCACCACA ACCGGCCACC TGATCTACAA ATGTGGTGGA 
181 AAGTTTGAGA AGGAGGCTGC TGAGATGGGA AAGGGCTCCT 
241 GACAAACTGA AGCTGAGCGT GAGGCTGGTA TCACTATTCG 
II 
LOCUS R8-26 315 BP OS-DNA 
DEFINITION - Alpha-1 (6) collagen 
ACCESSION - J04598 
LENGTH - 2300 
SOURCE - Balb/c 3T3 












R8-26.5 Length, 315 Nov 1, 1990 - 04,41 PM Check, 1755 .. 
1 TTCGGGAGAC CCAGGAGAGG ATAACAACGA CATTTCACCC CGTGGGGTCA AAGGGGCAAA 
61 GGGATACCGA GGCCCAGAAG GACCCCAGGG ACCTCCAGGA CATGTGGGAC CACCTGGGCC 
121 AGATGAGTGT GAGATCCTGG ATATCATCAT GAAAATGTGC TCCTGCTGTG AGTGCACATG 
181 TGGACCCATT GACATCCTCT TCGTGCTGGA CAGCTCGGAG AGCATTGGCC TACAGAACTT 
241 TGAGATTGCC AAGGACTTCA TCATCAAGGT CATTGACCGG TTGAGCAAGG ATGAGCTGGT 
301 CAAATTTGAG CCAGG 
II 
